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ABSTRACT 
The purpose of this thesis is to assess the need for TB/HIV collaborative programming in 
Saskatchewan through a needs assessment process. 
Globally, the occurrence of Tuberculosis (TB) and Human Immunodeficiency Virus/Acquired 
Immunodeficiency Deficiency Syndrome (HIV/AIDS) in a population has always turned out to 
be a deadly combination with each disease entity potentiating the prevalence, morbidity and 
death rate of the other.  According to the World Health Organization (WHO, 2012) this 
syndemic and synergistic interaction between both diseases resulted in one-third of people living 
with HIV/AIDS worldwide being infected with TB. HIV-positive people are nearly twenty times 
more probable to develop TB when compared to HIV- negative people (WHO, 2012). Thus, both 
diseases acts in synergy to potentiate the deterioration of immunological functions thereby 
leading to an elevated mortality rate. According to the Public Health Agency of Canada (PHAC), 
in 2015, the prevalence of TB and HIV in Saskatchewan was two times the national average, and 
the Indigenous peoples were over-represented in incidence and prevalence (PHAC, 2016). 
Therefore, these infections are of significant public health importance for Saskatchewan and 
require urgent intervention. 
The needs assessment employed qualitative research methods by conducting semi-structured 
interviews with 19 participants who were either administrators or clients in either the TB or HIV 
programs in Saskatchewan.  Participants were interviewed using questions derived from the 
PRECEDE framework of the PRECEDE-PROCEED model.  A combination of both deductive 
and inductive analytical processes using the PRECEDE model as the framework were utilized to 
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analyze and interpret the results with apriori themes derived from the PRECEDE model, and 
emergent themes from the data.  
The results show that the PRECEDE model was effective as a needs assessment tool for TB and 
HIV co-programming.  The PRECEDE model allowed development of an effective assessment 
tool including appropriate range of interview questions and apriori and emergent evaluation 
codes within the areas of social, epidemiologic, behavioral, environmental, educational, 
ecological, administrative, and policy. The results enunciated cultural, socio-economic, 
behavioral and administrative factors that increase the transmission of TB and HIV in 
Saskatchewan, particularly among the Indigenous peoples. The socioeconomic conditions 
identified were poverty, adverse effects of residential school system, low level of education, and 
abuse (physical, sexual and emotional). Behavioral factors of importance included a highly 
mobile population; living chaotic lifestyles as a result of drug addiction, prostitution, alcoholism; 
unprotected sex; and needle sharing. Environmental factors that were identified included the 
large geographical area in Saskatchewan and a large patient population in the rural and remote 
areas of the province. Educational factors identified were comprised of predisposing, reinforcing 
and enabling factors.  The predisposing factors were related to inadequate knowledge about the 
mode of transmission of TB and HIV. Stigmatization was a significant reinforcing factor of 
importance such that patients received minimal support from peers and community members. 
Enabling factors for consideration included inadequate qualified health personnel and a poor 
staffing situation made worse by large turnover.  Furthermore, recruitment of specialists to work 
in rural and remote areas of Saskatchewan is very challenging. Therefore, health facilities 
depend mostly on visiting specialists. The financial resources are inadequate, and this situation is 
compounded by multijurisdictional funding in off/on reserve communities in northern 
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Saskatchewan. Appointments to see service providers or specialists are difficult to arrange due to 
chaotic lifestyle, high mobility, lack of telephone services and homelessness. Diagnosis of 
administrative and policy factors reveal areas of gaps in the implementation of present programs.  
Gaps enumerated by participants are lack of coordination between separate TB and HIV 
programs, especially in data gathering. Other gaps are different locations of TB and HIV 
laboratories in Saskatchewan, difficulty with transportation in rural and remote areas, and 
difficulty getting TB and HIV medication.  
 There is a consensus among the participants about the desirability of establishing at least some 
form of TB/HIV collaborative program in Saskatchewan, but the ideal model of collaboration is 
not established.  Program officers favored the referral model while patients in the study favored 
the integrated model (one-stop). No matter the model, the desired goal of all participants was to 
reduce TB and HIV in Saskatchewan. To achieve this end, the results reveal that it is vital that 
there is effective coordination between TB and HIV programs to ensure that patients can access 
the care they need from both services. It is recommended that the various social, 
epidemiological, educational, behavioral and administrative factors that affect the epidemiology 
of TB and HIV in Saskatchewan, as identified in the PRECEDE model, be taken into 
consideration in the design of appropriate intervention and evaluation strategies. Furthermore, 
the entire planning and implementation of collaborative programming should follow WHO’s 
(2012) guidelines on TB/HIV collaborative services.  A Saskatchewan TB/HIV collaborative 
program that addresses the unique nature of the two diseases in the province, which is well 
designed, implemented, adequately funded, and purposefully evaluated, would result in a 
sustainable reduction of TB and HIV diseases in Saskatchewan. 
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1 THESIS OVERVIEW 
This thesis explores how collaborative activities between TB and HIV control programs 
in Saskatchewan can be established through evidenced-based needs assessment methods.  
According to the Public Health Agency of Canada (PHAC, 2016) in 2015, the prevalence of TB 
and HIV in Saskatchewan was two times the national average. Furthermore, the situation of HIV 
in on-reserves in Saskatchewan is alarming.  Of the 170 new cases of HIV in the province, 79 
percent self-identified as Indigenous people.  There is geographical diversity in the HIV crisis in 
Saskatchewan with large urban centers seeing decreases (27-38%) and some rural areas seeing 
percent change increases as high as 800% over a 9-year period (Saskatchewan Ministry of 
Health, 2017).  The rate of TB in Saskatchewan is 7.5 cases per 100,000 compared to a national 
rate of 4.7 cases per 100,000, 54% of TB cases occurring in the Indigenous population in 
Northern Saskatchewan, home to 3.6% of the provincial population (Saskatchewan Ministry of 
Health, 2017).  At present, the province runs separate TB and HIV control programs, an 
arrangement which to-date has not resulted in a reduction in the infection rates of TB and HIV. 
The high infection rates of both TB and HIV in Saskatchewan is of great public health 
importance.  The fact that each disease potentiates the prevalence, morbidity and mortality of the 
other, makes an urgent case to vigorously pursue policy options such as TB and HIV 
collaborative programming. 
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1.1 Thesis Organisation 
This thesis is organised into three distinct papers with appendices. The introduction 
comprises the objective for embarking on the research, the rationale for the study and the 
research questions that direct the process and methods of this research. 
The decision to embark on this topic for my doctoral thesis emanated from having 
firsthand knowledge of data on TB and HIV incidence and prevalence from my time as the 
Medical Health Officer in a First Nations organisation in Prince Albert, Saskatchewan. There 
was the realization that if nothing is done to improve service delivery to combat the rising 
incidence of TB and HIV, it may lead to catastrophic consequences in Saskatchewan.   
The overall direction for this thesis was based on my clinical and public health 
experience in which to treat an individual you have to take a history, conduct laboratory 
investigations, and use the data collected to decide on the management of the disease.  In this 
thesis, the same approach was employed at the population level.  In this study, the PRECEDE 
aspect of the PRECEDE-PROCEED model was analysed as a framework to be used to collect 
the history of TB and HIV service delivery in Saskatchewan (Paper 1). Data collected was 
analyzed by describing the participant views by theme or sub-themes, looking for the range of 
association and defining concepts to describe objectives (Paper 2). Finally, the results were used 
to develop recommendations for policy guidelines on TB/HIV collaborative services for 
Saskatchewan (Paper 3).  
 1.1.1 Paper 1: Using the PRECEDE model to develop an assessment tool for TB/HIV co-
infection control programming 
This paper describes the use and applicability of the PRECEDE aspect of the PRECEDE-
PROCEED model as a framework for conducting a needs assessment for TB/HIV collaborative 
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programming. The PRECEDE model is an acronym for Predisposing, Reinforcing and Enabling 
Constructs in Educational Diagnosis and Evaluation. This model was developed by Green and 
Kreuter (Green and Kreuter, 2005), and is a widely applied tool for health planning. This model 
is particularly suited for diseases like TB and HIV that are specifically associated with complex 
social, behavioural and environmental factors. The model was used as a guide to formulate 
interview questions for the needs assessment of HIV/TB collaborative programming that would 
elicit the social, behavioural and environmental factors that affect the TB and HIV diseases in 
Saskatchewan. The results from this paper were used for data collection and analysis for Papers 2 
and 3.  
1.1.2 Paper 2: A Needs Assessment of TB/HIV Collaborative Programming in Saskatchewan 
A needs assessment for TB and HIV co-programming in Saskatchewan was conducted 
using the PRECEDE model as described in Paper 1.  The needs assessment involved a systematic 
approach to data gathering and analysis to identify the population health needs and priorities, the 
situation analysis of TB and HIV in the population, the present state of implementation of 
intervention programs, and met and unmet needs related to the current TB and HIV programs. 
1.1.3 Paper 3: TB/HIV collaborative program: Policy guidelines on implementation in 
Saskatchewan 
This paper is a guide for the implementation of a TB/HIV collaborative program in 
Saskatchewan through utilization of data collected using the method from Paper 1 and data 
analysis from Paper 2, as well as the utilization of standard evidence-based best practices as 
described by the World Health Organization (WHO, 2012).   
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1.2 Rationale 
The literature indicates that TB and HIV infections potentiate the incidence, prevalence, 
morbidity and mortality of each other in a synergistic manner. TB and HIV share a common 
connection whereby HIV prevention, care and treatment should be a priority for the TB program; 
likewise, TB care and prevention should be a priority for the HIV program. Furthermore, 
implementing a collaborative TB/HIV program will lead to shared benefits by reducing mortality 
of these diseases in the population. According to WHO, an estimated 910,000 lives were saved 
globally over six years by improving collaboration between TB and HIV services (WHO, 2012).  
Saskatchewan currently operates its HIV and TB programs as silos with minimal overlap and 
collaboration.   
It has been posited that TB/HIV joint programming will allow for better health outcomes 
by efficient use of funds and other investments that are available for separate TB and HIV 
control programs. (Howard et.al, 2010). According to The Global Fund (2010), stronger 
collaborative services can be achieved through identification of areas of service alignment and 
support system already in place.  
The purpose of this research was to undertake a needs assessment for a TB/HIV 
collaborative program in Saskatchewan using qualitative research methods to understand the met 
and unmet needs and gaps for TB and HIV co-programming activities in Saskatchewan 
1.3 Research Questions 
In this project the needs assessment included a systematic review of the health issues 
facing a population. It assessed the size of the specific problem, current services that address this 
problem and their effectiveness, and the risks and benefits of a specific intervention (Bani, 
2008). The process also identified the unmet health and healthcare needs of a population that 
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would eventually enable the delivery of cost-effective services that would decrease the burden of 
TB and HIV in the population. To achieve this, my study is based on the following research 
questions: In Saskatchewan, 
1. What are the present intervention programs provided towards control of HIV and TB, 
and the various organizations and stakeholders that provide these services? 
2. What are the human, material and financial resources available for HIV and TB control 
programs, the service capacity and capability, and the barriers to accessing the 
services?   
3. What are the gaps (met and unmet needs) in HIV and TB programs? 
4. What are the collaborative TB and HIV key interventions that will decrease the burden 
of infection in the population affected by both diseases?  
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2. LITERATURE REVIEW 
2.1 The Global Burden of TB and HIV 
2.1.1 Tuberculosis 
 Mycobacterium tuberculosis bacteria causes Tuberculosis (TB), this disease is both 
curable and preventable, but constitutes a significant global public health concern regarding its 
contribution to significant morbidity and mortality in the world. According to WHO (2017a), the 
incidence rate of TB reported worldwide was 10 million and the highest percentage occurred in 
the South-East Asia Region (45%) followed by the African Region (25%) followed by the Western 
Pacific Region (17%), Mediterranean Region (7%), European Region (3%) and the Americas 
(3%). This same report also indicated that 1.7 million people died from TB worldwide 
(approximately 24% of this death is among those co-infected with HIV). Furthermore, greater than 
95% of TB deaths are found in low- and middle-income countries namely, India, Indonesia, China, 
Philippines, Pakistan, Nigeria, and South Africa.  
2.1.1.1  TB in Canada and Saskatchewan 
The incidence rate of TB in Canada in 2016 was 4.8 per 100,000, with 93% reported as 
new cases and 5% as retreatment cases. According to Vachon et al., (2018) the majority of TB 
cases in Canada occur among foreign-born individuals (71%), that is, those that came from 
countries where the prevalence of TB is high, followed by Canadian born Aboriginal people 
(17%), and then Canadian born non-Aboriginal (11%) cases. Regarding the geographic 
distribution of TB in Canada, there are areas with high and low incidence. The incidence rate in 
Nova Scotia is 0.2/100,000, Manitoba, Alberta, and Newfoundland 4.8%/100,000, and Nunavut 
at 143/100,000 (Vachon et al., 2018).   
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 The current rate of TB in Saskatchewan is 7.5/100,000. This one of the higher rates of  
TB among the Canadian provinces when compared to the Canadian national average of 4.7 per  
100,000 (Gallant et al, 2017). According to the 2013-2018 Saskatchewan Provincial TB strategy 
(Saskatchewan Ministry of Health, 2013), 54% of TB cases are in the northern Saskatchewan 
Indigenous population health districts of Mamawetan, Churchill River, Keewatin Yatthe and 
Athabasca, in which merely 3.6% of Saskatchewan population resides. In addition, rates of TB on-
reserve is twice that of off-reserve rates in Saskatchewan (Long et al., 2013).   
NOTE:  On December 4, 2017, the Saskatchewan Government transitioned from 12 regional health 
authorities to a single Saskatchewan Health Authority. 
2.1.1.2 Population most at risk 
In Saskatchewan, the majority of cases are in First Nations (42.9/100,000), Métis 
(29.1/100,000) and the northern population rather than foreign-born (14.5/100,000) 
(Saskatchewan Ministry of Health, 2013, pg.3). According to Long et al. (2013), in Alberta and 
Saskatchewan, on-reserve rates were more than twice that of off-reserve. The TB rates in the Métis 
and Registered Indians were similar in Saskatchewan (50.0 and 52.2 per 100,000 person-years, 
respectively). TB rates are highest in First Nations living on-reserve in the north together with 
others residing off-reserve in the three northern health authorities of Mamawetan, Churchill River, 
Keewatin Yatthe, and Athabasca (Long et al., 2013).  Most importantly, this area comprises only 
3.6% of the population but experiences 54% of the TB cases in Saskatchewan (Saskatchewan 
Ministry of Health, 2013, p. 3). 
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2.1.1.1 National and Provincial Response to TB 
Two federal healthcare agencies are responsible for implementing the federal framework 
for TB prevention and control in Canada. First, the Public Health Agency of Canada (PHAC), 
which provides national leadership related to the public health aspects of TB. Second, Health 
Canada, through Indigenous Services Canada handles TB on-reserve in First Nations 
communities. 
According to the Pan-Canadian Public Health Network (2012) and the Saskatchewan 
Provincial Tuberculosis strategy, 2013-2018 (Saskatchewan Ministry of Health, 2013), the 
national and the provincial goals are to reduce the incidence of reported TB to 3.6 per 100,000. 
The strategies to achieve this goal are unequivocal and prompt attention to early detection, 
treatment, and prevention of both active and latent TB in the population. Early detection of TB 
includes contact tracing and screening of high-risk populations, and aggressive treatment with 
anti-tuberculosis drugs to prevent treatment failure, drug resistance, and co-infection with HIV. 
Prevention activities that include health education that is pertinent to the culture of the 
population. 
2.1.2 HIV 
2.1.2.1 Globally 
According to the UNAIDS (2017), the prevalence of HIV globally is 36.9 million people 
and 1.8 million people were newly infected. One million people died of HIV-related illnesses 
worldwide in 2017, while 67% of all persons infected with HIV live in sub-Saharan Africa (World 
Health Organization, 2016). Globally, there are key populations that are at high risk of acquiring 
HIV, these are, men who have sex with men (MSM), intravenous drug users, female sex workers 
and transgender women, in descending order (UNAIDS, 2017). 
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2.1.2.2 HIV in Canada and Saskatchewan 
 Canada is classified generally as having a low HIV prevalence, but with a concentrated 
epidemic among some populations designated as high-risk.  In 2016, new cases reported in 
Canada was 2,344, and the total prevalence of HIV since reporting began in 1985 was 88,409 
(Bourgeois et al., 2017a). The same report also indicated variations of HIV incidence and 
prevalence across the country with Saskatchewan reporting the highest rate of new cases (15.1 
per 100,000), which is more than double the entire Canadian rate. In terms of age-sex 
distribution, Bourgeois et al., (2017b) posited that the highest rate of new cases occurs in ages 
between 30-39 years, and more men are diagnosed with HIV than women. 
2.1.2.3 Populations at Risk 
In Canada, the population at risk are MSM, people from countries with high incidence of 
HIV, Aboriginal populations, and inmates of correctional centres (Bourgeois et al. 2017b).  In 
2016, the men who have sex with men (MSM) accounted for a significant number of all reported 
HIV cases in adults (44.1%), followed by heterosexual contact (32.3%), and injection drug use 
(IDU) constituted the third most reported exposure category (15.1%) (Bourgeoise et al., 2017b).  
In addition, 40.4% of HIV cases are reported in whites, followed by 21.2% in Blacks and 21.2% 
in Aboriginal people. Among the Indigenous peoples, HIV was reported in 19.0% in First 
Nations, 1.6% in Métis, 0.4% in Indigenous-unspecified, and 0.3% among Inuits (Bourgeoise et 
al., 2017b). 
  According to the Saskatchewan Ministry of Health (2017a), the HIV rate in 2016 in 
Saskatchewan was 14.5/100,000, more than twice the national average. In the same year, 170 
people were newly diagnosed with HIV, with a significant increase of cases seen in Regina, 
Saskatoon and Prince Albert Parkland Health Region. More importantly, there was a notable 
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shift from urban to rural communities in the number of those infected with HIV. Those who self-
identified as Aboriginal people remain the most common group of those newly diagnosed.  In 
addition, eight in ten of newly diagnosed cases in Saskatchewan are females of child-bearing age 
(15-45 years) (Saskatchewan Ministry of Health, 2017b).  Due to the sensitive nature of HIV 
infection, it is difficult to obtain accurate numbers of those who have the disease. 
2.1.2.4 Provincial Response to HIV 
A provincial leadership team was established to implement an HIV strategy for 
Saskatchewan in response to a 2008 report that showed that Saskatchewan’s HIV rate was twice 
the national rate. According to Saskatchewan Ministry of Health (2017a pg. 10), the HIV rates in 
Saskatchewan still remains two times the national rates.  It was proposed then that the provincial 
team will implement the Saskatchewan HIV initiatives (Saskatchewan Ministry of Health, 2010, 
pg. 3) under four main categories and these are; 
 a) Community engagement and education. The activities entail community-
based programs, for example, education, information events, school-based 
curriculum development, and social marketing. b) Prevention and harm 
reduction, this involves, provision of easy access to HIV testing, support for 
programs that prevent high-risk behaviors and increase harm reduction 
services. c) Clinical management that supports mentorship and training of 
health care providers in prevention and harm reduction activities. Also, provide 
incentives that will encourage essential staff retention especially in rural and 
remote areas. d) Increase HIV surveillance and case detection. 
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Overall, there is an HIV epidemic in Saskatchewan with identified subgroups at greater 
risk for the disease.  Current provincial strategies to address the HIV epidemic have 
resulted in some success, but the epidemic persists and requires strategic attention. 
2.1.3 TB and HIV: A Deadly Syndemic 
The occurrence of Tuberculosis (TB) and Human Immunodeficiency Virus/Acquired 
Immunodeficiency Deficiency Syndrome (HIV/AIDS) in a population has always turned out to 
be a deadly combination, with each disease entity potentiating the prevalence, morbidity and 
death rate of the other. According to the World Health Organization (2012), this synergistic 
interaction between the diseases resulted in 33% of people living with HIV/AIDS worldwide to 
also have TB infection. Consequently, HIV-positive people are nearly 20 times more likely to 
develop TB when compared with HIV-negative people (World Health Organization, 2012). TB 
thereby presents as the most common opportunistic infection with an elevated mortality rate.  
TB and HIV pose a tremendous public health concern.  There is significant uncertainty in 
the level of co-infection in the country, and this poses considerable challenges in controlling the 
diseases.  It is estimated that the percentage of people with HIV who also have active TB range 
from 1.6% to 5.8%. The number of those infected with TB who are also HIV positive range from 
3.8% to 13.8%. (Harris et al. 2006) 
There are various challenges in patients with dual infection with TB and HIV, these are, 
difficulty in diagnosing TB among HIV patients, drug interaction, overlapping toxicity and tablet 
burden, all of which may reduce adherence and impact morbidity and mortality (Mendelson, 
2007). 
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2.1.3.1 The Syndemic Lens in TB and HIV co-programming 
Syndemic is a term used to describe the aggregation of two or more interrelated 
disease epidemics that interact to exacerbate the prognosis and burden of the diseases 
in a population (Kwan and Ernst, 2011).  Merrill Singer developed the term in the mid-
1990s by describing how infectious diseases intertwine with each other and with social, 
economic, environmental and political constructs in which the population resides 
(Singer et al 2017).   
Syndemic takes an alternative approach to current prevention and control 
strategies and includes policies and programs that address the underlying and often 
structural causes for the diseases.  For TB and HIV this includes the social determinants 
of health, which are similar for the two diseases, and which perpetuate the disease states 
and outcomes including poverty, urbanization, overcrowding, gender inequality, 
inequitable access to resources, and weak health service delivery mechanisms, which 
are often reflective of inadequate funding and political commitment (Karim et al., 2009; 
Padayatchi et al., 2010). As HIV and TB are Syndemic, any HIV/TB co-programming 
strategy must address the structural causes of the disease states. 
2.1.3.2 Current state of TB and HIV programming in Saskatchewan and Canada 
Although the WHO, in 2004, advocated some form of collaboration between TB and HIV 
control programs, and two national advisory bodies in Canada recommended universal HIV 
testing of TB patients (Long & Boffa, 2010), each control program at the national and provincial 
levels still run different programs with distinct human resources and funding. These individual 
programs may be necessary but are inadequate to manage the complex health challenges, 
including the syndemic that characterises the occurrence of these diseases (Steiner et al., 2013). 
13 
 
The implication is that the management of TB and HIV or TB/HIV co-infected patients is often 
fragmented, with little coordination (Seeley et al., 2012).  
In Saskatchewan, the TB program is centrally administered by the Ministry of Health’s 
TB Control Program, based in the city of Saskatoon and works in collaboration with provincial, 
federal, and First Nation partners. The emphasis of the program is on patient-centered care that is 
community and outpatient based.  Implementation is by a multidisciplinary team of healthcare 
professionals that treat and prevent active disease with a focus on children and high-risk 
individuals. The goal of the program is to; “1) eliminate TB within the province through 
surveillance, detection, treatment, and prevention. 2) Build strong relationship and partnership 
with relevant stakeholders” (Saskatchewan Ministry of Health, 2013, pp. 1-2). 
The provincial and federal governments share the cost of TB programming in 
Saskatchewan. First Nations TB programming is more fragmented with the First Nations Inuit 
Health Branch (Indigenous Services Canada) of Health Canada responsible for First Nations and 
Inuit persons living on-reserve while the Saskatchewan Ministry of Health is responsible for all 
persons living off reserve. 
2.1.3.3 Co-programming strategies for TB and HIV 
 It is expected that planning for TB/HIV joint programming will allow for better health 
outcomes through the efficient use of funds and other investments that are available for separate 
TB and HIV control programs as well as identification of areas of service alignment and support 
system optimization of programs already in place (Howard et. al., 2012),   
The desire to implement TB/HIV collaborative programming worldwide prompted the 
WHO’s Stop TB department and the department of HIV/AIDS to establish a global TB/HIV 
working group (Corbett et al., 2010). This group published three policy documents: These are; 
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A) Strategic Framework to Decrease the Burden of TB/HIV (Maher et al., 2002). B) Guidelines 
for Implementing Collaborative TB, and HIV Program Activities (World Health Organization, 
2004). C) Interim Policy on Collaborative TB/HIV Activities (World Health Organization, 
2004).  The final recommended policy for collaborative activities for HIV/TB programming 
(World Health Organization, 2012, pg. 9) is as follows 
“A.   Establish and strengthen the mechanisms for delivering 
integrated TB and HIV services 
▪ Set up coordinating body for collaborative TB/HIV 
activities, functional at Provincial and community).  
▪ Determine HIV prevalence among TB patients and TB 
prevalence among people living with HIV. 
▪ Carry out joint TB/HIV planning to integrate the delivery 
of TB and HIV services. 
▪ Monitor and evaluate collaborative TB/HIV activities 
B.   Reduce the burden of TB in people living with HIV and 
initiate early antiretroviral therapy (the Three I’s for HIV/TB). 
▪ Intensify TB case-finding and ensure high-quality anti-
tuberculosis treatment. 
▪ Initiate TB prevention with Isoniazid preventive therapy 
and early antiretroviral therapy. 
▪ Ensure control of TB infection in healthcare facilities and 
congregate settings. 
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C.   Reduce the burden of HIV in patients with presumptive and 
diagnosed TB. 
▪ Provide HIV testing and counselling to patients with 
presumptive and diagnosed TB. 
▪ Provide HIV prevention interventions for patients with 
presumptive and diagnosed TB. 
▪ Provide co-trimoxazole preventive therapy for TB patients 
living with HIV. 
▪ Ensure HIV prevention interventions, treatment and care 
for TB patients living with HIV.” 
 
The WHO recommended collaborative activities for HIV/TB programming are an 
important framework that should be considered in the development of effective HIV/TB 
co-programming activities. 
2.2 Summary and Gaps 
The literature review revealed the enormity of the TB and HIV epidemic globally, in 
Canada, and particularly in Saskatchewan. HIV causes massive challenges to the control of TB. 
TB is also the leading cause of morbidity and mortality among people living with HIV/AIDS.  In 
Saskatchewan, despite the individual TB and HIV control and prevention programs, the rate of 
these diseases continues to rise. Therefore, Saskatchewan has a very significant issue with TB 
and HIV infection and co-infection, particularly in the rural and northern First Nation 
populations.   
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At present, Saskatchewan still operates individual TB and HIV control programs with 
different management structures. The present strategies have not adequately addressed the 
burden of these infections in Saskatchewan, and in fact, the burden continues to rise in 
Saskatchewan. There is the need for a change of policy that could address the burden of TB and 
HIV in Saskatchewan. Based on the available knowledge, the establishment of a TB/HIV 
collaborative program could allow for the provision of continuity of quality care at service 
delivery level for people with or at risk of TB and HIV.  Collaboration between TB and HIV 
programs could ensure adequate access by those infected with TB and HIV to preventive, 
laboratory, and treatment services. This collaboration has the advantage of minimizing loss 
through service cracks and follow up.  
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3. METHODOLOGY 
3.1 Philosophical Assumption  
This needs assessment for TB/HIV collaborative programming study relies on the 
interpretivist paradigm.  Guba, et. al., (1994) defined paradigm as primary beliefs or worldview 
that controls research action or an investigation. Furthermore, Guba, et. al., (1994) posited that 
this research paradigm consists of its ontology (overall nature of a phenomenon), and 
epistemology (uncovering the knowledge to know the relationship between researcher and 
reality). Interpretivism therefore, is a form of qualitative methodology that relies on both trained 
researcher and human subjects to measure certain phenomenon using unstructured interviews or 
participant observation (Thanh et al., 2015).  The ontology of interpretivist paradigm believe that 
reality is” multiple and relative” (Hudson and Ozanne, 1988; Kivunja, & Kuyini., 2017). Also, 
the interpretivist approach seeks for a culturally derived and historically situated interpretation of 
the social world by going into details to look at culture and how they live (Hudson & Ozanne, 
1988). The epistemology of the interpretivist approach assumes that we cannot separate 
ourselves from what we know and believes that researchers and human subjects are 
interdependent and mutually interactive (Kivunja, & Kuyini., 2017). The interpretivist 
researcher, therefore, enters the field of study with past understanding of the research 
background but believes that this is not enough to be used for a rigid research design (Kivunja, & 
Kuyini., 2017). Furthermore, the researcher remains open to new knowledge throughout the 
study and this develops into an emergent and collaborative approach that is consistent with 
human beliefs and realities, and with the goal to interpret the meaning of human behaviour rather 
than predict cause and effect (Hudson & Ozanne, 1988). This research taps into the real-life 
experiences of health workers, patients and stakeholders with respect to what they consider an 
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appropriate approach to TB/HIV collaborative programming. This paradigm also seeks to 
understand people's perceptions and interpretations of their reality in terms of how they perceive 
prevailing health issues and what motivates their actions and behaviours (Kivunja, & Kuyini., 
2017).  
3.2 Conceptual Framework 
In this research process, the PRECEDE aspect of the PRECEDE-PROCEED model 
(Green & Kreuter. 2005) was used. This model of health promotion has been widely used and 
evaluated (Green et, al., 1996; Binkley et al., 2014; Phillips et al., 2012). 
3.2.1 The rationale for the PRECEDE model 
The PRECEDE model was selected for the following reasons: (1) it is a framework that 
offers a procedural structure for constructing an intervention and framework for critical analysis. 
It allows for an orderly structure that addresses the main issues in my study with the goal of 
improving the quality of life of patients with TB/HIV and the community, (2) several health 
behavior theories are embedded into the structure of the framework namely, a) the health belief 
model, which is a psychological health behavior that attempt to explain and predict health-related 
behaviors as it affect the uptake of health services. b) Health promotion model, which focuses on 
helping people achieve higher levels of well-being through not only helping patients prevent 
illness through their behavior, but in addition looking at ways in which a person can pursue 
better health or ideal health. c) Social learning theory, a theory of learning and social behavior 
which adduces that people learn from one another, via observation, imitation, and modeling.  
(Green & Kreuter, 2005). Hence, this model was seen as appropriate for evaluation of TB/HIV 
collaborative programming, which has complex multidimensional behavioral factors that affects 
its epidemiology. 
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PRECEDE is an acronym for Predisposing, Reinforcing and Enabling Constructs in 
Educational/Ecological Diagnosis and Evaluation and consists of five phases (Green & Kreuter, 
2005. p. 9-17)  
Phase 1: Social Assessment 
Phase 2: Epidemiological Assessment 
Phase 3: Behavioral and Environmental Assessment 
Phase 4: Educational and Ecological Assessment 
Phase 5: Administrative and Policy Assessment 
The key to the PRECEDE model is that it requires logical thinking about the desired end 
goal and then works backwards to achieve this goal. In this study, the goal is to reduce the 
incidence and prevalence of TB and HIV in Saskatchewan through collaborative programming. 
3.3 Data Collection and Data Analysis Process 
 The process utilized for data collection, analysis and interpretation in this study is akin to 
the clinical reasoning approach in medicine.  Data collection using the PRECEDE framework 
(Paper 1) is like taking the history of a patient.  Interpretation of the data (Paper 2) is akin to the 
diagnosis of the condition and developing a policy for TB/HIV collaborative programming in 
Saskatchewan is similar to treatment for the situation (Paper 3).   
3.3.1 Data Collection 
 The Phases of the PRECEDE model were utilized to develop relevant open-ended 
questions for the interviews (Table3.1).  The PRECEDE model was used to create questions that 
would elicit components of social, behavioral, environmental, educational, ecological, 
administrative, and policy factors that affect TB and HIV in Saskatchewan and would be important 
in an effective program model. 
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Table 3.1: Interview Questions and Goals for Data Collection Using PRECEDE Model 
PRECEDE phases Interview Questions 
Phase 1 and 2: Social and 
Epidemiological assessment 
1) Tell me about your role in the organization? 
Probe: defined responsibility 
2) What is your comment on the situation of TB and HIV in the 
community? 
Probe: Explore awareness/attitudes/perception   
 
The goal is to explore the situation analysis of TB and HIV in 
Saskatchewan and  determine how control programs are 
implemented 
Phase 3: 
 Behavioral and Environmental 
assessment 
3) Tell me about the services rendered towards TB and HIV 
control and method of implementation. 
Probe: type of services, resources and coordinating capacity. 
4) What factors affect access to the services? 
5) How adequate are the human, material and financial resources 
towards the implementation of services? 
 
The goal is to examine the reason for the epidemiology of TB and 
HIV infections in the context of socioeconomic, behavioral and 
environmental factors 
Phase 4: 
Educational and Ecological 
assessment 
6) What is your view about TB/HIV collaborative service? 
Probe: Barriers to existing program 
7) How do you think collaborative services will be received by 
healthcare personnel and patients? 
Probe: Specific ways of promoting TB/HIV care, inquire about 
service uptake 
 
The goal is to appraise the effectiveness the present TB and HIV 
control program. Identify gaps and the need for co-infection 
programming. Also identify pros and cons to collaborative 
program 
Phase 5: 
Administrative and policy 
assessment 
 
8) What collaborative model for TB/HIV collaborative program 
would you advocate? 
9) Do have any comment that you think would improve TB/HIV 
co- infection program? 
 
The goal is to identify policy plans and action for collaborative 
services between TB and HIV programs that will enhance 
efficiency, accessibility, sustainability and improved quality of 
life. 
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3.3.2 Deductive and Inductive Analytical Processes and Coding 
This research utilized the combination of both deductive and inductive analytical 
processes. The deductive approach (Elo & Kyngash, 2008), by tests categories, concepts, 
hypothesis or models (Marshall & Rossman, 2014). In this research the PRECEDE model, a 
predetermined framework, was used to analyze data, which started with using an organizing 
framework via codes (Huberman & Miles, 2002). These pre-determined codes helped to 
integrate concepts already well-known in the literature.  The PRECEDE model was utilized for 
generating a priori codes/themes (Table 3.2) from the data collection.  Inductive approach begins 
with an in-depth familiarity with the data, seeking patterns, then theorizing about these patterns.  
Emergent codes evolved through inductive reasoning and surfaced through analysis of the 
participants’ responses from the interviews.  These emergent codes were similar 
thoughts/insights that surfaced during the review of the interview data and were coded as 
important themes.  The advantage of using this combination is that it enables a more 
comprehensive account of the data and overcomes the boundaries of only using the 
predetermined themes. (Tramm et al., 2012). As a result, new information that is relevant to the 
study analysis and might reveal important insights for the findings was not ignored because it did 
not fit into the pre-determined codes 
  
32 
 
Table 3.2: A priori Codes/Themes using PRECEDE 
Codes/Theme child /sub node 
Phase 1 & 2 
Community 
- Urban/Rural/Remote 
- Type of service in community 
- Disease situation in community 
Phase 3 
Behavior linked with TB or HIV 
- Risk factors 
- Help seeking behaviour 
Phase 4 
Predisposing factors 
- Values 
- Perception 
- Knowledge 
- Attitudes 
Enabling Factors - Referrals 
- Manpower availability and skill 
- Availability of resources 
- Accessibility 
Reinforcing factors - Social determinants 
- Peers 
- Attitudes and behavior of health 
personnel 
Environmental assessment 
            Physical environment 
- Define problems of individual or 
community 
Phase 5 
Medication for TB and HIV 
Effectiveness of programs 
- Side effects 
- Adherence 
- Utilization 
- Stigmatization 
- Screening methods 
- Data management 
- Barrier 
Gaps in services - Unmet needs 
- Met needs 
 
3.3.3 Framework Approach for Data Analysis 
 Framework analysis is "an emerging method of qualitative thematic data analysis that is 
increasingly popular in healthcare study" (Ward et al., 2013. p. 2424). Developed by policy 
researchers in the UK (Ritchie & Spencer, 1994; Ritchie et al., 2002), it is a practical approach to 
real-world investigation. The Framework Approach to data analysis was chosen for the following 
reasons. First, there is the need to capture different phenomena of what participants expressed, 
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and the Framework approach is particularly suited for this (Ritchie et. al., 2003). Second, 
interpretation of what participants expressed is transparent and straightforward and offers a 
conclusion that can be linked back to the original data (Gale et al., 2013). Third, charting in 
Framework analysis allows for transparency (Dixon-Woods, 2011). Fourth, the movement from 
data management to developing rational analysis and interpretation to sufficiently answer 
research questions can be a challenge, especially to a new researcher. Therefore, the  
interconnected stages in Framework analysis help the researcher to approach data analysis in a 
systematic and explicit manner (Smith & Firth, 2011).  
The Framework approach consists of five stages: 
1. Familiarisation; the researcher is the sole person who interviewed the participants. The 
audio recordings were sent to a transcriptionist for verbatim transcription. The transcribed texts 
were then loaded into NVivo for analysis. For adequate familiarization with the substance of the 
interviews, transcripts were read and reviewed several times. Field notes were also taken by the 
researcher to know in which context some comments were made. Field notes were useful when 
developing the codes and indexing. 
2. Coding: The initial themes and nodes /child nodes were predetermined from the 
PRECEDE model (Table 3.2), and other nodes added were emergent issues raised by 
participants. This stage was done using NVivo software, where statements of each participant 
were “cut and pasted” into relevant Nodes /child nodes. Nodes were constantly reviewed 
throughout data analysis whenever new insights emerged. 
3. Indexing: From the draft framework developed from the coding, key phrases or 
paragraphs were summarised in each node by the researcher without changing the context in 
which participants made statements. Indexing allowed further immersion in the data so that 
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nodes and child nodes could be refined (Ritchie & Spencer 2002). The product of this stage is a 
refined framework in which data fit in only one theme and is not repeated in others. 
4. Charting:   This involves building a picture of the data as a whole (Huberman, & 
Miles, 2002). Framework matrix (spreadsheet) produced by NVivo aided the researcher to view 
participants’ comments in an orderly form to establish patterns for analysis. Charting required 
that data from the participants are summarised by categories or themes. A good charting depends 
upon the skill to strike a balance between condensing the data on the one hand and keeping the 
original meanings expressed by participants in the interview (Gale et al., 2013). 
5. Mapping and interpretation: The Framework matrix was used to describe the 
participant views in each theme/nodes or sub nodes/sub-themes and were used to look for a 
dimension of association, nature of phenomena, developing strategies, and defining concepts. 
This step was guided by the research questions, linking to the original response of participants, 
and the knowledge from the literature review (Huberman & Miles 2002).  
In this study, the combination of PRECEDE model and Framework analysis guided the 
needs assessment for collaborative program, and the development of a logic model.   The logic 
model set the stage for policy design and program implementation for TB/HIV collaborative 
programming and evaluation.  The final goal was to use the results from the study to help design 
in detail, TB/HIV collaborative programming options for Saskatchewan. 
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Table 3.3: Example of a Framework matrix 
Node/Theme Participant 01 Participant 02 Participant 03 Participant 04 
Community     
Behavior linked with 
TB or HIV 
    
Effectiveness of 
programs 
    
Physical 
environment 
    
Predisposing factors     
Enabling factors     
Reinforcing factors     
Environmental 
assessment 
    
Treatment Schedule 
for TB and HIV 
    
Medication for TB 
/HIV 
    
Gaps in Services     
 
3.4 Setting and Participants  
Participants in the study were chosen from the following Saskatchewan health regions: 
Prince Albert, Mamawetan Churchill River, Keewatin Yatthé, Saskatoon, Regina Qu’Appelle, 
and the Northern Inter-Tribal Health Authority (NITHA), which is solely responsible for the 
"off-reserve" First Nations population, located mostly in northern Saskatchewan. (Please note 
that in 2018 Saskatchewan formed a single Health Region, called Saskatchewan Health 
Authority). 
Participants were recruited from the following categories: medical health officers, family 
physicians, social workers, TB and HIV program managers, epidemiologists, provincial 
laboratory workers, pharmacists, patients, and stakeholders involved with TB and HIV. 
The selection criteria for participants in this study included involvement with HIV and 
TB activities in the province of Saskatchewan. Recruitment to this study was by purposeful 
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sampling and snowballing procedure. Participants were contacted initially via e-mail (Appendix 
1 and 2) and appointments confirmed by telephone. This helped to accomplish the goal of 
selecting information-rich individuals, groups, and organizations that provided the most 
significant insight into the research questions (Fossey et al., 2002). Demographics such as age, 
education, economic status etc. are not variables that were collected in this study, because this is 
a qualitative descriptive research that focuses on determining the desirability of establishing, 
designing, and implementing TB/HIV collaborative programming in Saskatchewan through the 
perspective of participants involved with TB and HIV programs. 
Participants were interviewed until saturation occurred, which according to Morse and 
Richards (2007) is ‘when no new or relevant data emerges from interviews with various 
participants on the topic under study’. Data were collected from 19 participants through a semi-
structured interview (Appendix C) in their place of choice. The interview process for each 
participant lasted between 30 minutes and one hour and was audio recorded. All participants 
were given an invitation to participate in the study information sheet (Appendix A) and asked to 
sign a consent form (Appendix B) before the start of the interview. This document explained the 
purpose of the study, as well as the benefits, risks and procedures involved. The identity of the 
participants was shielded by giving them unique study identification numbers to maintain 
confidentiality.  Participants were also informed that they could withdraw from the study at any 
point in time with no repercussions.  
Audio recordings of the interviews were sent to a professional transcriptionist for 
verbatim transcription. These data were loaded into NVivo (NVivo qualitative data analysis 
Software; QSR International Pty Ltd. Version 10, 2012.), a software program which supports 
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qualitative research methods and allows the data generated from the interviews to be organized 
and analyzed. 
Validity: Trustworthiness  
Qualitative researchers are always faced with the issue of trustworthiness of their studies 
regardless of the approach to data collection. Assessing the trustworthiness of study findings 
requires a transparent research process, sound in relation to the application and appropriateness of 
methods undertaken, and the integrity of the final conclusion (Noble & Smith, 2014). Guba (1981), 
indicated four general criteria to assess trustworthiness in qualitative research, and these are;  
A) Transferability: Is the extent to which research study’s findings could be applicable to other 
contexts, situations, times, and populations. The strategies used to enhance transferability in this 
study included; 1) detailed description of the overall research context. 2) The use of PRECEDE-
PROCEED model which is a multi-theoretical based framework developed by Green and Kreuter 
(2005). This model has been utilized in public health for over 40 years and holds potential for use 
in a needs assessment for TB/HIV collaborative programming. This model embodies two key 
aspects of intervention: a) planning and b) evaluation. The use of this model is similar to what 
obtains in clinical diagnosis, that is, just as a medical diagnosis precedes treatment, so should 
evidence- based educational diagnosis precede an intervention plan that would improve quality of 
life. In addition, the use of this well-tested model eliminates personal bias that may influence 
findings. 3) The participants purposively chosen were diverse in terms of their role in TB and HIV 
programs and geographical locations. This ensured representativeness of findings in relation to TB 
and HIV programming. Also, these participants were willing to share their experiences in-depth. 
B) Dependability: This is important to trustworthiness because it establishes the research study’s 
findings as consistent and repeatable. That is, different researchers will obtain similar results 
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using the same context with same methods and the same participants. Marshall and Rossman 
(2014) noted that ensuring dependability in qualitative research can be problematic, because 
reality is socially built and constantly changing, that is, no two situations or reality are ever 
identical.   According to Shenton (2004), issues concerning dependability can be addressed by 
giving a detailed report on the processes used in the study. This include the exact methods of 
data gathering, analysis, and interpretation, thereby enabling a future researcher to repeat the 
work and probably obtain the same results. The strategies used in this study are: 1) Interviews 
were audio recorded and transcribed verbatim. Data collected was stored into NVivo software 
later to be retrieved for the process of data analysis. This was done to confirm the accuracy of 
findings and ensure that findings are supported by the data collected. Themes emerging from 
data collected can be repeatedly revisited to ensure they aligned with participants’ accounts. 2) 
Use of verbatim extracts from interview participants assists readers to make judgement about 
whether themes fit with participants’ accounts. 
C) Confirmability: This has to do with the level of confidence that the research study findings are 
based on the participants’ account and response to interview questions rather than researcher 
biases. The steps taken in this research to establish the confirmability of the research findings are: 
1) Audit trail. This is a process in which data collection, data analysis, and data interpretation were 
recorded in detail. The information required in audit trail are: audio recordings and verbatim 
transcription, data reduction and analysis using the Framework analysis, data reconstruction 
leading to the construction of a “framework matrix”, and logic model design for program planning 
and implementation (Morrow, 2005). 2) Reflexivity. This is the approach that a qualitative 
researcher maintains when collecting and analyzing the data. The researcher should acknowledge 
his or her own background and position to see if not at conflict with the research process that is, 
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selecting the topic, choosing the methodology, analyzing the data, interpreting the results, and 
presenting the conclusions (Ruby, 1980). In this study, the researcher indicated that he is a medical 
doctor and public health practitioner. He got the inspiration to embark on this study when he 
worked as Medical Officer of Health in a First Nation organization in Prince Albert Saskatchewan, 
Canada. In this capacity, he had a firsthand knowledge about the statistics of TB and HIV in First 
Nation communities. There was the realization that if nothing is done to improve service delivery 
to combat the rising incidence of TB and HIV it may lead to catastrophic consequences in 
Saskatchewan. The overall direction for this thesis was based on my clinical and public health 
experience in which in order to treat an individual you must take a history, conduct laboratory 
investigation and use the data collected to decide on management of the disease.  In this thesis, the 
same approach was used at the population level.  
D) Credibility: Credibility essentially asks the researcher to clearly link the research study 
findings with reality to demonstrate the truth of the research study’s findings. In other words, 
credibility deals with the question, how consistent are the findings with reality?  (Patton, 1999). 
Therefore, to promote confidence in the study this researcher used research methods and 
frameworks that are well established and tested. For example, this study used PRECEDE aspect 
of the PRECEDE-PROCEED model to develop research questions, Framework analysis and 
categorization for data analysis and interpretation.  
3.5 Ethical Approval 
This research proposal was approved by the University of Saskatchewan Behavioral 
Research Ethics Board under the category of minimal risk study (BEH-13-275.). The following 
health regions also provided operational approval Regina Qu’Appelle, Prince Albert, 
Mamawetan Churchill River, Keewatin Yatthé, Saskatoon Health region, and the Northern Inter-
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Tribal Health Authority (NITHA).  Hard copies of transcribed data and consent forms will be 
kept securely at the University of Saskatchewan and stored for five years after the end of study 
as suggested by the University of Saskatchewan Behavioral Research Ethics Board. 
 
 
 
 
 
 
 
 
 
 
Footnote: On December 4, 2017, the Saskatchewan government transitioned from 12 Regional Health 
Authorities to the single Saskatchewan Health Authority. NITHA is not a health region but an “off-reserve” 
First Nations' partnership organization which comprised of Meadow Lake Tribal Council, Lac La Ronge 
Indian Band, Prince Albert Grand Council and Peter Ballantyne Cree Nation. 
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4. PAPER 1:  THE PRECEDE MODEL AS AN ASSESSMENT AND DATA COLLECTION 
TOOL FOR A NEEDS ASSESSMENT OF TB/HIV COLLABORATIVE PROGRAMMING IN 
SASKATCHEWAN 
 
4.1 Contribution of paper 1 to the overall thesis 
The PRECEDE aspect of the PRECEDE-PROCEED model was used to design a 
questionnaire for participants in which the result of their responses would serve as a guide for the 
design of TB/HIV collaborative programming activities in Saskatchewan. The PRECEDE model 
considers multiple factors that contribute to the epidemiology of TB and HIV in the community. 
The PRECEDE components involve assessing social, epidemiological, behavioral, 
environmental, educational, and administrative factors that affect the epidemiology of diseases in 
the population.  The paper describes how the PRECEDE model was adapted as a method for 
needs assessment and describes the applicability and effectiveness of the model in assessing HIV 
and TB control strategies in Saskatchewan.   
4.2 Abstract 
The PRECEDE model is an acronym for Predisposing, Reinforcing and Enabling Constructs in 
Educational Diagnosis and Evaluation. This model was developed by Green and Kreuter and is a 
widely applied tool for health planning (Green and Kreuter, 2005). This model is particularly 
suited for diseases like TB and HIV that are specifically associated with complex social, 
behavioral and environmental factors.  The goal of this paper is to describe the use and 
applicability of the PRECEDE aspect of the PRECEDE-PROCEED model as a framework in 
conducting a needs assessment for TB/HIV collaborative programming in Saskatchewan.   
46 
 
This study used the PRECEDE aspect of the PRECEDE-PROCEED model as a framework that 
provided a "road map" for gathering the relevant data needed to evaluate the current TB and HIV 
programs in Saskatchewan. The purpose of undertaking a needs assessment for a TB and HIV 
collaborative program in Saskatchewan is to systematically identify areas of met and unmet 
needs in order to determine the necessity and requirements to establish the components of an 
effective collaborative program.  The PRECEDE model was used to develop questions that 
would elicit components of social, behavioral, environmental, educational, ecological, 
administrative, and policy factors that affect TB and HIV in Saskatchewan and would be 
important in an effective program model. The PRECEDE model was beneficial in identifying 
which factors are to be a priority, which factors are most amenable to intervention, and which 
factors are necessary to address to improve the health of those infected with TB and HIV in 
Saskatchewan.  Furthermore, emergent factors, outside the anticipated apriori themes, identified 
relevant factors important to understanding the met and unmet needs of the current programs. In 
conclusion, this framework achieved the purpose of a useful tool to conduct needs assessment for 
TB/HIV collaborative programming.  
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4.2 Introduction 
Globally, the occurrence of Tuberculosis (TB) and Human Immunodeficiency 
Virus/Acquired Immunodeficiency Deficiency Syndrome (HIV/AIDS) is a deadly combination, 
with each disease entity potentiating the prevalence, morbidity and mortality of the other. 
According to the World Health Organization (2012), this synergistic interaction between the 
diseases resulted in one-third of people living with HIV/AIDS worldwide also being infected 
with TB. HIV-positive people are nearly 20 times more likely to develop TB when compared 
with HIV-negative people (WHO, 2012). TB thereby presents as the most common opportunistic 
infection in persons with HIV, with an elevated mortality rate. 
The prevalence of HIV among TB patients in Canada is estimated at between 9% and 
19% (WHO, 2004; Corbett et al., 2007). It can be assumed that co-infection is a public health 
issue needing urgent intervention, despite the lack of available data. This is particularly true 
when considering the argument against the background of unfavourable socio-economic and 
behavioural determinants that seem to enhance the transmission of TB and HIV in Saskatchewan 
and Canada. According to Public Health Agency of Canada PHAC (2015) reports show a steady 
rise in those who test positive for HIV infection among the Indigenous population, and this has 
the potential to exacerbate the poor state of TB control within this same population. The 
Indigenous (Aboriginal) population is described by Statistics Canada (2017), 
 "Aboriginal identity population is attributed to people who identify with one 
Aboriginal group, that is, First Nations, Métis or Inuit, and/or those who 
reported being a Treaty Indian or a Registered Indian as defined by the 
Indian Act of Canada, and/or those who reported they were members of an 
Indian band or First Nation"   
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Furthermore, 11% of the Indigenous population in Canada lived in Saskatchewan and 
they made up 16% of the total population of the province with a significant portion residing in 
the urban centres 15% residing in Saskatoon, 13% in Regina, 10% in Prince Albert, but a large 
majority residing on-reserve and in northern Saskatchewan (Government of Saskatchewan, 
2016). 
The high rates of TB and HIV in Saskatchewan suggest that a review of current 
programming strategies needs to be undertaken. Currently, in Saskatchewan, the HIV and TB 
control programs are run separately, with separate human resources and funding.  The WHO in 
2004 advocated some form of collaboration or integration between TB and HIV control 
programs, and this is supported by national advisory bodies (Long & Boffa, 2010).  A needs 
assessment of the current Saskatchewan programs and potential for a collaborative approach to 
programming is an essential element in response to the high disease rates.  The PRECEDE model 
was adapted as the tool to undertake a needs assessment of TB and HIV programming in 
Saskatchewan. 
The PRECEDE-PROCEED model has been utilised in public health over a long period of 
time and holds potential for use in planning for TB/HIV collaborative programming. It is a 
framework developed by Green and Kreuter (2005) for comprehensive assessment and health 
program planning. PRECEDE is an acronym that stands for Predisposing, Reinforcing and 
Enabling Constructs in Educational Diagnosis and Evaluation. The use of this model is similar to 
clinical diagnosis; that is, just as medical diagnosis precedes treatment, so should evidence-based 
program diagnosis precede an intervention plan intended to improve quality of life for TB and 
HIV patients.  Health behaviours are complex and multidimensional, and particularly so in TB 
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and HIV. These behaviours are influenced by socio-economic, epidemiological, cultural and 
psychological factors, all of which are dynamics assessed by the PRECEDE model.  
The key to the PRECEDE model is that it requires logical thinking about the desired end 
goal and then works backwards to accomplish this goal (Green and Kreuter, 2005). In this study, 
the goal is to reduce the incidence and prevalence of TB and HIV in Saskatchewan through 
collaborative programming and then design a layout to achieve this goal. 
4.3 Phases of the PRECEDE model 
As shown in Figure 4.1, the PRECEDE model utilizes five phases to assess health 
programs: (1) social assessment, (2) epidemiological assessment, (3) behavioral and 
environmental assessment, (4) educational and ecological assessment, and (5) administrative and 
policy assessment (Green and Kreuter, 2005). 
4.3.1 Phase 1: Social Assessment 
The goal of Phase 1 is to assess the quality of life of patients affected by TB, HIV or both 
diseases. TB and HIV are diseases of public health importance in Saskatchewan. They 
substantially impinge on the quality of life of the community because both diseases have a high 
level of stigmatisation and discrimination by people in the community. Key investigation 
questions in making a thorough social diagnosis were the situation of TB and HIV in the 
community; the type of health services in the community; and the barriers to the utilization of 
services at the individual, community or geographical levels. Other sources of information and 
insight included living conditions, support systems within the community and cultural practices. 
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Figure 4.1: The PRECEDE-PROCEED Model 
Taken from Health Program Planning: An Educational and Ecological Approach (p. 10), by 
L.W. Green and M.W. Kreuter, 2005, McGraw-Hill, Higher Education Company. Copyright 
2005. Taken with permission. 
 
4.3.2 Phase 2: Epidemiological Assessment 
The essence of this step is to establish achievable health-related objectives by which the 
success of the program can be measured (Green and Kreuter, 2005). For these objectives to be 
realistic, the study requires existing baseline data for TB and HIV infection in the population 
including national, provincial and health regions' statistical data, and socioeconomic data.   The 
baseline data on co-infection is currently unavailable in Saskatchewan and would be a key 
outcome if collaborative programming was implemented in the province.  How to access this 
level of information could be ascertained in the study. 
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4.3.3 Phase 3: Behavioural and Environmental Assessment 
The purpose of Phase 3 is to ask questions to establish the pattern of distribution of TB, 
HIV and co-infection, and to discover why a peculiarity of distribution occurs within the 
population. The questionnaire was designed to determine the behavioural and environmental 
factors that promote the propagation of TB and HIV infection in the community and affect the 
quality of life of those affected by the diseases. The information obtained assists in identifying 
those factors that can be changed to reduce the incidence and prevalence of TB, HIV and co-
infection.  
The behavioural determinants consist of three levels.  The first level is proximal, which 
are behaviours or lifestyle that contribute to the severity of TB and HIV infections (e.g., needle 
sharing, stigma, poverty, poor access to facilities).  The second level is the behaviour of others 
that directly affect those individuals at risk of TB and HIV.  The third level is the action of 
decision makers whose decisions affect the social or physical environment of the individual at 
risk (e.g. community empowerment advocacy, communication and mobilisation; staffing, 
turnover, staff training). 
4.3.4 Phase 4: Educational and Ecological Assessment 
This phase involves understanding if a unique plan for TB/HIV collaborative 
programming is likely to increase or decrease the likelihood that behavioural and environmental 
changes (Phase 3) will occur. This understanding is gained through the identification of 
predisposing, reinforcing and enabling factors (Green and Kreuter, 2005). Predisposing factors 
include an individual or group's increased or decreased likelihood to be infected with TB and 
HIV based on their knowledge, attitudes, perceptions and beliefs.  Reinforcing factors are factors 
that propagate or decrease TB and HIV infections in the community. Enabling factors represent 
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the necessary conditions that must be present for a successful implementation of TB/HIV co-
infection programming. These factors include the availability and accessibility of financial and 
human resources.   
It is also essential to know what is currently being done about TB/HIV collaborative 
programming at the community and provincial levels and the plans and resources that might 
already exist in support of collaborative programming. 
4.3.5 Phase 5: Administrative and Policy Assessment 
This phase aims to identify the policies, resources and organisation models that exist and 
are seen as required for the implementation and sustainability of TB/HIV collaborative 
programming. This phase assesses the gaps (met and unmet needs) in the way existing programs 
are implemented. 
The phases of the PRECEDE model were utilised in generating apriori themes that were 
then developed into open-ended questions.  Table 4.1 shows how the PRECEDE model was used 
as a “road map” to develop interview questions for the semi-structured interviews. 
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Table 4.1: The PRECEDE model as a tool to develop interview questions and categories of data 
analysis 
Category Of 
Analysis 
PRECEDE 
Phase 
apriori themes Interview Questions 
Contextual: 
The goal is to 
explore the situation 
analysis of TB and 
HIV in 
Saskatchewan and  
determine how 
control programs are 
implemented 
Phase 1 and 2: 
Social 
Assessment 
- Nature of population 
needs. 
- Type of service in 
the community. 
- Urban, rural and 
remote community 
Epidemiological 
Factors 
- existing baseline 
data for TB and HIV 
infection in the 
population 
1) Tell me about your 
role in the organization? 
Probe: defined 
responsibility 
2) What is your comment 
on the situation of TB 
and HIV in the 
community? 
Probe: Explore 
awareness/attitudes/perce
ption   
 
Diagnostic:  
The goal is to 
examine the reason 
for the epidemiology 
of TB and HIV 
infections in the 
context of 
socioeconomic, 
behavioral and 
environmental 
factors. 
Phase 3: 
Behavioral and 
Environmental 
assessment 
 
-Behavior linked to 
TB and HIV co-
infection. 
-Predisposing factors. 
-Enabling factors. 
-Reinforcing factors. 
-Data management  
3) Tell me about the 
services rendered 
towards TB and HIV 
control and method of 
implementation. 
Probe: type of services, 
resources and 
coordinating capacity. 
4) What factors affect 
access to the services? In 
terms of behaviour and 
environment 
5) How adequate are the 
human, material and 
financial resources 
towards the 
implementation of 
services? 
Evaluative: 
 The goal is to 
appraise the 
effectiveness the 
present TB and HIV 
control program. 
Identify gaps and the 
need for 
collaborative 
programming. Also 
Phase 4: 
Educational 
and Ecological 
assessment 
  
-Effectiveness of 
program. 
-Gaps (met and unmet 
needs) 
A) Predisposing 
factors 
B) Reinforcing 
factors 
6) What is your view 
about TB, HIV and 
TB/HIV collaborative 
service? 
Probe: Barriers to 
existing program, 
predisposing, enabling, 
and reinforcing factors. 
7) How do you think 
collaborative services 
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identify pros and 
cons to collaborative 
program 
C) Enabling 
factors 
will be received by 
healthcare personnel and 
patients? 
Probe: Specific ways of 
promoting TB/HIV care, 
inquire about service 
uptake 
Strategic: 
The goal is to 
identify policy plans 
and action for 
collaborative 
services between TB 
and HIV programs 
that will enhance 
efficiency, 
accessibility, 
sustainability and 
improved quality of 
life. 
Phase 5: 
Administrative 
and policy 
assessment 
 
 
Administrative and 
Policy Factors 
 
8) What collaborative 
model for TB/HIV co-
infection program would 
you advocate? 
9) Do have any comment 
that you think would 
improve TB/HIV co- 
infection program? 
 
 
4.3.6 Emergent themes  
The raw data collected from semi-structured interviews of participants are usually 
unstructured. Therefore, the researcher must provide coherence and structure through thematic 
analysis and at the same time retain the link to the original account and observation. 
Subsequently, rigorous analysis of data collected is crucial to the generation of good evidence 
that serves as the basis for change in policy and practice. In this research, the process derived 
from apriori themes from within the PRECEDE model as well as describing other themes that 
emerged.  
The themes in Table 4.2 emerged during the data collection process and coding. These 
emergent themes were identified as necessary for answering my research questions, identifying 
essential characteristics to understanding the state of TB and HIV, and drawing the big picture 
that would help design intervention strategies. In this research, emergent themes arose out of the 
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ultimate objective to identify gaps in the present implementation of TB and HIV control and then 
use the information collected to design a TB/HIV collaborative program. The emergent themes 
emerged from an iterative reading of interview transcripts, field notes, and the process of 
abstraction that is, creating categories from the complexity of the data collected. Therefore, the 
emergent theme is grounded empirically in the data obtained using the PRECEDE model. 
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Table 4.2: Emergent Themes 
Phase in 
PRECEDE model 
Emergent themes New Probes /Interview Questions 
Phase 1 and 2 
Social Assessment 
-Disease situation in community 
-Discrimination and gender 
-Physical environment 
(overcrowding) 
Tell me the categories of individuals 
in the population that are mainly 
affected by TB and HIV and what 
factors lead to increase disease 
prevalence? 
Phase 3 
Behavioral and 
Environmental 
assessment 
-Risk takers and chaotic life style 
-Drug addiction and needle 
sharing 
-Highly mobile population 
As above probe questions 
Phase 4 
Educational and 
Ecological 
assessment 
 
-Support from community, peers 
and health staff 
-Stigmatization 
-Financial and human resources 
- Screening methods 
- Utilization and access to health 
services (including barriers) 
-What type of support is available 
for those affected by TB and HIV in 
the communities? 
-How important is stigmatization to 
those affected by TB and HIV? 
-Is funding an important factor 
-What are factors that affect 
utilization of services?  
Phase 5 
Administrative 
and policy 
assessment 
-TB/HIV collaborative services 
-Data management 
-Met and unmet needs 
-What model of collaboration 
between TB and HIV services do 
you think should be adopted? 
 
4.4 Discussion 
 The planning cycle of health programming usually begins with a needs assessment. 
Health needs assessment is defined as a systematic method of reviewing the health issues facing 
a population, leading to agreed-upon priorities and resource allocations that improve health and 
reduce inequities (Wright et al., 1998). The design of an effective and sustainable health program 
depends on the data gathered being of high quality. The PRECEDE aspect of the PRECEDE-
PROCEED model is a useful framework and provided a useful "road map" for interview 
questions that would fully assess the current situation of TB and HIV in the province and 
57 
 
therefore collect the relevant data needed to assess and evaluate the need for a TB/HIV 
collaborative program. 
The PRECEDE model has enhanced the design for collection of quality data from 
participants about needs assessment for a TB/HIV collaborative program. The model integrates 
relevant theory and models in its phased component in order to give information about factors 
that affect the propagation of TB and HIV in the population. These theories are the health belief 
model, health promotion model and social learning theory (Gielen et al., 2008).  Furthermore, the 
model allows for the identification of met and unmet needs, which is a critical component of 
needs assessment, and for the determination of areas of collaboration or integration of services 
between TB and HIV programs that would not only allow for easy accessibility and 
acceptability, but also prevent unnecessary and wasteful spending of scarce resources.  
The concepts and questions were developed according to the principles for program 
collaboration and service integration outlined by Friedland et al. (2007) and the Center for 
Disease Control (2009, p.9) and fit well into a needs assessment for collaborative programming 
for HIV/TB.  Regarding comprehensiveness, it is expected that program collaboration between 
TB/HIV services will promote joint planning and coordination of resources that facilitate 
comprehensive prevention, treatment and risk-reduction services. Regarding Continuity of care, 
the process evaluates political will to ensure sufficient support at all governmental levels for 
TB/HIV co-infection programming and stakeholders including staff training and capacity 
development. In terms of Competence, the process evaluates intervention strategies that should 
have a favorable outcome. That is, they should ensure treatment success, cure or completion of 
therapy; reduced HIV and TB disease progression and mortality; and decreased transmission of 
both diseases. The strategies should facilitate unhindered access to medication and promote 
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coherence of communication between TB and HIV services.  The process integrates 
Compassion by evaluating reduction or elimination of stigmatisation and discrimination. It also 
involves taking care of the prevailing socio-economic problems of patients and community 
members.  The process also evaluates Cost-effectiveness in terms of the design of any 
intervention and taking into cognisance the prevalence of limited financial and human resources. 
Investment in TB/HIV co-infection programming should produce the desired outcome of 
effectively reducing morbidity and mortality and if this can be accomplished through combining 
operational resources and the use of shared infrastructure to reduce overhead costs (Dobrow et 
al., 2004). 
The information provided from the PRECEDE can be used to form the basis of a logic 
model for implementation and evaluation of a TB/HIV collaborative program. This is important, 
as an intervention plan should have an evaluation component. Evaluation gives insight into the 
challenges and successes of a program, and this information can be used to make changes as 
needed in order to enhance the accessibility and effectiveness of a program.  If a TB/HIV 
collaborative program is implemented in Saskatchewan, the PROCEED portion of the 
PRECEDE-PROCEED model could be utilised for evaluation. 
4.5 Conclusion 
Using the PRECEDE model as a needs assessment tool for TB and HIV collaborative 
programming is applicable and useful for developing a data collection tool. The strength of the 
model include the integration of relevant theory and models in its phased components (phases 1-
5 of PRECEDE) and provided valuable information on the incidence, prevalence and social 
determinants of TB and HIV in Saskatchewan. In addition, the model allows for the 
identification of met and unmet needs and the determination of potential areas of collaboration or 
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integration of services which are critical components of a needs assessment. Furthermore, the 
model has the potential to work in other groups and settings. Also, the PRECEDE model forms 
the basis from which, if implemented, a collaborative program can be evaluated using the 
PROCEED phase of the PRECEDE-PROCEED model. Due to the complex nature of the 
infections in Saskatchewan, specific themes emerged that were not originally construed using the 
PRECEDE model.  These emergent themes could be important considerations when using the 
PRECEDE model as a needs assessment for these specific diseases 
The PRECEDE-PROCEED model has its limitations, the phases of emphases are 
restrictive to be used for needs assessment for TB and HIV collaborative program. These are 
diseases that also has complex interaction with history, cultural and local environmental in which 
they exist. Therefore, I would suggest including historical, cultural, politics, ideology and 
community values assessment to the process of PRECEDE framework to adequately capture any 
planned community-based health promotion activities that is designed to benefit Indigenous 
peoples. In addition, the PRECEDE-PROCEED framework should incorporate Community-
based participatory research conceptual model, that is, collaborative approach to research that 
equitably involves all partners (e.g. community members, organizational representatives), all 
contributing their expertise to the research process, and sharing in policy decision making and 
ownership. (Israel et al., 1998).  Inclusion of Health Quality Improvement phase in the 
framework is also important. 
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5. PAPER 2:  A NEEDS ASSESSMENT OF TB/HIV COLLABORATIVE 
PROGRAMMING IN SASKATCHEWAN 
 
5.1 Contribution of paper 2  
 Paper 2 provides the results from the needs assessment for TB and HIV co-programming 
in Saskatchewan conducted using the PRECEDE model as described in Paper 1.  Using the 
approach described in Paper 1 resulted in a systemic approach to data gathering and analysis that 
identified the population health needs and priorities, the situation analysis of TB and HIV in 
Saskatchewan, the present state of implementation of TB and HIV intervention programs and 
met and unmet needs related to the current TB and HIV programs. 
5.2 Abstract 
A needs assessment for TB/HIV co-programming in Saskatchewan was conducted using the 
PRECEDE framework (Paper 1).  Currently in Saskatchewan patients with TB/HIV must 
navigate two separate health care programs to receive appropriate treatment. This systematic 
need assessment evaluated the present state of the current TB and HIV control programs and met 
and unmet needs for TB and HIV programs in Saskatchewan.  
Methods: Qualitative semi-structured interviews were conducted with 19 participants who were 
purposively selected among health workers, administrators of TB and HIV programs, patients 
and stakeholders in Saskatchewan, Canada. The PRECEDE part of the PRECEDE-PROCEED 
model, as previously described (Paper 1) was used to guide the qualitative data collection.   
Results: The PRECEDE model helped to identify/diagnose the social, behavioral, 
environmental, educational and administrative factors in the current TB and HIV programs in 
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Saskatchewan, and the needs that could be met through collaborative programming options. The 
socioeconomic conditions identified were poverty, adverse effects of residential school system, 
low level of education, and abuse (physical, sexual and emotional). Behavioral factors of 
importance included a highly mobile population; living chaotic lifestyles as a result of drug 
addiction, prostitution, alcoholism; unprotected sex; and needle sharing. Environmental factors 
that were identified included the large geographical area in Saskatchewan and a large patient 
population in the rural and remote areas of the province. Educational factors identified were 
comprised of predisposing, reinforcing and enabling factors.  The predisposing factors were 
related to inadequate knowledge about the mode of transmission of TB and HIV. Stigmatization 
was a significant reinforcing factor of importance such that patients received minimal support 
from peers and community members. Enabling factors for consideration included inadequate 
qualified health personnel and a poor staffing situation made worse by large turnover. 
Furthermore, recruitment of specialists to work in rural and remote areas of Saskatchewan is 
very challenging. Therefore, health facilities depend mostly on visiting specialists. The financial 
resources are inadequate, and this situation is compounded by multijurisdictional funding in 
off/on reserve communities in northern Saskatchewan. Appointments to see service providers or 
specialists are difficult to arrange due to chaotic lifestyle, high mobility, lack of telephone 
services and homelessness. Diagnosis of administrative and policy factors reveal areas of gaps in 
the implementation of present programs.  Gaps enumerated by participants are lack of 
coordination between separate TB and HIV programs, especially in data gathering. Other gaps 
are different locations of TB and HIV laboratories in Saskatchewan, difficulty with 
transportation in rural and remote areas, and difficulty getting TB and HIV medication.  
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Conclusion: There is a consensus among the participants about the desirability of establishing at 
least some form of TB/HIV collaborative program in Saskatchewan, but the ideal model of 
collaboration is not established.  Program officers favored the referral model while patients in the 
study favored the integrated model (one-stop). No matter the model, the desired goal is to reduce 
the incidence of TB and HIV in Saskatchewan population. To achieve this end, it is vital that 
there is effective coordination between TB and HIV programs to ensure that patients can access 
the care they need from both services. It is recommended that the various social, 
epidemiological, educational, behavioral and administrative factors that affect the epidemiology 
of TB and HIV in Saskatchewan as identified in the PRECEDE model be taken into 
consideration in the design of appropriate intervention and evaluation strategies. Furthermore, 
the entire planning and implementation of collaborative programming should follow WHO’s 
(2004) guidelines on TB/HIV collaborative services.  
5.3 Introduction 
Globally, the occurrence of Tuberculosis (TB) and Human Immunodeficiency 
Virus/Acquired Immunodeficiency Deficiency Syndrome (HIV/AIDS) in a population has 
always turned out to be a deadly combination with each disease entity potentiating the 
prevalence, morbidity and death rate of the other. According to the World Health Organization 
(WHO, 2012), this synergistic interaction between both diseases resulted in a 67% of people 
living with HIV/AIDS worldwide being infected with TB. HIV-positive people are nearly 20 
times more probable to develop TB when compared with HIV negative people (WHO 2012).  In 
Canada two National advisory bodies recommended universal HIV testing of TB patients (Long 
& Boffa 2010). 
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The province of Saskatchewan runs separate TB and HIV control programs with distinct 
personnel and funding.  According to Public Health Agency of Canada (PHAC) in 2015, the 
prevalence of TB and HIV in Saskatchewan was two times the national average. There are no 
reliable data in Canada and Saskatchewan on TB/HIV co-infection, which is attributed to lack of 
concurrent surveillance for the two diseases (Long & Boffa, 2010). TB, HIV, and TB/HIV co-
infection are likely to become a public health issue that requires urgent intervention. To address 
the dual burden of TB and HIV, WHO in 2004 advocated some form of collaboration/integration 
between TB, and HIV control programs (WHO, 2004). 
Needs assessment is a complex, multidimensional approach to health service planning 
that ensures quality evidence-based management to improve the health of a community with the 
goal of applying available resources efficiently. Through needs assessment, health issues are 
prioritized, and inequalities in health and access are identified. TB and HIV infections have 
substantial social, cultural, behavioral, educational and administrative components that are 
important in their epidemiology and these factors are important when designing intervention 
strategies. It is essential to incorporate an evaluation formula to health intervention or promotion 
strategies, and this can be addressed by the PRECEDE-PROCEED Model (Phillips et al., 2012). 
Whilst the importance of collaboration/integration has been widely advocated (WHO, 
2004), there is no acceptable service model for TB/HIV collaborative programing. This paper 
therefore intends to look at the current TB and HIV programs implementation, the gaps, the met 
and unmet needs, and areas of synergy that would contribute to development of co-programming 
options for Saskatchewan.  
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5.4 Methods 
5.4.1 Setting 
In this study, selection of participants were from six health regions in Saskatchewan, 
geographically described as Northern (Prince Albert,  Mamawetan Churchhill River, Keewatin 
Yatthe and the Northern Inter-tribal Health Authority (NITHA) which is solely  responsible for 
the “Off-reserve” First Nation population of Northern Saskatchewan) , Central (Saskatoon health 
region), and  Regina Qu’Appelle . This was deliberate to cover a range of ideas, cultural and 
geographical diversity that exists in the province that may significantly influence program design 
and activities. 
The selection criteria for participants in this study were: individuals knowledgeable in 
HIV and TB prevention and treatment in the province of Saskatchewan, engaged as program 
management, or involved with decision-making processes (Cresswel & Clark, 2011). Participant 
categories were: TB and HIV administrators and program managers, clinicians, social workers, 
stakeholders, provincial laboratory workers, epidemiologists, pharmacists, Medical Health 
Officers, and patients.   
The research proposal was approved by University of Saskatchewan Behavioral Research 
Ethics Board. Operational approval was provided by health regions (Prince Albert, Mamawetan 
Churchhill River, Keewatin Yatthe, Saskatoon, Regina Qu’Apelle and NITHA). 
5.4.2 Data sources and Participants 
Epidemiological data were obtained from the Public Health Agency Canada (PHAC) and 
Statistics Canada (2016) websites which provided baseline data for TB and HIV infections in the 
population. Recruitment to the study was by purposeful and snowballing sampling. This helped 
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to accomplish the goal of selecting information-rich individuals, groups, and organisations that 
provided the most significant insight into the research questions (Fossey et al., 2002). 
Semi-structured open-ended interviews drawn from the PRECEDE model were used to 
guide the structure and direction of interviews. An invitation to participate in the study and 
information sheets were sent to each participant by e-mail. Confidentiality was maintained by 
giving participants unique identifying numbers. Informed consent was obtained from all 
participants before the start of the interview. Interviews were conducted in participants’ place of 
choice with the process lasting from 30 minutes to 1 hour. Audio recordings of interviews were 
sent to a professional transcriptionist for verbatim transcription. 
Interviews took place until saturation was achieved, which according to (Fossey et al., 
2002) is ‘when no new or relevant data emerges from interviews with various participants on the 
topic under study’. The final sample was 19 participants, and the categories of those interviewed 
are TB and HIV frontline workers, administrators and patients. 
5.4.3 Data analysis 
The interview transcripts were loaded electronically into NVivo 10 software. Data 
analysis started as soon as each transcript was received. 
The “framework” analysis, which is a form of thematic analysis, was used as the data 
management process to classify and organise data according to key themes, concepts and 
emergent categories (Ritchie, et. al., 2013, Srivastava & Thomson, 2009).  
The first step in the management of collected data was to become familiar with 
transcribed data by reading and reviewing the transcript several times. This allowed the 
researcher to gain enough understanding of what participants were saying about the concept of 
TB and HIV and recognising key themes and emerging themes in the data.  In the second step, 
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the data were coded using NVivo software into two broad areas, pre-set themes (also referred to 
as "apriori themes") derived from the PRECEDE model. The other set of themes called the 
"emergent themes” evolved and were refined (as an iterative process) through reading and 
familiarisation with raw data and making sure that the original research questions were 
adequately addressed. After that, summarised statements from participants were manually 
extracted from the transcripts and assigned to relevant themes to form a matrix. This allowed the 
researcher to view comments in a better-organised form to establish patterns for analyses 
(Appendix 4). 
The final step was mapping and interpretation of data using participant views as the guide 
in each theme or sub-theme, looking for the range of association, nature of phenomena, 
developing strategies, and defining concepts. 
5.5 Results 
Table 6 and Figure 2 summarize the results by PRECEDE phase and apriori and 
emergent themes to diagnose the social, environmental, behavioral, educational, and 
administrative policy factors responsible for TB and HIV epidemiology in Saskatchewan  
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Table 5.1: A priori and emergent themes 
Phase in PRECEDE model apriori themes Emergent themes 
Phase 1 and 2 Social Factors 
- Nature of population needs. 
- Type of service in the 
community. 
- Urban, rural and remote 
community 
Epidemiological Factors 
- existing baseline data for 
TB and HIV infection in the 
population 
- Disease situation in 
community 
-Discrimination and gender 
-Physical environment 
(overcrowding) 
Phase 3 Behavioral Factors  
-Behavior linked to TB and 
HIV co-infection. 
-Predisposing factors. 
-Enabling factors. 
-Reinforcing factors. 
-Data management 
-Risk takers and Chaotic life 
style. 
-Drug addiction and needle 
sharing. 
-Highly mobile population 
Phase 4 Educational and Ecological 
Factors  
-Effectiveness of program. 
-Gaps (met and unmet needs) 
A) Predisposing factors 
B) Reinforcing factors 
C) Enabling factors 
 
-Knowledge, attitude and 
belief about TB and HIV. 
-Support from community, 
peers and health staff. 
-Stigmatization 
-Financial and Human 
resources. 
Screening methods 
- Utilization and access to 
health service (including 
barriers) 
Phase 5 Administrative and Policy 
Factors 
 
-TB/HIV collaborative 
services  
-Data management 
-Met and unmet needs 
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Figure 5.1: Summary of results categorized by PRECEDE model phases. 
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5.5.1 Phase 1 and 2: Social and Epidemiological diagnosis 
From the social diagnosis, the major factors that impact TB and HIV and quality of life of 
for those infected by the diseases as identified by participants are: poverty, poor self-esteem 
mostly as a result of history of residential schools, chaotic life style, poor housing, 
sexual/emotional abuse and low level of education. 
Table 5.2: Quotes of participants on Social Diagnosis. 
Factors from 
Social Diagnosis 
Quotes from participants 
History of 
residential school 
Poverty, residential school survivors so lots of sort of co-existing factors 
that created a scenario where people were either had such poor self-
image or self-esteem that they didn’t feel it was worth protecting 
themselves. (07/2). 
 
Chaotic lifestyle Many of the people that I see that have drug addiction, have a history of 
trauma: abuse, neglect, sexual abuse, physical abuse, emotional abuse 
and neglect, so long history of problems related to that and simply being 
able to navigate complex systems is challenging and may be heavily 
street involved, marginalized, maybe not have a high level of formal 
education (01/2). 
We do a lot of drugs and alcohol and we have difficulty getting out the 
habit.(04/01) 
HIV is a big problem in community (04/2) 
Lots of my friends have HIV and Hep C.(04/3) 
 
Sexual/emotional 
abuse 
There are some people that I’ve had as patients that have told me, why 
should I be treated for my HIV? I don’t care. I don’t care. It just makes 
me live longer. Why would I want to live longer? The best day of my life 
was the day that I beat my father up before he could rape my sister. That 
was his single greatest accomplishment in life. So when you think about 
the trauma and  the violence and so on in that kind of a setting, here’s a 
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person who really hadn’t seen anything in life that was of great value to 
him. (01/2). 
5.5.2 Phase 3: Behavioral and Environment Diagnosis 
According to the participants there is a constellation of behavioral factors that are 
attributed to acquiring TB and HIV in the population (Tables 5.3, 5.4, 5.5)  
The first level of behavioral diagnosis the proximal, which are behaviors or lifestyle that 
contributes to the severity of TB and HIV infections. These are unhealthy behaviors 
characterized by needle sharing by Injection Drug Users (IDU) that encourages HIV 
transmission, and inappropriate health seeking behavior caused by patients’ reluctance to 
undergo testing because of stigma.  
Table 5.3: Quotes of participants on behavioral and environmental diagnosis. 
Factors Quotes from participants 
Intravenous drug users (IDU) -They live in close community, close homes and a lot 
of IV drug use. First Nations community has high 
rates of IV drug use and limited access to needle 
exchange program so they end up sharing needles. 
(02/2) 
- 70%-80% of HIV in Saskatchewan caused by IDU 
(1/02) 
 
Inappropriate health seeking 
behaviours 
-They know doing drugs is illegal, this push them 
underground. They are not ready to talk about this. 
(8/01) – seems like the people do not want to disclose 
and the community do not want to admit that there 
might be somebody there that have HIV and they just 
don’t want to discuss it. (2/01) 
 
Stigmatization -Lots of stigmatization because people are not 
educated enough (4/03) 
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- In Rural and remote areas, stigmatization is a 
challenge because of familiarity of patient with 
service provider. Confidentiality may not be assured 
(3/01) 
- Rude and judgmental health workers. Some wear 
gloves even when taking the pulse. Some people 
behave badly to you. (4/03) 
-Double stigmatization with TB/HIV co-infection, 
especially in northern community. Patient may shut 
down (7/01) 
 
 
 
The second level of behavioral diagnosis is the behavior of others that directly affect 
those individuals at risk of TB and HIV. These are alcoholism, prostitution, overcrowding, active 
TB in the community, and unknown HIV carrier status.  
Table 5.4: Quotes of participants on behavioral factors 
Factors Quotes from participants 
Alcoholism, 
Prostitution, 
overcrowding 
-Drugs, Alcohol and difficulty getting out of the habit (4/01) 
- TB is caused by deprivation, poor housing, and poverty (1/02) 
Unknown HIV carrier 
status 
- Scared to tell about HIV (4/01) 
- Fear to disclose HIV so that they are not labelled (7/02) 
 
The third level of behavioral diagnosis is the action of decision makers whose decisions 
affect the social or physical environment of the individual at risk. Examples are, community 
empowerment at grass root level using effective advocacy.  
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Table 5.5: Quotes of participants on behavioral factors. 
Factors Quotes from participants 
Community - In some reserves HIV is criminalized and vilified {sic}(1/01) 
-Smooth delivery of treatment in reserves depends on leadership and 
health care staff who are non-judgmental (1/01) 
 
5.5.3 Environmental diagnosis: Physical Environment 
Environmental factors are those social and physical factors external to the individual, 
often beyond the personal control of those at risk of TB and HIV infections.  These factors as 
enumerated by participants are: large geographical area of Saskatchewan in which a substantial 
area is rural and remote, and the communities are spread over this vast land.  
Northern Saskatchewan poses geographical challenge in terms of communities spread 
out over a very vast area. (08/1) 
 
5.5.4 Phase 4: Educational Diagnosis 
Educational diagnosis includes the predisposing, reinforcing and enabling factors. 
In this phase health program planners take into consideration the antecedents to behavior that 
provide the rational or motivation for the behavioral change that the health intervention wants to 
achieve. This phase involves developing a unique plan for TB and HIV collaboration program 
that increases the likelihood that behavioral and environmental changes will occur through 
identification of predisposing, reinforcing, and enabling factors.  
1) Predisposing Factors (Table 5.7) are antecedent to behavior that provide motivation for 
actions. They include knowledge, attitudes, and beliefs about TB and HIV infections.  
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The views expressed by participants about knowledge of TB and HIV are a 
misconception about the mode of transmission and those at risk of getting the infections. 
Table 5.6: Quotes from participants on predisposing factors 
Predisposing factors Quotes from participants 
Knowledge - Knowledge about HIV is increasing but some people still call it 
dirty disease. (08/1) 
- A big concern in the general population, HIV education has 
come a long way. (02/1) 
- Lot of misconception about how it is transmitted. Some people 
feel it is a gay disease. People have the opinion it is a death 
sentence. A lot of people do not think it is a problem. Because it 
affect mainly the IDU (the forgotten people). (07/1) 
Attitudes and Beliefs -We made bad choices in life and we go through daily life struggles. 
(04/1) 
-They know doing IDU is illegal, this pushes them underground. 
They are not ready to talk about this. (07/1) 
 
 
Attitudes and beliefs influence the perception of individuals to accept the disease entity 
as a threat, which on the long run affect how preventive measures and treatments are sought. 
Some of the participants, especially the patients, admitted they made bad choices in life. Others 
alluded to having series of challenges in life. 
2) Enabling Factors (Table 5.7) represent the necessary conditions that must be present for a 
successful implementation of TB/HIV co-infection program. These factors include availability of 
health resources, which can be described in terms of human and material resources, and 
accessibility of services and community/government laws policies and priorities.  
The participants highlighted the challenges as a lack of coordination between TB and 
HIV, inadequate personnel and substantial staff turnover especially in rural and remote areas, 
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few infectious disease specialists, limited and multiple sources of funding, and difficulty in 
appointment arrangement for patients. 
Table 5.7: Quotes from participant on enabling factors 
Factor Quotes from participants 
Enabling -Always short of staff. Rotate available staff to work with ID 
physician, Lab, and skin testing. (2/02) 
-Need for staff training and additional funds for TB/HIV co-
infection. Struggling to recruit Infectious disease doctors. There is 
long waiting list of newly diagnosed cases. Sometimes wait for 1 
year. (2/03) 
 
 
3) Reinforcing factors (Table 5.8): these are attitudes of the people in the community that help 
to support or make difficult healthy behaviour necessary to reduce impact of TB and HIV 
diseases.   
The responses from participants that are identified as reinforcing factors are: 
stigmatization and confidentiality. Also, negative attitude of peers, community, and health staff 
towards those infected by TB and HIV.  
Table 5.8: Quotes from participants on reinforcing factor 
Factor Quotes from participants 
Reinforcing factor -There is worry about confidentiality and anonymity in the reserves, 
although this varies from place to place.  In some reserves HIV is 
criminalized and vilified. (01/1) 
-Rude and judgmental health workers. Some wear gloves even when 
taking the pulse. Some people behave badly to you. (04/3) 
 
 
5.5.5 Administrative and Policy assessment 
This aims at identifying the gaps in present policies, resources, and organizational model.  
Aboriginal health policy in Canada is complicated. It is made up of complex policies, legislation 
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and agreements that delegate responsibility between federal, provincial, municipal, and 
Aboriginal governments.  This complicates policy and leads to jurisdictional confusion in health 
funding and barriers to equitable access to health care and services. 
The participants identified separate TB and HIV programs, conflicting model of funding, 
lack of coordination of referrals, difficulty in setting up appointments, difficulty in getting TB 
and HIV medications, adherence to medication, difficulty with transportation, shortage of human 
resources and different location of TB and HIV testing laboratory as factors inherent in the 
present implementation of TB and HIV programs.   
Table 5.9: Quotes of participants on policy and administrative factors. 
Gaps  Quotes from participants 
Conflicting model 
for funding 
-Multiple sources of funding; Ministry of health and Saskatoon health 
region fund TB program. There is funding to recruit physicians. PLP 
has its own funding from provincial health. HIV strategy funds have 
first time funds for 3 years. Lots of Funding for HIV, but is mainly 
temporary. Need for staff training and additional funds for TB/HIV co-
infection. (2/03) 
-TB funding is different from HIV funding for northern support. (2/02) 
-2/3 of funding from Public health agency of Canada (Federal 
government). Rest from provincial funding and donations and 
fundraising. Rely mostly on volunteers and are used mainly for 
fundraising (8/01) 
Lack of 
coordination of 
referrals and 
difficulty setting up 
appointments 
-Very mobile population (2/01) 
- Difficult to contact patients by phone. Numbers may have changed or 
no reception in the area (2/02) 
-Patients move back and forth through the province and the 
correctional centers (provincial or federal). No continuity on release 
from prison (9/01) 
-Appointments are difficult arranged with patients. This may be due to 
patient’s disruptive life. May be structural when patients are expected to 
come back after 3 days for reading (2/03) 
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-Referral cannot be tracked to know if appointments were honored 
(2/02) 
- Schedule appointment don’t work. Except drop in. RUH location is 
difficult to access and therefore difficult to manage appointment (2/03) 
Difficulty getting 
medication 
-Getting medication is a challenge it depends on where they live. TB 
drugs are dispensed to TB crew. HIV drugs are access through regular 
pharmacy (9/01) 
- Stocking of drugs is a challenge, especially in rural areas (9/01) 
- Access to medication is central in Saskatoon. This is restrictive. 
Patients have to travel to get medication. 2 pharmacists. Saskatoon 
takes care of Northern SK. Regina the South (9/01) 
Difficulty with 
transportation 
-Transportation is a problem (4/02) 
-Transportation in small communities is the biggest problem. (10/01)) 
-Expansion of services depends heavily on the specialists. 
Transportation to Northern Saskatchewan needs to be addressed (3/01) 
Adherence to 
medication 
-Adherence is poor. Completion of treatment is affected by lack of 
knowledge. They stop medication when they get better. Start medication 
when they experience a flare up (8/01) 
- The pharmacists are important to improve adherence. Most patients 
have a good relationship with them (8/01) 
- Challenges with DOT providers at provincial level. Unique structure 
in the reserves versus RHA (2/01) 
-Determinants of adherence to medications are; housing, addiction 
issues, chaotic lifestyle affecting medical appointment, and medication 
fatigue (2/03) 
- A lot of success with DOT when it comes to methadone. But not 
everybody is on methadone (2/03) 
Shortage of human 
resources 
-Always short of staff. Rotate available staff to work with ID physician, 
Lab, and skin testing (2/02) 
-HIV/TB collaborative program will need rework of staff training and 
funds (2/03) 
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Policy on TB/HIV 
collaborative 
programming 
- Administratively, data collection, policy, and budget, TB and HIV 
programs work in silos. 
-Data for TB and HIV co-infection cannot be easily verified. TB does 
not have access to HIV data (6/01) 
- No provincial TB/HIV co-infection or collaborative program (1/01) 
Accessibility - Due to the mobility of the first nation’s people, some services can be 
accessed in the city. Access is better in rural where service is culturally 
sensitive (1/02) 
- Access difficult for those living outside these communities, they may 
need to travel to the big centers in Saskatoon or Prince Albert (3/01) 
- Access to HIV service hindered due to other social concerns, for 
example; no housing, no food for some days, some have warrant for 
arrest. (8/01) 
- People do not want to access services close to their homes. They may 
be familiar with the service providers. (3/01) 
Laboratory services - Lots of problems getting the patient to come back to read Mantoux test 
(2/03) 
- Communicable disease control laboratory is in Regina. Completely 
separated from TB control laboratory which is based in Saskatoon 
(10/01) 
- There are issues about tracking down people who need testing and 
collecting samples. There is need for a mobile lab. If you have mobile 
clinic why not mobile lab. There is point- of -care diagnostics in 
Saskatchewan but verification should be done in Regina. (10/01) 
 
5.6 Discussion 
Demographic information of participants: The participants were 19 adults comprising 
11 females and 8 males. This purposively collected sample were in two groups: Group A are 
Clinicians, TB and HIV program officers, administrators, social workers, and stakeholders. The 
length of service in their present position ranged from 5-20 years. Group B were mainly patients 
with HIV. Their ages ranged from 15-30 years, and education level below grade 12. 
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The initial step in needs assessment involves conducting a situation analysis. This 
involved gathering information about the health problem, its causes and severity. It is also 
essential to identify those people that are mostly affected, the broad context in which the health 
problem exist and the factors that inhibit or facilitate behavioral change. According to WHO 
(2017), situation analysis entails the appraisal assessment of the current health situation and is 
crucial to designing and updating national policies, strategies and plans. Furthermore, WHO 
posited that situation analysis should not only describe the epidemiology, demography and health 
status of the population, instead should be comprehensive, with the inclusion of the full range of 
current and potential future of health issues and their determinants.  
This paper illustrates the findings in the study of a needs assessment for TB/HIV 
collaborative programming in Saskatchewan through the framework of PRECEDE aspect of 
PRECEDE-PROCEED model. 
5.6.1 Historical and Cultural perspective 
Saskatchewan has one of the highest rates of TB and HIV among Canadian provinces. 
The epidemiology of TB in Saskatchewan is different from other provinces in that most cases are 
among the Aboriginal people and northern populations rather than foreign-born.  
 The Indigenous population in Canada: According to Statistics Canada (2017), in 2016 there 
were 1,673,785 Indigenous people in Canada, accounting for 4.9% of the total population. 
Indigenous population in Saskatchewan: The overall population of Saskatchewan is 1,168,058 
(Saskatchewan Bureau of statistics, 2017). Data from 2016 Census, shows Saskatchewan 
population of self-identified Indigenous people was 175,020 or 16.3% of the total population. 
The largest population of this group is the First Nations people who are 114,570 (10.7% of the 
population), followed by Métis 57,875 (5.4%) and Inuit 360 (0.18%). Among the First Nations 
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living in Saskatchewan in 2016, 54,460 (47.5%) lived on the reserve. 15,775 (5.5%) lived in city 
of Saskatoon, Regina 13,150 (5.7%) and Prince Albert 9,045 (21.3%). Among the Métis, those 
who lived in Saskatoon are 14,900 (5.2%). In Regina 7,975 (3.7%) and Prince Albert 7,570 
(17.9%). 
Constitution Act, 1982 Section 35 (The Canadian Encyclopedia, 2006) is part of the 
Constitution Act that provides a constitutional safeguard that protects the rights and treaty of 
Indigenous peoples in Canada. This act also defines the Aboriginal peoples to include the Indian, 
Inuit and Métis peoples of Canada, as well as, right to land claim agreements 
The coming of European settlers in Canada had an adverse repercussion on the 
Indigenous people. These impacts are in the form of devaluation of culture, language and 
traditions through the establishment of residential schools. A scoping review by Wilk et al. 
(2017) on residential school and the effect on Aboriginal health and well-being indicated that 
residential school had a long-lasting and intergenerational effect on the physical and mental 
wellbeing of Aboriginal people of Canada.  In the same note, Milloy, (2006) describe the impact 
of residential school as the most damaging of the many elements of Canada’s colonisation, and 
their consequences still affect the lives of Aboriginal people up to this day. Many health issues 
including addictions, poverty and mental health issues can be traced back to the residential 
school legacy. This influence was well articulated by a participant who indicated that poverty 
and residential schools constitute important co-existing factors that created a scenario where 
people either had a poor self-image or low self-esteem that they did not feel it was worth 
protecting themselves. 
TB remains a significant public health problem for Indigenous people living on reserves 
and those residing in the inner city (Young and Casson, 1988). Historically, death rates from TB 
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infection in the 1930s and 1940s among the First Nation peoples resulted in the death of 
700/100,000. This is described as the highest ever reported in a human population. The cause of 
high mortality was attributed to malnutrition, overcrowding in reserves and lack of immunity 
among the First Nation peoples. (Grzybowski & Dorken., 1983) 
In the past, the overall prevalence of HIV/AIDS in Canada was relatively low (Joint 
United Nations Programme on AIDS, 2016).  However, since 2000, the number of newly 
reported HIV infections has increased.  Officials suggest that this increase may be partly due to 
improved surveillance and reporting which, in most provinces and territories, also includes 
immigrants who now require mandatory testing.  Another comment on this worrisome trend of 
HIV in Saskatchewan indicated that Aboriginal communities in rural Saskatchewan are 
experiencing HIV rates that are among the highest in the world which is comparable to countries 
in the developing world (Soloducha, 2017). The participants express a high incidence of HIV 
among the Aboriginal communities in Saskatchewan.   
5.6.2 Socio-economic and environmental Determinants 
The World Health Organization (WHO) defines social determinants of health as the 
conditions in which people are born, grow, live, work and age (Commission on Social 
Determinants of Health, 2008). The main group of social determinants of health as described by 
WHO are; a) Physical environment (Including shelter, building, climate and peace). b) Social 
environment (education, income, social justice, access to health, social support network, and 
working conditions). c) Biological and behavioural determinants (genetic factors, personal health 
practices and coping skills, gender, ethnicity and lifestyles). Therefore, to reduce the impact of 
HIV and TB on communities that are unequally affected, the social determinants must be 
confronted (Centers for Disease Control and Prevention, CDC 2011). Accounts from this study 
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indicated that Indigenous peoples are overrepresented in the incidence and prevalence of TB and 
HIV infections in Saskatchewan, similar to what obtains in the rest of Canada. The factors that 
are responsible for these inequalities are complex and multifaceted (Dean and Fenton, 2010). 
The physical environment is vital in determining the health of Indigenous people, 
especially in the area of housing shortages and poor quality of existing homes (Bryant et al., 
2004). About 50% of the Indigenous population in Canada lives in rural and hard-to-reach 
communities, where life expectancy is shorter than in most of Canada (Reading & Wein, 2009). 
From the current study, the remoteness of these communities usually led to decreased access to 
health and social services. Of great concern are lack of health professionals, counselling services, 
confidentiality, and difficulty with transportation. Furthermore, unemployment rates for all 
Indigenous groups continue to be at least double the rate of the non- Indigenous population and 
Registered Indians have the highest unemployment rate of any Indigenous group (Reading & 
Wein, 2009). 
5.6.3 Unhealthy behaviour and lifestyle 
Unhealthy behaviour and lifestyle increase the risk or vulnerability of an individual to TB 
and HIV infections. In this study, the behavioural factors that increase the likelihood of being 
infected by TB and HIV generally described these individuals as living a risky lifestyle that 
participants attributed to a history of residential schools. As a result, the individuals who 
experienced these stressful conditions are involved with alcoholism, injection drug use, and 
prostitution. Participants in the study described TB as a disease of deprivation, inadequate 
housing and poverty. There is a strong connection between HIV and drug addiction in which 
70%-80% of HIV in Saskatchewan is seen among intravenous drug users (Yang et al., 2010. 
PHAC, 2016). Also, many of these drug addicts have a history of trauma, neglect, and physical, 
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emotional, and sexual abuse. The chaos in daily lives includes lack of housing leading to 
homelessness and high mobility within and outside the province, low-income support, and 
involvement with criminal activities or sex trade. TB and HIV weaken the patient’s physical, 
social, economic, and mental functioning.  Deribew et al. (2009) study included HIV positive 
individuals with and without TB. They found lower mean scores on all domains for people co-
infected with HIV and TB compared to people living with HIV without TB. These patients 
experienced depression, poor physical health and self-stigmatization as a result of being infected 
with TB and HIV. In Saskatchewan, the population affected by TB and HIV already experience a 
lower quality of life, because the majority of those affected are found amongst Intravenous Drug 
Users (IDU), homeless people, those with a history of child abuse and family violence 
(Government of Saskatchewan, 2017). It is therefore imperative that measures to alleviate these 
life stressors should be embedded in the design of intervention programs for TB and HIV. 
Accounts from a participant in this study noted that there is a need to stabilize the individual first 
before medication. This notion is supported in the literature by Coates et al. (2008) in which they 
indicated that a combination of behavioural, biomedical and structural interventions provides the 
most effective approach to HIV prevention and treatment, and this should be in concomitant to 
addressing social, economic and cultural barriers that affect community members. 
5.6.4 Stigma 
The most important interpersonal factor that affects the spread of diseases and utilization 
of TB and HIV services is stigmatization. Infected individuals are at risk of stigma-related social 
and economic consequences. It is a widely accepted fact that TB and HIV stigma contributed to a 
delay in diagnosis and negatively affects treatment compliance (Courtwright & Turner, 2010). 
The structure of a community’s beliefs and norms about a disease and the resulting stigma can 
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substantially impact health. According to Nyblade et al. (2009), the effect of HIV related stigma 
on health-seeking behaviour may result in individuals afraid of getting tested.  For people living 
with HIV/AIDS, being stigmatised may result in a delay to seek treatment, and lack of adherence 
to treatment regimen. In this study patients indicated that they experienced lots of stigmatisation 
in their communities and this had affected the following; a) Illness disclosure whereby infected 
patients would not disclose TB or HIV status or only tell those they are associated with. Fear of 
disclosure, mistrust in healthcare staff and concerns regarding patient confidentiality were 
frequently cited concerns of people living with HIV/AIDS. b) Utilization of services, because of 
familiarity with health providers in their communities and confidentiality cannot be assured. c) 
Adherence to medication, whereby stigma prompted patients to skip medication doses. Similar 
reasons for nonadherence were documented with TB/HIV co-infection (Gebremariam et al., 
2010; Naidoo et al., 2009), particularly when patients lack concurrent social support (Shin et al., 
2008). 
5.6.5 Addressing Predisposing, Enabling and Reinforcing factors for TB and HIV 
Predisposing factors are knowledge, attitude, and beliefs of participants towards TB and 
HIV infections.  Knowledge about and beliefs regarding these infections could impact user 
acceptability of TB/HIV collaborative program. If knowledge is high and users believe that TB 
and HIV infection pose a severe threat to health, they are more likely to have a stronger 
commitment to a TB/HIV infection program. In this study participants expressed that knowledge 
about TB and HIV infections is improving in the population, but some people call HIV a “dirty 
disease” or “Gay disease”. Some attributed it to be mainly among the “forgotten people”, that is, 
Intravenous Drug Users (IDU). Furthermore, there are many misconceptions about the mode of 
transmission of TB and HIV, and the general opinion is that HIV is a death sentence. Knowledge 
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about these diseases is believed to be linked with determinants of health-seeking behaviour as 
well as adherence to preventive measures and treatment (Goudge et al., 2009). Achieving a high 
level of TB and HIV awareness is essential for the success of prevention and treatment efforts, 
especially in high-risk groups. Knowledge about TB and HIV could impact user acceptance of a 
TB/HIV collaborative program and compliance with medical regimens (Deye et al., 2016). Also, 
to implement HIV prevention strategies among TB patients, it is essential to know the level of 
knowledge about HIV in a population. Disease-related stigma and knowledge are believed to be 
associated with patients’ willingness to seek treatment and adherence to treatment (Jittimanee et 
al., 2009). A study in Peru found inadequate levels of knowledge about HIV transmission and 
prevention among newly diagnosed TB patients (Millard et. al., 2015). 
Another predisposing factor is health beliefs about TB and HIV, which is how an 
individual perceives the risks of having the diseases and the severity of the diseases, and if there 
is a belief that taking recommended action will lead to a positive outcome (Godfrey-Fausset & 
Ayles, 2003).  The Health Belief Model (HBM) is a psychological model that attempts to explain 
and predict health behaviour by concentrating on the attitudes and belief of individuals (Glanz & 
Bishop, 2010). According to Abraham et. al., (2007), the variables in this model are perceived 
threat, perceived benefit, cues to action, and perceived self-efficacy.  Perceived threat consists of 
perceived susceptibility and perceived severity of the diseases. For example, does the individual 
believe he or she is at risk of contracting TB through overcrowding, or HIV through unprotected 
sexual intercourse. Perceived severity indicates whether an individual believes that TB and HIV 
is a severe or lifelong illness that can lead to death.  Perceived benefit is the belief that the 
strategies designed to reduce the threat of illness are going to be effective. While a perceived 
barrier is the potential negative consequences including, but not limited to physical, 
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psychological and financial. Cues to action are triggers that prompts an individual to engage in a 
behaviour that promotes healthy living and includes interpersonal or environmental cues (i.e. 
media publicity) that motivates a person to act to improve their health. The cues require 
perceived self-efficacy to have the confidence in one’s ability to successfully act on the cue. This 
incorporates the need to feel competent to effect long-term change. For example, the attitudes 
and beliefs expressed by those infected with HIV is the realization that they made bad choices as 
they go through daily life struggles. They inject drugs intravenously and are not ready to disclose 
this habit or HIV status. 
Enabling factors represent the necessary conditions that must be present for a successful 
implementation of TB/HIV collaborative programming (Crosby & Noar, 2011). These factors 
include availability of health resources which can be described in terms of geographical location, 
human and material resources. In remote and arduous to reach areas, lack and retention of 
adequately trained health personnel are commonly problematic. These areas also experience a 
high turnover of staff. Another critical factor is the financial input into the implementation of 
TB/HIV collaborative programs, and this is tied to strong political will considering that other 
programs compete for scarce resources. According to Harries et al. (2009), there is a scarcity of 
printed data on human resources for TB/HIV collaborative program. As a result, it is difficult to 
comment with sound evidence on the current state of human resources nor the additional human 
resources required to implement a collaborative program. 
Reinforcing factors are attitudes of the people in the community that help to support or 
make difficult healthy behaviour necessary to reduce the impact of TB and HIV diseases. These 
reinforcing factors play significant roles in reinforcing positive or negative behaviours through 
reward, feedback and punishment (Green & Kreuter, 2005). Psychosocial support is an integral 
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component that care providers regard as essential for people with HIV (Gonzalez et al., 2004). 
Support for patients and families can have a positive effect on adherence to therapies thereby 
contributing to the essential aim of integrating prevention with treatment and care (Padian et al., 
2011). People Living with HIV/AIDS and TB experience so-called “double stigmatization”. HIV 
stigma emanates from its association with socially undesirable sexual behaviour (Mbonu et al., 
2009). A common cause of TB stigmatization arises from fear of transmission from TB-infected 
individual to susceptible community members. The effects of stigmatization are the prevention 
of adequate social and medical care, and people are less likely to disclose infection, therefore, 
less likely to be tested (Courtwright & Turner, 2010). In this study, the participants expressed 
that the attitudes of the community members towards patients with TB and HIV varies from 
place to place depending on the attitude of the community member or healthcare staff. The 
patients also reiterated that some community members are helpful, and some stay away from 
you. One of the participants in the study said the LGBTQ community in University of 
Saskatchewan has good support system. 
5.6.6 Gaps in TB and HIV Services 
The following gaps emanated from the study: 
5.6.6.1 Access to health care 
Access to health care can be described as the appropriate use of personal health services 
to accomplish the best health outcomes. Attaining access to proper care involves the following 
specific steps: 1) Enter the health care system. 2) Get access to the location of care facilities 
where patients can receive needed services. 3) Find a health care provider whom the patients 
consider as trustworthy and they can communicate with (Levesque et al., 2013). The extent to 
which a population gains access to health care depends on financial, organizational and social or 
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cultural factors. (Gulliford et al., 2002). In this study, participants indicated that entering the 
healthcare system is hindered by the rurality and remoteness of the community in which they 
live. Also, they must travel to big health centres in Saskatoon, Regina, and Prince Albert to 
access needed health care services, and for those that live on-reserve lack of transport is a 
constant challenge. Furthermore, participants expressed concern about the proximity of health 
services to their area of abode in which they are reluctant to access care because of familiarity 
with service providers. According to Canadian Institute for Health Information (2011), rural 
populations are particularly vulnerable with respect to accessing health care because many 
Indigenous populations live in rural or remote areas.  This geographical distance, sometimes 
compounded with seasonal isolation and lack of transportation, can limit their ability to reach 
health care services. 
5.6.6.2 Funding 
In this study, participants disclosed that funding for TB and HIV is through multiple 
sources and this has impaired the services provided concerning efficiency and effectiveness of 
services. Also affected is staff recruitment, role and discipline of health providers due to this 
differential funding sources. In Saskatchewan funding for TB control services is provided by the 
Ministry of Health, and various health regions who are responsible for funding “off reserve” 
Aboriginal populations.  The former First Nation and Inuit Health Branch (FNIHB) of Health 
Canada, now called the Indigenous Health Service (created in 2018) is responsible for provision 
of   funds for “on reserve” Indigenous population, and this includes Northern Intertribal Health 
Authority (NITHA) which comprises of 33 “on-reserve” Indigenous communities, a partnership 
of Lac LaRonge First Nations, the Peter Ballantyne Cree Nation, and the Prince Albert Grand 
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Council.  NITHA also functions to design and implement the communities’ health programs and 
employ most of their health staff through funding contribution agreement with FNIHB. 
This complex health funding system among the Indigenous populations is attributed to 
the multijurisdictional funding of health programs in which funds are channeled from 
Province/Territories, Federal and Agencies. The challenges that emanate from this funding 
system are lack of coordination and inefficient delivery of services (Storch, 2005). 
Funding for HIV in Saskatchewan is through the provincial government, and this is distributed to 
Regional Health Authorities (RHA) to implement intervention strategies developed by the 
Saskatchewan HIV Strategy. The funds are used for engagement of clinical expertise, social 
marketing, education/training, HIV Point of Care (POC) Testing and peer-to-peer pilot 
programming. 
In general health care in Canada is predominantly delivered through a publicly funded 
health care system.  However, this is according to the provision of the Canada Health Act of 
1984 (Government of Canada, 1985). Health care is organized, delivered and funded by the ten 
provinces. The federal government co-finances 20% of total provincial/territorial health care 
expenditures. The federal government also provides direct delivery of services to Inuit, First 
Nations residing on-reserves and to those living in their traditional territories; and members of 
Canadian Forces. 
5.6.6.3 Surveillance for TB and HIV 
According to UNAID (2017), surveillance is recognized as the most important activity in 
understanding the trends of epidemics and make possible sound strategies are developed for 
responding to them. Surveillance of HIV among TB patients is increasingly seen as important, as 
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the HIV epidemic has continued to fuel the TB problem and as new solutions have emerged to 
tackle this developing situation.  
This study reveals that in Saskatchewan surveillance of TB and HIV is performed 
separately and there is no process for sharing data between the two control programs. To achieve 
satisfactory outcomes concerning health program planning and implementation, the importance 
of conducting surveillance cannot be overemphasized. Several studies conducted in Canada show 
inconsistency in the rate of TB and HIV co-infection (Long & Boffa., 2010). The World Health 
Organization recommends routine, universal HIV testing of patients with TB. In Canada, several 
official statements and peer-reviewed publications dating back to 1992, have recommended 
routine, universal HIV testing of patients with TB (Long and Boffa. 2010) 
5.6.6.4 Transportation 
In this study, participants expressed difficulty with transportation, and this is particularly 
felt in rural and remote communities, especially among Indigenous people that live on reserves. 
The need to travel for treatment and services imposes a financial burden in the form of 
transportation costs and hotels. The availability of dependable transportation impacts a person’s 
ability to access appropriate and well-coordinated health care. According to a publication by 
three northern health regions in Northern Saskatchewan, in both the Athabasca Health Authority 
(AHA) and Mamawetan Churchill River Regional Health Authority (MCRRHA) regions, 
transportation issues are of primary concern. Three of the AHA communities are accessible only 
by air and the remaining two have only seasonal road access.  
To solve the transportation issue, some First Nation members are covered by Medical 
Transportation Benefits of Non-Insured Health Benefits (NIHB) Program. The NIHB Program 
provides a confined range of medically necessary health-related services not provided through 
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private insurance plans, provincial/territorial health or social programs or other publicly funded 
programs to eligible registered First Nations and recognised Inuit. The NIHB benefit applies only 
to status Indians and Inuits, and not include Métis and other Indigenous people who are not 
eligible for registration under the Indian act (Lavoie & Forget., 2018). This adds to the 
complexity of the healthcare system amongst the Indigenous population leading to unequal 
access to health. 
5.6.6.5 Coordination of referrals 
According to the WHO successful implementation of TB/HIV collaborative services 
requires the joint efforts of implementers of TB control programs and HIV control programs as 
well as their equivalent in nongovernmental organizations, other civil society organizations 
including communities and faith-based organizations, and the private-for-profit or corporate 
sector. In this study, coordination of referrals is hindered by factors such as patient’s chaotic life, 
difficulty in accessing services due to location, the high mobility of patients, and insufficient 
human resources. It is essential that the referral system should be robust enough to capture most 
patients with the diseases who would then be able to access existing clinical or public health 
services including any extended coverage. 
Most importantly it is required that patient is not lost within the health system thereby 
leading to catastrophic consequences of disease progression or multi-drug resistant TB. It is 
therefore essential to identify synergies in both programs and to look for opportunities for entry 
points that would provide links for counselling, diagnosis, treatment, and prevention services for 
patients with TB or HIV infections. In this study, participants attributed the frequent loss to 
follow-up to differences in location and distance of treatment and care. 
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5.6.6.6 Health System constraints 
The study identified several widespread health system deficiencies and policies that 
contribute to suboptimal access to TB and HIV services including human resources, staff 
turnover, medication, laboratory, and adherence support.  
High turnover and difficulty in the recruitment of qualified staff were significant themes 
identified in the study, especially for small and remote communities in Saskatchewan.  The study 
found that many disease-specific health care staff and specialists preferred working in urban 
communities. According to participants in the study, there are no infectious disease or internal 
medicine specialists in First Nations communities, and they rely on visiting specialists to conduct 
clinics. The shortage of specialized staff, and staff shortage in general lead to overburdened staff 
and inability to successfully manage HIV and TB patients and programs. 
The assurance that the public has in the health care system is associated with the 
availability of safe and effective medicine, and measures put in place to ensure its’ rational use. 
In past decades, advances have been made in HIV therapy with six drug classes comprising 24 
individual antiviral agents (Tseng et al., 2012). Patients who are adherent to use of medications 
with undetectable viral load has made HIV a manageable chronic disease. In contrast to HIV, TB 
is curable with the administration of effective drug treatment regardless of age, sex, gender or 
type of TB disease.  
5.6.6.6.1 Medication support 
As part of implementing patient-center care a component of WHO’s End TB strategy 
(WHO, 2015), all patients should receive educational, emotional and economic support. In 
Saskatchewan, participants indicated that there are challenges concerning availability, access, 
and distribution of TB and HIV medication, especially in rural areas.  
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Adherence to treatment is crucial to the treatment of TB and HIV infections because it 
affects the extent and duration of response to TB and HIV pharmacotherapy. Treatment for TB 
must be taken daily for at least six months, and antiretroviral treatment for HIV is a lifelong 
journey. However, patients frequently stop taking their medication once they start to feel better.  
In 1994, WHO (1997) endorsed the strategy of Directly Observed Therapy (DOT) to improve 
adherence to TB medication by requiring health workers, community volunteers or family 
members to observe and record patients as they take their medication.  
In Canada, DOT is still the standard practice to significantly improve adherence (Alverez 
et al. 2015). The challenges to implement DOT for all TB patients are the considerable human 
resources cost, timing of visits that is appropriate for client and DOT provider, privacy regarding 
the location of visit, and geographical distance which limits the number of clients one DOT staff 
can see in a day. Rigid adherence to medication is fundamental to sustained HIV suppression, 
reduced risk of drug resistance, improved overall health, quality of life, survival, as well as to 
decrease the risk of transmission (Chesney, 2006).   
Adherence to treatment can be influenced by a patient’s social situation and clinical 
conditions, the prescribed regimen, and the patient-provider relationship (Schneider et al., 2004). 
From participants’ perspectives in the study, nonadherence is often due to behavioral, structural, 
and psychosocial barriers, for example, low level of social support, stressful life events, high-
level of substance misuse, homelessness, poverty, nondisclosure of HIV status, denial, and 
stigma. To improve adherence to TB and HIV medication comprehensive multidisciplinary care 
is required that would support patients' complex needs.  Examples are case managers, 
pharmacists, social workers, government and non-government stakeholders involved with TB 
and HIV, and mental health care providers. Drug abuse treatment programs are essential to 
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address substance use.  A respondent suggested a strong link of medication disbursement with 
methadone therapy because it is rare that methadone patients miss their medication. 
5.6.6.6.2 Laboratory support for TB and HIV 
This is an essential part of the diagnosis, treatment, prevention and control of TB and 
HIV. Early diagnosis and timely treatment of any form of drug-susceptible or drug resistance TB 
are fundamental to control measures. WHO endorses rapid TB diagnostics and DST should be 
available to all who need it, in line with the TB strategy (WHO, 2017). Delays in laboratory 
confirmation of TB and reporting of drug-susceptibility results can lead to delays in initiation of 
therapy, prolonged infectiousness, and inappropriate therapy and missed opportunities to prevent 
transmission. There is a growing concern in many countries facing extremely high rates of 
tuberculosis (TB) and HIV co-infection with an increase in multidrug-resistant (MDR) and 
extensively drug-resistant (XDR) infections (WHO, 2017). According to WHO (2015), the main 
framework in TB control as it concerns diagnostics are; A) active case finding/systemic 
screening. This is the systematic identification of people with suspected active TB, in a 
predetermined target group, using tests, examination or other procedures that can be applied 
rapidly. B) Contact tracing, TB contacts are people who have close contact with active or 
infectious TB patients. They are highly susceptible to infection and should be investigated 
systematically for active TB infection. Screening tools used for TB diagnosis are Radiography of 
the chest, sputum smear microscopy, growth-based detection, molecular techniques (Nucleic 
Acid Amplification Testing. NAAT), tuberculin Skin test (TST), Interferon-gamma Release 
Assay (IGRA). In Saskatchewan respondents identified the following as gaps in the provision of 
excellent laboratory services; 1) different location of TB and HIV laboratory services. TB control 
laboratory is in Saskatoon, while HIV is located in Regina. 2) At point of care, getting a patient 
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to come back for their result of Mantoux test is often problematic.3) It is difficult to track down 
people who need testing and collection of samples. Therefore, it is suggested that a mobile 
laboratory should be established in rural and remote areas. 
5.6.6.6.3 HIV control: Model for success. 
In 2014, UNAIDS published an ambitious treatment target to help end the AIDS 
epidemic called 90-90-90 (UNAIDS, 2017). This states that by the year 2020, 90% of all people 
living with HIV will know their HIV status, 90% of all people diagnosed with HIV will receive 
sustained antiretroviral therapy (ART), and 90% of all people receiving ART will have viral 
suppression (UNAIDS, 2014, p.1). The strategy is to get HIV under control based on the 
principle of universal testing and treatment. HIV testing is essential to achieve the first 90%, that 
is, people in a population that will know their HIV status. This service according to WHO entails 
pre-test information and post-test counselling; linking the patient to appropriate HIV prevention, 
treatment and care service, and other clinical and support service; and coordinating with 
laboratory services.   
According to a publication by the Government of Canada in 2018, there are several 
factors associated with achieving each of the 90-90-90 targets. To address the first target will 
require increased effort on HIV testing uptake by ensuring robust advocacy on risk perception, 
accessibility of services, community knowledge and awareness. The second target to treat all 
diagnosed with HIV with ART is a policy that is relatively recent in Canada and would take 
some time for physicians and patients to adjust to. Prompt initiation of treatment, and more 
tolerable regimens and adherence support to influence uptake of treatment over time.  The third 
target requires that patients remain engaged to care. In this study, a participant suggested that a 
clear policy on diagnosis, prevention and treatment, together with an increased effort to track 
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down people who need testing by use of the mobile laboratory is required and would support a 
provincial strategy. This is consistent with the WHO’s 2015 report on consolidated guidelines on 
HIV testing services, which advocated that countries should address the testing gap, push testing 
into the communities, support linkage to care, encourage focused and appropriate targeting, and 
improve quality to prevent misdiagnosis (WHO, 2015). 
In Saskatchewan, there are significant challenges to implement 90-90-90 strategies, 
which are still not endorsed by the Saskatchewan Ministry of Health and various agencies. 
However, Dr. Ryan Meili an infectious disease specialist and member of a group called 
Saskatchewan HIV/AIDS Research Endeavour (SHARE), in news posted in CBC (August 
2015), proposed prompt implementation of 90-90-90 strategies to boldly attack the HIV 
epidemic in Saskatchewan, but necessary resources are yet to be mobilized (CBC news, 2015).  
5.6.6.7 Need for collaborative service 
The need for TB and HIV programs to collaborate was internationally recognised by 
WHO in 2004 when an interim policy was published by WHO’s HIV department and Stop TB 
(WHO, 2004). In areas with high TB and HIV incidence and prevalence, it is essential to ensure 
effective coordination between TB and HIV services so that patients can access the care they 
need from both services. This is especially important in TB/HIV co-infected patients where they 
have to navigate two separate health care systems, thereby leading to additional time and 
transport cost. This view was expressed by participants in the study in which collaboration 
should be extended to other pertinent specialities, for example, Addiction and Infectious diseases 
specialities.   
Successful implementation of TB and HIV collaborative activities depend upon the 
background knowledge of the epidemiological, socio-economic, behavioural and administrative 
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characteristics that affect the diseases and therefore, tailoring interventions in a manner that 
enables logical introduction into existing programs that are often overwhelmed with large 
numbers of patients and a deficiency of human and other resources (Howard & El-Sadr, 2010). 
Furthermore, building on well-established TB control infrastructure would be cost effective due 
to long-term experience in providing, monitoring, and supervising the care of patients (Harries et 
al., 2006).  
According to Friedland et al. (2007), three types of models are proposed for a TB/HIV 
collaborative program (Fig 5.2). In this study, participants expressed different preferences to 
which model is the ideal (Model 1) Referral model of a patient between separate TB and HIV 
programs. Patients seek HIV testing service, HIV care and treatment support at a different 
location than the TB clinic (Model 2) Partial integration of services. This can be achieved 
through deliberate efforts by health providers and facilities to ensure that services are delivered 
on the same day, within the same facility, but not the same staff or in the same clinic (Model 3) 
Full integration of services, TB and HIV services (Counselling, and testing for HIV, ART, TB 
screening and treatment) are provided in the place by the same staff (Ansa et al. 2012). Despite 
different delivery models, it is expected that outcomes should be identical by ensuring TB 
treatment success-cure/completion of therapy, reduction in HIV disease progression and 
mortality, and a decrease in transmission of both diseases (Friedland 2007).  
In a study by Daftary et. al. (2007) in South Africa, patients compared their experiences 
at TB and HIV clinics. At the TB clinics, they complained of lack of individual attention and 
privacy, and referral to DOTS and hospital facilities were rushed and impersonal. In comparison, 
they found that services for HIV were more personalised and attitudes were friendly. Also, some 
patients refused to access HIV services at TB and/DOT clinic out of fear of status disclosure or 
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being recognised by neighbours due to where HIV clinic is not far from home. This is especially 
significant in rural and remote areas where everyone knows each other. This is similar to what 
participants alluded to in this study.  
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Figure 5.2: Model of TB/HIV collaborative services. 
5.7. Conclusion 
The primary purpose of this study is to make a case for the establishment of a policy on 
TB and HIV collaborative services in Saskatchewan. There is no policy on collaborative 
programming even though the statistical evidence pointed towards a high incidence and 
prevalence of TB and HIV in the province, especially among the Indigenous peoples living in 
urban, rural, on and off-reserve areas. Therefore, there is an urgent need to plan for an 
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appropriate intervention that is effective and sustainable and would reduce the epidemic of TB 
and HIV in affected or vulnerable populations. The plan should include strategies that would 
address all aspects of the social determinants of health, that is, physical, social, economic, 
environmental, biological and behavioral factors that affect TB and HIV in Saskatchewan 
communities. In addition, it is crucial to provide appropriate human and material resources and 
establish inter-sectoral collaboration with other services from within the health sector and 
beyond, including civil society, professional associations, international, inter-governmental and 
non-governmental organizations, that are essential to TB and HIV prevention, control and 
treatment. Also important is ensuring that intervention strategies adopt a sustainable people-
centred integrated care that support adequate housing and diet, support from family and friends, 
socially stable environment, good employment and working conditions, proper education and 
literacy.  
To accomplish the establishment of this TB/HIV collaborative policy, this study started 
with a needs assessment study, which involved a systematic approach to data gathering and 
analysis that identified the population health needs and priorities, the situation analysis of TB 
and HIV in the population, the present state of implementation of intervention programs, and met 
and unmet needs. The PRECEDE aspect of the PRECEDE-PROCEED model was used as a 
guide to formulate appropriate questions in the semi-structured interviews that were used in the 
needs assessment.  
Using the PRECEDE framework helped to provide a template to develop a consistent 
procedure for evaluating TB/HIV programming. Furthermore, the model gives relevant 
information about social, epidemiological, environmental, behavioural, and administrative 
factors that affect TB and HIV infections in the Saskatchewan population. The results of this 
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study gave insight into the identification of gaps in the present implementation of TB and HIV 
control programs in Saskatchewan, which is described under the following headings; access to 
health care, funding structure for TB and HIV programs, surveillance for TB and HIV, 
transportation challenges, coordination of referrals, and health system constraints.  The 
PRECEDE framework was effective in identifying the met and unmet needs of the current TB 
and HIV programs in Saskatchewan and elements for a collaborative program that will lead to 
improved program performance and improve outcomes. 
To achieve an efficient joint TB and HIV programming, there should be harmonisation of 
evidence-based national and provincial policies and program direction established on 
internationally acceptable policies and guidelines.  The results from this needs assessment can be 
used to plan and implement TB/HIV collaborative programming in Saskatchewan (paper 3). 
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6. Paper 3:  TB/HIV COLLABORATIVE PROGRAMMING: POLICY GUIDELINES ON 
IMPLEMENTATION 
 
6.1  Contribution of Paper 3 to the thesis 
 Paper 3 proposes a means to intervene in the epidemic of TB and HIV in Saskatchewan, 
using evidence-based methods of diagnosis of social, epidemiological, behavioural, educational 
and administrative factors in PRECEDE aspect of PRECEDE-PROCEED model. The results 
from paper 2 were used to develop a logic model which provides the framework for 
implementation. This paper is yet to be published. 
6.2  Abstract 
Objective: To develop policy recommendations on the implementation of TB/HIV collaborative 
programming in Saskatchewan through the application of a locally developed logic model 
combined with WHO recommendations with the goal of reducing the incidence and prevalence 
of TB and HIV in Saskatchewan. 
Method: The process of developing the Logic model for TB/HIV collaborative programming in 
Saskatchewan consisted of 3 steps; Step 1 is the exploratory step or needs assessment step in 
which the PRECEDE model, social, cultural, epidemiological, behavioural, environmental, and 
administrative assessments, were utilized as a template to design interview questions for the 
needs assessment data collection, (Paper 1). Step 2 involved data analysis and identification of 
unique factors that affect the epidemiology of TB/HIV in Saskatchewan (Paper 2).  Step 3 is the 
intervention step, with the primary objective of defining specific evidence-based interventions 
and activities to target identified factors that affect the occurrence of TB and HIV. Also, the 
result of data analysis was incorporated into WHO recommendations for TB/HIV collaborative 
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activities (2012) to form the logic model.  The overall goal of TB/HIV collaborative activities is 
to establish and strengthen the mechanisms for delivering collaborative/integrated TB and HIV 
services, which in effect will reduce the burden of TB in people with HIV, and also reduce the 
burden of HIV in patients diagnosed with TB.  
Results: A logic model which graphically depicts the relationships between the objectives, input, 
activities, and outcomes for implementing TB/HIV collaborative programming in Saskatchewan, 
Canada, was designed.  
Conclusion:  Collaborative TB and HIV programming in Saskatchewan is expected to bring 
about best practices in social support, clinical care, and public health strengthening necessary to 
reduce the incidence and prevalence of TB and HIV in the population. This collaborative 
programming will also lead to efficient use of both human and financial resources through the 
search for, and eliminating, areas of service duplications in both programs.  Furthermore, 
synergised program management and efforts in the areas of surveillance and data management, 
laboratory services, drug management, treatment, health education/ promotion, monitoring and 
evaluation will result in better health outcomes and enhanced impact. 
6.3  Introduction 
The synergistic relationship between TB and HIV infections potentiates the incidence and 
prevalence of both diseases in the population.  The lifetime risk of a person infected with TB to 
develop clinical TB is 5-10% in an HIV negative person, whereas it is 50% in an HIV positive 
person (Corbett et al., 2007).  Therefore, in settings where the prevalence of HIV is high, TB is 
the most common infection to develop among people living with HIV. This reality indicates that 
TB control will not be accomplished unless a joint HIV control is put in place.  
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The improvement of outcomes of both diseases depends upon looking at varying degrees 
of collaboration and integration between existing TB and HIV programs (WHO, 2004). WHO 
started a collaborative pilot program in 3 sub-Sahara African countries (Malawi, Zambia and 
South Africa) referred to as the ProTest (promotion of voluntary testing), the project aimed to 
develop a district-based strategy for a joint TB and HIV response. Evaluation of these projects 
shows that TB and HIV control programs can work together effectively by providing 
comprehensive prevention, care and support services for people living with HIV/AIDS and/or 
TB. Also, collaborative activities were both necessary and feasible (Howard et al., 2012). Terris-
Prestholt et al. (2008) in the study of the cost of Zambia ProTest initiatives that integrate TB and 
HIV services among people living with HIV concluded that when the two services are integrated, 
or there is some form of collaboration, it is relatively inexpensive. Also, collaborative 
programming has the advantage of prompt diagnosis of HIV among patients with TB or HIV 
among TB patients resulting in early initiation of life-saving TB or HIV treatment (WHO, 2012). 
Established in 2001, the global TB/HIV working group was charged with the responsibility to 
advise the WHO on the development of policy on collaborative TB/HIV activities and to identify 
key activities to decrease the burden of TB and HIV infections in populations affected by both 
diseases (WHO, 2004). WHO global initiatives and initial results support the need for 
collaborative programming (WHO, 2009).  
In Canada, TB and HIV control services remain separate and often fragmented and are 
likely to lead to suboptimal outcomes. Canada operates a federal system of government and 
health costs are shared across federal, provincial, and territorial governments. Health care 
delivery to most of the population is by the provincial government, while the federal government 
is responsible for health care services to specific populations including First Nations people 
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living on reserve, Inuit communities, and federal prisons (Government of Canada, 2016). The 
federal government also provides policy direction on health matters in partnership with 
provincial and territorial governments. Also, the federal government provides funds for the 
health systems, health research, and enforcement of health regulations.  
Funding for TB and HIV care is derived from multiple sources, fragmenting care delivery 
and accountabilities. Separate initiatives for HIV and TB control in Canada have been 
implemented. For HIV, in 2005, the Government of Canada launched the Federal Initiative to 
address HIV/AIDS in Canada (Government of Canada, 2012). This initiative provided funding 
for prevention and support programs reaching key priority populations, as well as research, 
surveillance, public awareness, and evaluation (Government of Canada, 2013). The goals were to 
prevent the acquisition and transmission of new infections, slow the progression of the disease, 
improve quality of life, and reduce the social and economic impact of HIV/AIDS. In response to 
substantial increases in HIV since 2003, a provincial leadership team was established to develop 
the Saskatchewan HIV strategies. The goals were similar and linked to the federal initiative 
which includes a reduction in the number of new HIV infections, improving the quality of life 
for HIV infected individuals, and reduction in risk factors for acquisition of HIV infections 
(Government of Canada, 2012) 
The Government of Canada demonstrated its commitment to reducing the burden of TB 
in the population through implementation of a “Federal Framework for Action” that addressed 
the high rates of TB within affected communities and the factors that propagate the spread of the 
disease (PHAC, 2014). This framework focused on the population that contributed to the high 
burden of TB, which are, Canadian-born Aboriginal people and foreign-born individuals from 
high endemic TB regions. The goal was to reduce the incidence of reported TB cases by 3.6 per 
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100,000 or less by 2015 (this goal is yet to be achieved). The TB Partnership Working Group 
was established to ensure a collaborative approach to addressing the complex issues that 
contribute to TB in Saskatchewan (Government of Saskatchewan, Ministry of Health, 2013, pg. 
8). The goals are linked to that of the federal framework for action against TB. Membership 
includes TB Control Saskatchewan, the Ministry of Health, regional health authorities, First 
Nations health authorities, and First Nations and Inuit Health Branch (FNIHB) of Health Canada.  
The Federal and Provincial responses to TB and HIV co-infection are minimal. The 
actual level of TB-HIV co-infection in Canada is unknown, which is attributed to a lack of 
concurrent surveillance for the two diseases (Long & Boffa 2010). The Canadian Tuberculosis 
Standard recommended that all people with active TB disease should be tested for HIV and all 
HIV-infected people should be assessed for active TB or exposure to TB (Alvarez et al., 2014). 
There is no established policy toward TB/HIV co-infection programming in Saskatchewan, but 
the screening of TB patients for HIV and HIV patients for TB is promoted. As recommended by 
WHO, collaborative programming is necessary to reduce the burden of both diseases (WHO, 
2009) 
6.3.1 Rational for Collaborative Program 
TB/HIV collaboration is mainly about changing the process of care, and multidisciplinary 
collaboration is expected to enhance the focus on patients, improve coordination, and maintain 
continuity (Ansa et al. 2012). At the program management level, Tuberculosis and HIV 
prevention and control programs share mutual concerns. HIV prevention care and treatment 
should be a priority for tuberculosis control programs, and tuberculosis prevention and treatment 
should be a priority concern for HIV prevention and control programs because both diseases 
impact the morbidity and mortality of each other. It can, therefore, be concluded that joint 
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program planning, implementation, and coordination of activities is critical to the successful 
control of both diseases. 
6.4  TB/HIV Collaborative Programming in Saskatchewan 
The proposed Saskatchewan TB/HIV Collaborative Programming model is based on 
objectives recommended by the WHO (2012). Also, the various activities to implement these 
objectives were derived from the analysis of participants’ responses to interviews in the study.  
The WHO’s objectives are: “(1) establish and strengthen collaboration between TB and HIV 
control programs; (2) reduce the burden of TB in those with HIV, and (3) reduce the burden of 
HIV in patients with TB” (WHO, 2012, p. 9). The logic model for TB/HIV programming (Fig. 
10) is the visual representation of the major elements of the suggested program for 
Saskatchewan. The structure identifies the main program components (objectives, inputs, 
activities and outcomes) and how they relate. It is a useful tool to build understanding and clarity 
about the program, identify resources needed for sustainable implementation, identify the 
sequence of activities that should be implemented, and serve as a basis for program evaluation 
In this study, a total of 19 participants were interviewed using the PRECEDE framework 
as the template for the semi-structured interview to do the needs assessment. Analysis and 
interpretation of data collected were done using framework analysis which identified the social, 
cultural, epidemiological, environmental, and administrative factors that affect the epidemiology 
of TB and HIV in Saskatchewan. After that, the results of data analysis were incorporated into 
WHO recommendation of TB/HIV collaborative activities to form a logic model. 
The process of how the results from PRECEDE model are incorporated to describe the logic 
model are described in the table below. 
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Table 6.1: Process of how results from the PRECEDE model are incorporated to describe the 
logic model 
PRECEDE model Result from study Logic model 
Phase 1 and 2 
Social and Epidemiological 
diagnosis 
a) High TB and HIV rates 
b) Socio-economic 
determinants e.g. poverty, 
poor housing, sexual and 
emotional abuse, history of 
residential school system.  
 Objectives: Establish and 
strengthen mechanism of 
collaboration between TB and 
HIV. 
Input/Activities  
-Set up TB/HIV coordinating 
at provincial level 
-Determine TB and HIV 
prevalence in the community 
-Develop operational 
guidelines for TB/HIV 
collaborative programming 
that would link to other 
relevant agencies that are 
responsible for reduction of 
socio-economic impact on TB 
and HIV in the communities. 
-Improved accessibility of 
services to make sure that 
patients get appropriate 
treatment and care by trained 
staff 
-Establish high level 
laboratory that would aid 
surveillance through routine 
offering of HIV and TB 
counselling and testing.  
 
Phase 3  
 
 
 
 
 
 
 
 
 
 
 
Behavioral diagnosis 
-Chaotic life style 
-drug addiction, alcoholism, 
unprotected sexual practice, 
needle sharing 
 
Objectives: Reduce the 
burden of TB in people living 
with HIV and HIV in people 
with TB 
Inputs/activities 
-Enhanced harm reduction 
services to prevent the spread 
of HIV and reduce other 
harms associated with drug 
use (e.g. easy access to clean 
needle, methadone therapy 
under medical supervision 
Environmental diagnosis 
-Large geographic areas 
which are mostly rural 
-Saskatchewan northern 
communities 
 
126 
 
Phase 4 Predisposing factors 
Misconception about mode of 
transmission 
 
Reinforcing factors 
Minimal support from peers, 
community members 
 
Enabling factors 
-Inadequate manpower and 
lots of turnover of staff 
-Limited and different 
sources of funds 
-Difficulty in setting up 
appointments 
-Transportation difficulty 
-Reduction of stigmatization 
and discrimination through 
targeted information, 
education and communication 
for community members, 
people who inject drugs and 
sexual partners. 
-Ensure comprehensive 
contact tracing 
-Improve resource 
mobilization, alignment and 
deployment. 
-Provide adequate workforce, 
and training 
-Provide access to efficient 
and subsidized medical 
transportation especially in 
rural and remote areas 
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Figure 6.1: Logic Model for Saskatchewan TB/HIV collaborative program
Goal: The goal of collaborative TB/HIV activities is to decrease the burden of TB and HIV infections in Saskatchewan population.  
Objectives Outcomes Activities Input 
A1) Set up TB/HIV 
coordinating body at 
provincial level 
A2) Determine TB 
and HIV prevalence 
in community 
A3) Monitor and 
evaluate services 
Early diagnosis and 
treatment of TB and 
HIV patient 
Prevention of HIV 
in TB patient 
 
C) Reduce the 
burden of HIV in 
patients with TB 
B) Reduce the 
burden of TB in 
people living with 
HIV 
A) Establish and 
strengthen 
mechanism of 
collaboration 
between TB/HIV 
programs 
• Advocate increase political and resource 
commitment, and community strengthening. 
• Develop evidence based governance and operational 
guidelines 
• Describe model of delivery 
• Develop Intersectoral collaboration to address Social 
determinants of TB and HIV 
• Resource mobilization, alignment and deployment 
• Appropriate work force and training 
• Improved access to service 
• Establish a single surveillance system for TB and 
HIV 
• Tackling TB and HIV in underserved population 
• Laboratory support  
• Define, monitor, and report in accordance with 
appropriate indicators and target 
• Ensure comprehensive contact tracing 
• Coordinate treatment for PLWHA 
• Ensure TB control in health care setting 
• Adherence support 
• Drug Management 
• Routine offering of HIV counselling and testing 
• Promotion of safer sex 
• Provide ART for HIV patient 
Short term 
• Reduce 
infectiousness 
• Improved 
patient health 
• Positive 
behavior 
change 
Intermediate 
• Decreased 
TB/HIV 
morbidity 
• Decreased 
TB/HIV 
transmission 
• Increased 
public health 
knowledge of 
transmission 
network 
Long Term 
• Reduced 
TB/HIV 
incidence 
• Reduced cost 
• Improved 
public health 
and quality of 
life 
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6.4.1 Objective 1: Establish and strengthen mechanism of collaboration between TB and HIV 
control program 
According to The Global Funds (2008), the purpose of TB and HIV joint programming is 
for a better concentration of resources and harmonization of efforts that will lead to enhanced 
efficient, effective and sustainable services.  Identifying areas for alignment of plans, and 
improving support systems and integration of services will, in turn, result in stronger 
collaborative TB/HIV activities (The Global Funds, 2008). The guiding principle should be that 
the provincial TB and HIV programs collaborate to ensure people with TB and HIV receive a 
continuum of high-quality care that is devoid of discrimination and stigmatization.   In 
Saskatchewan, the participants expressed disconnection between TB and HIV control programs 
regarding lack of policy for collaborative services, data collection, access to services, the model 
of collaborative services, and building of partnerships with communities, stakeholders and other 
relevant Government services. 
According to Havlir et al. (2008) implementation of collaborative TB/HIV activities 
requires coordination between TB and HIV programs at all levels. Therefore, inputs to achieve 
each objective in the logic model were derived from a combination of WHO recommended 
activities for TB/HIV collaboration, gaps identified from the study, and TB/HIV collaborative 
initiatives from other countries (for example, European Union countries, South Africa, Zambia, 
Botswana, Myanmar, and Nepal). 
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Figure 6.2: Excerpt of logic model for Objective 1 
6.4.1.1 Objective 1, Input A1: Set up a TB/HIV coordinating body at the provincial level.  
At the provincial level members will be drawn from the existing TB partnership working 
group, Saskatchewan HIV provincial Leadership team (HIV PLT), community leaders from 
“high incidence TB and HIV areas,” Community based organizations in Saskatchewan province, 
and non-governmental organizations. (Appendix E for a list of CBOs, NGOs’ and Stakeholders 
in Saskatchewan).  
The role required from this coordinating body at the provincial level are to advocate for 
increased political and resource commitment to TB/HIV collaborative activities and develop 
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joint capacity building.  Joint capacity should include, governance and operational guidelines, 
planning, coordination and implementation of collaborative TB/HIV services. This is similar to 
the proposed implementation TB/HIV collaborative programming in Ethiopia, Kenya and 
Rwanda sponsored by United State President’s Emergency Plan for AIDS Relief (PEPFAR), 
(Howard et al. 2012). Furthermore, this body should come up with the models of delivery of 
TB/HIV collaboration/integration that are evidence-based, client and family-centered, and 
compatible with national, provincial, health regions, and First Nations health authorities. In this 
study, there are differences in opinion about the model of service integration/collaboration 
among patients and service providers. The service providers and stakeholders prefer referral or 
partially integrated model, that is patient may either access TB services and be referred for HIV 
care or HIV care and be referred for TB services, the reason being that not all of them has the 
expertise or the training to provide both TB and HIV services at the same location.  Patients 
prefer the fully integrated model whereby access to both TB and HIV care are in one location, 
because key clinical services like screening, voluntary counselling and testing, comprehensive 
medical management, screening and treatment for substance abuse can be obtained in one 
location without loss to follow-up. According to the Global Fund, it is essential to recognize that 
there is no” one- size –fits- all” approach but there should be a strong consideration for “one-stop 
service” approach in which integrated services begin at the patient’s entry point. Finding a 
balance that meets the patient needs yet satisfies the service provider is an important 
programming aspect that needs to be addressed before program implementation. Also, they 
should develop inter-sectoral collaboration with other programs, especially those that cater to 
alleviating social determinants that impact both diseases. Examples are; Mental Health and 
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Addiction action plan, housing, transportation, and health education, which is like what 
participants said in the study.   
The most important consideration is the type of service that will be efficient, effective, 
and accessible to patients. The choice of type of collaboration /integration depends on many 
factors, such as availability of human resources, location of existing facilities, government 
policies, and infection control consideration.  
There is a need to ensure an appropriate workforce are available to deliver collaborative 
TB/HIV control. The success of TB/HIV collaborative activities depends on having good quality 
and adequate staff. From the responses of study participants, it is apparent that there is a shortage 
of human resources concerning quality and quantity to cope with the burden of TB and HIV. The 
challenges identified are, a) insufficient Directly Observe Therapy (DOT) providers at the 
community level, b) difficulty in recruitment of infectious diseases specialist doctors to cope 
with long waiting list of newly diagnosed TB and HIV cases, c) high turnover or inability to 
retain qualified staff in rural and remote areas especially in far northern Saskatchewan, d) need 
for training or re-training of staff to cope with TB/HIV co-infection, e) need for interdisciplinary 
teamwork to provide addiction and harm reduction services, f) and differential hiring of staff by 
government organizations which create challenges in supervision and accountability role of TB 
and HIV program workers. For example, TB workers in on-reserves communities are hired by 
Health Canada, whereas the health regions are responsible for hiring off-reserve workers.  To 
ensure appropriate workforce, the health region and First Nations organizations need to give 
realistic estimates of human resources needed to deliver TB/HIV services. In addition, there 
should be financial incentives for working in rural and remote areas with the goal of retaining 
their services. It is important to strengthen the role of Non-governmental organizations, 
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community-based organizations and other relevant stakeholders to provide support programs for 
TB and HIV services at the community level. To improve competencies in the management of 
TB and HIV infections, it is essential to provide training to staff on a regular basis.  
Health outcomes improve with better healthcare access, and the extent to which a 
community gains access to health services depends on socio-economic, cultural and 
environmental conditions that prevail within the community. (Gulliford et al., 2003).  Limited or 
poor access to TB and HIV services leads to advanced disease situations that are catastrophic for 
the patient.  From this study, the following factors are barriers that affect access to health care;  
1. Physical and environmental barriers. According to the participants, Northern Saskatchewan 
poses the geographical challenge in terms of communities spread out over a very vast area. 
This geographical distance, sometimes compounded by seasonal isolation and lack of 
transportation especially among First Nations that resides off- reserves, limit patients’ ability 
to reach health care services.  
2. a) Barriers at health facility level: The participants identified the following challenges; 
location of   health facilities, difficulty in arranging appointments which may be due to 
patients’ life circumstances, lack of coordination of referrals which may lead to difficulty in 
navigating the health system, difficulty in getting medications, and shortage of staff. b) 
Barriers at health worker level: The health workers play a crucial role in providing caring, 
non-discriminatory and quality health services to patients with HIV and TB. However, 
different behavioral patterns that often emanate from the health workers have direct 
influences on the health-seeking behavior of the patients. The participants identified common 
behaviors displayed towards them as negative and are perceived as stigmatizing behaviors. c) 
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Barriers at the patient/community level: The main barrier at this level is the fear of stigma 
and discrimination.  
Therefore, to improve access to health care services, it is recommended that coverage of 
existing Medical Transportation Benefit of Non-Insured Health Benefit (NIHB) should be 
expanded to include all Indigenous peoples living on and off reserves and Metis, because now 
there are criteria to be eligible for this benefit. This is expected to improve honoring of dates and 
time of appointments and easy identification of where health facility is located.  A joint TB/HIV 
advocacy, media communication, and social mobilization should be developed to ensure 
consistent communication that would target the individual needs of clients and patients. It is also 
critical to build partnerships with communities, PLWHA, NGOs, the private sector and 
stakeholders to address and raise awareness to tackle stigma among populations at high risk. 
These recommendations were consistent with that of Okot-Chono et al. (2009) who indicated 
that implementation and utilization of collaborative TB/HIV services would remain suboptimal if 
barriers to TB and HIV programs are not identified and addressed, especially in the area of 
policy dissemination, training health providers, logistics management and monitoring. 
Community empowerment: This should be an essential component of joint TB and HIV 
programming and with the focus on the delivery of integrated community-based TB and HIV 
services. Community-based organizations often have the comparative advantage of knowledge 
and understanding of the local context and have more flexibility in adapting to local situations. 
Community systems also tend to have more capacity to function in difficult-to-reach, remote 
areas and conflict zones, which offers a unique opportunity for increased efficiency and 
maximized synergy between relevant programs. The critical issues as adduced by respondents in 
this study are the varying attitudes of peers and community members to people with TB and 
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HIV. The participants also indicated that in some First Nations reserves HIV is vilified, while in 
other reserves stigmatization is less experienced by patients as a result of nonjudgmental 
leadership and healthcare staff. Implementing community strengthening system is consistent 
with the core components of The Global Fund (2014), which are; 
 A) Providing enabling environments for improving policy and governance 
affecting the determinants of TB and HIV epidemiology.  B) Identifying 
community networks and relevant stakeholders to coordinate effective 
collaborative activities for TB/HIV. C) Ensure adequate funding, human 
resources and organizational capacities. D) Planning service delivery should 
be comprehensive to ensure proper accessibility to all in need of the service. 
F) Effective monitoring and evaluation should be embedded into program 
planning and implementation. (The Global Funds, 2014, pg.6)  
People living with HIV/AIDS (PLWHA) and those infected with TB have always been 
stigmatized leading to profound social consequences that are linked to their rights, self-identity, 
accessibility to health care service and social interaction (Mawar et al., 2005). Daftary et. al, 
(2012) in her study of TB and HIV co-infected patients in South Africa described a unique form 
of stigmatization because of the dual diagnosis. According to Daftary et. al. (2012), even though 
HIV was the driving factor behind disease-related stigma and discrimination, the intricate 
association between the two illnesses led to identities associated with TB becoming even more 
undesirable and stigmatized. Therefore, integrated services may reinforce negative public 
perceptions and could impact on the uptake of TB care. In this study respondent that are HIV 
positive indicated their reluctance to disclose to others their HIV status and would not access 
TB/HIV facilities that are close to their area abode due to fear of being recognized.    
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The activities to strengthen the community against TB and HIV stigmatization involve 
raising community awareness and addressing fears and misconceptions.  Possible avenues 
include provision of information on TB and HIV in acceptable written form, mass media and 
meetings with relevant community members (Courtwright & Turner, 2010). 
6.4.1.2 Objective 1, Input A2: TB and HIV prevalence in the community. 
Surveillance of HIV among TB patients and TB among HIV patients is recognized as 
necessary in TB/HIV collaborative programming because HIV epidemic continues to fuel the 
global TB epidemic. It is therefore essential to ensure that HIV positive TB patients are 
identified and treated accordingly (WHO, 2012). 
6.4.1.2.1 Establish single surveillance system.  
According to participants in the study, TB programs do not have access to HIV data 
because both programs work in “silos”.  Therefore, data for TB and HIV co-infection cannot be 
easily verified. Surveillance is critical to monitoring the progress of implementing TB/HIV co-
infection programs. It is essential that accurate data be reported from both TB and HIV programs 
and shared with appropriate staff in the community, health region and at provincial and national 
levels. Information collected when analyzed will enhance communication, planning and 
execution of prevention and care programs. According to the WHO (2014), evidence from 
descriptive studies has shown that robust HIV surveillance among TB patients is critical to 
understanding the trends of the epidemic and in the development of sound strategies to address 
the dual TB/HIV epidemic. In addition, community-based studies have reported high rates of 
undiagnosed TB both among people living with HIV and HIV-negative individuals (Wood, 
2007).  
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To determine the prevalence HIV among TB patients and TB among HIV patients in the 
populations require the establishment of an effective surveillance system that allows for early 
detection of any warning in TB-HIV epidemiology and calls for adequate action through a better 
understanding of the magnitude of the problem. This can be achieved by offering provider-
initiated diagnostic counselling and HIV testing to all TB patients with an option to opt out, 
which is HIV test performed on a patient after notifying him or her that the test will be 
performed, the patient has the option to decline. Furthermore, there should be effective referral 
linkages between TB program, HIV program and harm reduction services to ensure access TB 
and HIV prevention, diagnosis, treatment inclusive of drug treatment services for people who use 
drugs.  
All people living with HIV should routinely be screened for TB using a clinical 
symptom-based algorithm (Getahun, 2011) which are current cough, fever, weight loss or night 
sweats at the time of first presentation for HIV care or contact with a health-care worker. 
6.4.1.2.2 Tackling TB and HIV in underserved and vulnerable population. 
TB and HIV infections tend to affect the same subpopulation of high risk and socially 
marginalized groups comprising of injecting drug users, prisoners, homeless people, sex 
workers, and men who have sex with men (MSM). In Saskatchewan, the Indigenous and rural 
Indigenous population are mostly affected. These groups are at the risk of delayed diagnosis, 
drug resistance, and poor treatment outcome. Participants in the study well articulate this socio-
economic determinant. According to them, TB and HIV are mostly among drug users, those 
involved in the sex trade, chronic alcohol users and sexual transmission. Also, poverty, 
residential school survivors, and factors that create a low self-image or poor self-esteem are also 
implicated as socioeconomic determinants that affect TB and HIV.  
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Those affected by TB and HIV also have a history of trauma: abuse, neglect, sexual 
abuse, physical abuse, emotional abuse and neglect. All these problems create profound 
challenges to navigate a complex health care system. As a result, it is highly essential to give 
priority to these groups with “chaotic” lifestyles to improve the efficacy of TB/HIV intervention 
program because the effectiveness of program depends on psycho-social stabilization. Patients 
will find it difficult to access health care if they must contend with underlying social problems 
Activities for tackling TB and HIV in underserved populations are; a) Establishment of 
integrated, multidisciplinary, case management support for underserved and vulnerable 
population, with the involvement of appropriate stakeholders, NGOs, and CBOs in 
Saskatchewan that have necessary skills, organization and resources that would manage people 
with complex social and clinical needs. b) Ensure a standard of TB/HIV health care in prisons 
(WHO, 2016). 
6.4.1.2.3 Laboratory services. 
Laboratories play a central in TB and HIV control and surveillance as well as patient 
diagnosis and care. According to WHO (2009), essential to care of patients with TB and HIV is 
“a robust network of TB and HIV laboratories with adequate biosafety, modern methods of 
diagnosis, standard operating procedures and appropriate quality assurance” (WHO, 2009, pg. 
26) 
Strengthening the provincial laboratory system is critical to the implementation of TB 
and HIV collaboration. As suggested by a participant in the study, the resources that go into 
communicable diseases should be under one group. Presently, the HIV and Hepatitis C 
laboratory is under communicable disease in Regina. This is completely separated from the TB 
control laboratory which is based in Saskatoon. 
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Activities for TB and HIV laboratory services in Saskatchewan derived from the study, 
and which are also in conformity with some the suggestions made by Hochgesang et al. (2017) 
are; a) Provision of common laboratory services for TB and HIV based in the same facility. In 
remote and hard to reach areas, mobile laboratory services should be provided. b) Strengthen 
TB/HIV collaborative activities through routine HIV testing of all TB patients and routine CD4 
count for all HIV positive TB patients. c) Establish policies that would improve information 
management system, that is, specimen tracking, test result reporting, information sharing 
between TB and HIV programs and between physicians and public health officials. 
6.4.1.3 Objective 1, Input A3: Monitor and Evaluate services 
HIV program and TB-control program should lay the foundation for coordinated 
indicators to collect data for monitoring and evaluation of collaborative TB/HIV activities 
(WHO, 2009 p. 19-41). (Appendix F). 
6.4.2  Objective 2: Reduce the burden of TB among people living with HIV 
 
Figure 2.3: Excerpt of logic model for Objective 2 
6.4.2.1: Objective 2 Input 1: Early diagnosis and treatment of TB in HIV patients  
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Early diagnosis with prompt initiation of treatment are important for an effective TB 
control in HIV patients. Delayed diagnosis leads to poor prognosis at the individual level and 
transmission of TB at the community level. Drug-resistant TB in form of multidrug-resistant 
(MDR) TB and Extensively Drug Resistant (XDR) TB has emerged as a serious global epidemic 
and poses a threat to HIV infected people (Dubrovina et al., 2008). HIV has been linked to 
increase mortality in susceptible and drug-resistant TB (Quy et. al., 2006). Therefore, ensuring 
comprehensive screening of people exposed to a case of active TB has the potential to improve 
early diagnosis and prevent further transmission especially in HIV patients with high risk of 
disease progression.  
From the study and WHO (2012) recommendations, the activities to ensure early 
diagnosis of TB among HIV patients are: 
Activity 1: Ensure comprehensive contact tracing is undertaken, and that it aims to identify all 
close contacts of active TB cases, not just household contacts, and provide appropriate follow-up 
and treatment, this being particularly important for underserved populations such as the 
homeless, prisoners and individuals with complex and chaotic lives. 
Activity 2: Coordinated treatment of People Living with HIV/AIDS (PLWHA) who have TB 
with anti-TB medications and antiretroviral therapy (ART). This requires careful clinical 
management, but the treatment of TB should have priority over ART (WHO, 2003). Adherence 
to medications is enhanced by Directly Observed Therapy (DOT) (Gaur et al. 2010).  
Activity 3: Adherence support. Lack of adherence to treatment remains a significant obstacle to 
effective treatment of TB and HIV. Co-infection presents further adherence problem because of 
high pill burden and adverse effect. Adherence to taking TB and HIV medications is crucial to 
the treatment of these diseases to prevent treatment failure that leads to high mortality or the 
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development of drug-resistant strains.  According to participants in the study, adherence to 
medication is poor among patients with TB and HIV due to stigmatization, poverty, lack of 
transportation, cultural issues, social exclusion, and access to health services.  
Activities for adherence support include strengthening of Directly Observe Therapy for 
TB and HIV treatment at the level of health facilities and community. A participant suggested 
that DOT should be combined with Methadone therapy because Intravenous Drug Users will in 
most cases not miss taking Methadone medication. 
Activity 4: Drug management and improvement. Improvement of health outcomes for those 
infected with TB and HIV requires an effective logistics management system that ensures 
adequacy of drugs and other supplies at various levels of the health system and health facilities. 
Strengthening existing procurement and supply chain management systems is essential for joint 
TB and HIV programming (WHO, 2004). 
 Study results recommended activities to improve drug management and procurement are 
that include; a) inclusion of a pharmacist as a member of the provincial committee that develops 
the policy for TB/HIV collaborative services. This ensures that pharmaceutical management is 
considered at the TB and HIV planning phase and throughout different layers of health 
intervention to promote an uninterrupted availability of medications. b) Review drug distribution 
network to ensure adequate drug delivery, accessibility, prompt access to drugs which will 
thereby improve adherence. c) Constant revision of provincial guidelines to incorporate new 
development of TB/HIV medications. d) Identify enough financial and human resources during 
the planning phase to build capacity for TB and HIV medication delivery. 
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6.4.3 Objective 3: Decrease the burden of HIV in TB patients 
 
Figure 6.4: Excerpt of logic model for Objective 3 
 
6.4.3.1 Objective 3, Input 1: Surveillance of HIV among TB patient. 
Surveillance of HIV should also be conducted among TB patients to inform program 
planning and implementation. According to the participants, surveillance for TB and HIV in 
Saskatchewan is performed separately, and there is no process for sharing data between the two 
control programs.  In 2013, Saskatchewan proposed to increase screening uptake for HIV in 
individuals with TB by 50%.  This includes screening process for HIV tests in all TB patients 
above 13 years whether on treatment or prophylaxis.   
From the study results and WHO (2012) recommendation, the activities for surveillance 
of HIV among TB patients are, a) making HIV testing as an entry point for HIV care and 
treatment services. b) Offering provider-initiated diagnostic counselling and HIV testing to all 
TB patient. c) Encourage HIV prevention methods using male and female condoms, prevention 
of sharing of contaminated needles among injection drug users, and behavioral therapy. d) All 
health facilities should implement standard procedures for reduction of occupational and 
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nosocomial exposure to HIV such as injection safety, blood safety, and safe waste disposal. d) 
Initiation of prophylaxis and treatment is strongly recommended by WHO (2004). This is 
starting Anti-retroviral therapy (ART) in all TB patients living with HIV irrespective of their 
CD4 count.  
The use of a logic model in this research has produced a graphical description of TB/HIV 
collaborative programming that communicates program goal, activities, output, and intended 
outcome. Furthermore, this model has helped to incorporate evidence-based research to design a 
program that integrates planning, implementation, performance measurement and evaluation. To 
health planners, the model produces a clear description of how a program should be designed and 
how success will be measured by addressing existing gaps in the surveillance system, referral 
process and preventive effort as it pertains to TB/HIV collaborative programming. 
6.5 Conclusion 
The paper sets the framework for an effective collaboration between TB and HIV/AIDS 
program in Saskatchewan, by using the logic model and results from the interviews conducted 
using the PRECEDE framework, with the intention to aid program planning, implementation and 
evaluation.  
The overall success to implementing this collaborative program will be measured through 
evidence of sustained political commitment, intensified case finding, strengthening of 
surveillance procedure, and coordinating treatment to ensure that people with HIV/AIDS and 
people with TB receive a continuum of high-quality care that is equitable in accessibility to the 
whole population, and is devoid of discrimination or stigmatization. To be fully successful, the 
overall program design and implementation should be within available resources. The short term 
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and long term expected outcomes are reduction in TB/HIV incidence and prevalence in 
Saskatchewan.  
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7.  CONCLUSIONS 
The purpose of this study was to undertake a needs assessment for TB-HIV collaborative 
programming in Saskatchewan.  The aim was to identify key areas that will support operational 
collaboration within the separate TB and HIV programs that are currently implemented. The 
purpose is based on the rationale that both diseases are intricately linked with each other, and 
therefore can be termed a Syndemic because they share the same underlying social, economic, 
environmental, behavioral factors that promote such interaction and worsen the diseases. The most 
significant risk of developing active TB is infection with HIV, and the leading cause of mortality 
among people living with HIV is TB. The Syndemic framework, therefore, presents a way of 
knowing why diseases cluster together in a population immensely affected by poverty, social 
exclusion, gender-based violence and other forms of social and environmental stress (Singer, et. 
al,. 2017). To accomplish a better understanding of how epidemics, interact both at the level of 
population and individual, Tsai et al. (2017) proposed that studies should incorporate data from 
multilevel analysis and the information obtained would help in the identification of appropriate 
interventions to improve health of the vulnerable population.   
This concluding chapter summarizes the use of PRECEDE aspect of PRECEDE-
PROCEED model to develop interview questions for data collection (Paper 1), analysis of result 
using the Framework analysis (Paper 2), policy recommendation for TB/HIV co-programming in 
Saskatchewan (Paper 3), strengths and limitations of this study, contribution of the study to 
research, suggestions for future research, and practical implications of the study. 
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7.1 Using the PRECEDE model in a needs assessment for TB/HIV co-programming in 
Saskatchewan 
A qualitative approach was adopted through a semi-structured interview of participants to 
conduct this needs assessments process that answered the research questions. The research 
questions were: 
• What are the intervention services provided towards the control of HIV and TB and the 
various organizations and stakeholders that provide these services? 
• What is the human, material and financial resources available for HIV and TB control 
programs, the service capacity and capability, and the barriers to accessing the service?  
• What are the gaps (met and unmet needs) in HIV and TB programs?  
• What is collaborative TB and HIV key interventions that will decrease the burden of 
infection in the population affected by both diseases? 
The PRECEDE aspect of the PRECEDE-PROCEED model was used to develop the 
questionnaire for participants, and their responses were analyzed to provide insight into ways 
collaborative TB/HIV program will be designed and implemented. The use of this model is similar 
to the approach used in clinical diagnosis in individual patients, whereby, just as a medical 
diagnosis precedes treatment, so should evidence-based educational diagnosis precede an 
intervention plan. PRECEDE has the advantage of incorporating health behavior theories that are 
important in conducting research into TB and HIV services because these infections have complex 
multidimensional behavioral factors that affect its epidemiology in a population. The strength of 
using PRECEDE in this study are: 
1) It provides a comprehensive structure and template for assessing health needs for 
designing, implementing and evaluating health intervention. 
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2) The phases in the model help researcher to develop a coherent plan that addresses the 
necessary issues.  
3) The model significantly provides useful guidance for coding and analyzing data.  “a 
priori” codes were derived from the PRECEDE framework and its associated theories, 
while emergent codes where inductively derived from familiarization with data 
collected. Findings were organized according to major components of PRECEDE.  The 
model gives insight to ways successful collaborative TB and HIV programming will 
be planned and implemented through the identification of multiple social, 
environmental, behavioral and other factors affect the epidemiology of both diseases 
in Saskatchewan. This process supported the Syndemic framework, which is the 
overarching theory that supported this study (Singer et. al., 2017). 
7.2 The state of TB and HIV in Saskatchewan 
Key findings that emerged from the study described escalating TB and HIV infections in 
Saskatchewan, and this is compounded by unreliable data on TB/HIV co-infection rates because 
the two programs operate differently and do not share data. Social factors play an important role 
in the epidemiology of TB and HIV in Saskatchewan and these conditions disproportionately affect 
the Indigenous communities. A critical social factor described by participants is the psychosocial 
effect of residential schools on the Indigenous people. The horrendous abuse experienced by those 
who attended these schools has been linked to intergenerational transmission of personal trauma, 
compromised family system, poverty, homelessness, intravenous drug use (IDU), chaotic lifestyle, 
low level of education, history of sexual and emotional abuse (Wilk et al., 2017). All these socio-
cultural factors are directly or remotely linked to increasing transmission of TB and HIV (Reading 
& Wien, 2009). 
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Behavioral factors broadly affect TB and HIV programs in two ways; first, they influence 
patient’s health-seeking behavior. Second, they impact medication adherence and completion 
rates. Participants described that fear of isolation through stigmatization, the attitude of health 
staff, peers and community members lead to concealment of disease and delay in seeking 
treatment. Furthermore, the Indigenous population in Saskatchewan is mobile as described by a 
participant in this study, there is frequent movement from one community to the other, either 
within the province or outside the province. This is supported by Snyder & Wilson (2012), they 
reported that in Canada, approximately 54 per cent of Aboriginal peoples are urban and change 
their place of residence at a higher rate than the non-Aboriginal population. This high rate of 
mobility may affect the delivery and use of health service. In this study, the participants indicated 
that frequent movement affect negatively, the booking an appointment or ensuring adherence to 
TB or HIV. 
Environmental factors affect the risk of exposure, the risk of infection and risk of 
developing the diseases. The plan was to identify controllable or preventable factors related to TB 
and HIV infections that would aid in planning for intervention. Doing this would involve 
identification of the effect physical and socioeconomic and their implication on TB and HIV 
epidemiology in Saskatchewan. Regarding the physical environment, Saskatchewan has large 
areas with geographically isolated communities, and there are communities designated as “off and 
on” reserves where the First Nations live. According to Statistics Canada (2017), “36% of on-
reserve and 16% of off-reserve First Nations people in Saskatchewan lived in crowded homes, that 
is, more than one person per room”. Furthermore, First Nations peoples living in these reserves 
report poor health outcomes, high level of at least one chronic disease, poor mental health, being 
unemployed, and limited access to healthcare services.  
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Educational and ecological diagnosis involves the development of a unique plan that 
increases the likelihood that changes in behaviors already identified will occur through the 
identification of predisposing, reinforcing, and enabling factors. Predisposing factors are 
antecedents to behavior that provides the rationale or motivation for individual practices that 
promote the propagation of TB and HIV in the population. These are knowledge, attitude, and 
beliefs. Knowledge about TB and HIV is high amongst the community and patients in 
Saskatchewan through the effort of intensified awareness by both TB and HIV control programs. 
According to participants, the attitude and beliefs exhibited by patients infected with these diseases 
are affected by chaotic lifestyle, lack of education, drug addiction, poverty, homelessness, 
overcrowding and stigmatization. These conditions mostly affect the Indigenous population which 
then explain why they are over-represented in the incidence and prevalence of TB and HIV in the 
province. Reinforcing factors represent behavior that provides continued reward or incentive for 
persistent or repetition of the action. Participants identified minimal support from peers and 
community members, high level of stigmatization, rude and judgmental health staff as reinforcing. 
Enabling factors represent the necessary conditions that must be present for a successful 
implementation of TB/HIV collaborative program. These factors include availability and 
accessibility of health resources and service. In Saskatchewan remote and hard to reach areas, lack 
and retention of adequately trained health personnel are experienced continuously. The financial 
input to collaborative services is critical, and this is tied to strong political will considering that 
other programs compete for scarce resources. 
Administrative and Policy diagnosis identified policies, resources, and model of service 
delivery that is needed for implementation and sustainability of TB/HIV collaborative 
programming. This includes challenges, barriers, met and unmet needs to program intervention.  
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Fundamental strategies include prompt health sector response to emerging TB and HIV epidemic. 
This should be done through the establishment and harmonization of National and Provincial 
guidelines that would provide TB and HIV collaborative care and services at health facilities and 
community levels, and develop national protocols and standard for good clinical practices. 
Furthermore, this should be in partnership with TB and HIV stakeholders which including 
government and non-government organizations, clinicians, pharmacists, epidemiologists, public 
health officials, drug control agencies, representatives of relevant ministries, and leaders of 
affected communities. The scope and timing to start TB and HIV collaborative services should be 
phased-based depending on prevailing local conditions to avoid disruption of services. Priority 
should be given to TB and HIV high incidence areas in Saskatchewan. 
7.3 Policy recommendations for moving to TB/HIV co-programming in Saskatchewan 
TB and HIV collaborative program reforms should identify areas of synergies that will 
minimise duplication of activities through alignment of critical components of the health system. 
From the study, these include the following; 
• Funding for TB and HIV programs in Saskatchewan should be streamlined through 
coordination and input from National and Provincial TB and HIV programs, 
stakeholders that are involved with TB and HIV activities, and other relevant bodies to 
address funding needs and allocation. Uninterrupted funding is necessary because TB 
treatment ranges from six to eight months, while HIV treatment with ART is lifelong.  
• The entry point to TB and HIV preventive, diagnostic and treatment services should be 
effective and prevent loss-to-follow-up as patients navigate the health system including 
other essential services, such as social services, harm reduction services among drug 
injecting users, contact tracing and prevention chemotherapy.   
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• Establishment of joint information dissemination strategy by TB and HIV programs 
that would reduce risky behavior and vulnerability and minimize the risk of 
occupational TB and HIV infections. 
• Clinical management of TB and HIV should improve patient’s access to services 
regarding distance, time, cost of medication, universal access to antiretroviral therapy 
and anti-tuberculous drugs, regular drug supply and Direct Observation Treatment 
(DOT).  Ensure early diagnosis by providing access to high-quality diagnostics, ensure 
comprehensive TB and HIV contact tracing, improve data collection through 
comprehensive joint surveillance and monitoring, and tackle TB and HIV in high-risk 
groups.  
• Encourage inter-sectoral collaboration that will address the issues of complex socio-
economic determinants of TB and HIV, including high-risk behaviors that are 
significant drivers of disease transmission. There is also the need to use social 
determinants approach to reduce health inequities among and between Saskatchewan 
populations. Building a partnership with communities, PLWHA, Non- governmental 
organizations, and private sectors in the areas of transportation, education and 
community mobilization. 
• Co-location of services improves access, referral and coordination of services. 
• Address inadequate human resources especially in rural and remote areas of 
Saskatchewan. Given the scope of TB and HIV epidemic, there is a need for additional 
staff. Existing staff may need to be trained or retrained.  
• The overall program design must be within the constraint of available resources in order 
to be successful.  
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TB and HIV are diseases of high public health importance. The occurrence of both diseases 
in a population often leads to catastrophic consequences when control and eventual elimination of 
these diseases are not urgently and adequately addressed. The incidence and prevalence of TB and 
HIV have reached an epidemic proportion in Saskatchewan, despite present “siloed” control 
measures. This study provides evidence for implementation of collaborative programming 
between TB and HIV through systematic qualitative research using PRECEDE framework to guide 
interview questions (Paper 1), Data analysis (Paper 2), and guidelines for TB/HIV collaborative 
programming at program management and health facility levels (Paper 3). 
Strengths of the study 
Statistics indicated that TB and HIV constitute a public health crisis in Saskatchewan that 
disproportionately affects Aboriginal peoples. To fully understand the problem of TB and HIV, it 
is essential to know the extent of interaction between these diseases and the social, economic, 
behavioral, educational, and administrative factors that operate dynamically to influence the 
vulnerability of individuals and excess burden of diseases in the population. In this study, the use 
of Syndemic theory and PRECEDE model provided a “roadmap” that incorporated these factors 
in data collection, analysis, and design of TB/HIV collaborative programming. 
Limitations of study 
Only patients with HIV consented to be interviewed. No patient with TB or TB/HIV co-
infection volunteered to be interviewed. This may introduce the possibility of bias to the study as 
patient experiences in each of the programs, as well as those requiring services from both 
programs, were not included. There is also the need to stay within the confines of my ethics 
approval, which is minimal risk. Ethics application approval that include vulnerable and 
Indigenous communities are usually long in duration and cumbersome. 
159 
 
7.4 Contributions to research 
My research has made some contribution to health policy development in Saskatchewan. 
There is no established policy on TB/HIV collaboration programming in Saskatchewan, therefore, 
this needs assessment study is the first to be done in the province. The results and recommendations 
are baseline evidence-based information for researchers and health policy makers towards 
planning and implementing effective TB and HIV collaboration services that would decrease the 
occurrence of both diseases in the population. Also, the research has major contributions from 
patients on the ways they want collaborative programming to be implemented.  
7.5 Recommendations for future research and practical applications 
Research plays a vital role in shaping the policy for TB and HIV collaborative programs. 
Identified areas for future studies include A) Medium and long-term joint strategic planning to 
successfully and systematically scale up collaborative TB/ HIV activities nationwide and deliver 
integrated TB and HIV services, preferably at the same time and location with due consideration 
to the prevention of TB transmission should be developed. B) Further research is needed to 
investigate factors that enhance or act as barriers to adherence to preventive measures and 
medications use. That is, what are the variables that predict nonadherence or what promote 
adherence to medication. The focus should be on vulnerable populations to TB and HIV in 
Saskatchewan. These are; injection drug users, alcohol-dependent individuals, inmates in 
correctional centres, children, homeless people, refugees and migrants. 
The perceptions of these participants gave valuable insights into the desirability, 
challenges, identification of support frameworks, and service realignments that participants 
perceived as being able to aid implementation of a collaborative TB/HIV program and improve 
accessibility, acceptability, and coverage. 
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APPENDIX A 
Invitation to participate in interview and information sheet 
 
Researcher(s): 
Dr.  Abayomi Olaniyi, Doctoral student, Health Sciences Program, University of Saskatchewan.  
Dr. Shelley Kirychuk, Department of Medicine, Canadian Centre for Health and Safety in 
Agriculture, University of Saskatchewan.  
Dr. Heather Ward, Department of Medicine, Division of General Internal Medicine, University 
of Saskatchewan.  
 
Funding:  Department of Medicine, University of Saskatchewan 
 
Contact Phone Number:  Dr. Abayomi Olaniyi. 306-966-6073 
 
Introduction: 
You are invited to participate in this research study because you are involved in patient 
programming related to TB and/or HIV.  This research project is a needs assessment for co-
programming for those individuals co-infected with Tuberculosis (TB) and Human 
Immunodeficiency Virus (HIV) in Saskatchewan.    
Your participation is voluntary. It is up to you to decide whether or not you wish to take part. If 
you wish to participate, you will be asked to sign this form. If you do decide to take part in this 
study, you are still free to withdraw at any time and without giving any reasons for your 
decision.  The interview will be audio-recorded, and the audio record will be transcribed into a 
typed document. You may request to have the audio-recording turned off at any time. You may 
refuse to answer any question that you are uncomfortable with. 
Please take time to read the following information carefully. You can ask the researcher to 
explain any words or information that you do not clearly understand. You may ask as many 
questions as you need.  
 
Who is conducting the study? 
This study is being conducted by Dr. Abayomi Olaniyi, a doctoral student in the Health Sciences 
program at the University of Saskatchewan.  He is supervised by Drs Shelley Kirychuk and 
Heather Ward of the Department of Medicine of the University of Saskatchewan. 
 
Why is the study being done? 
The aims of this study are to: (1) identify key issues that may support operational collaboration 
of TB and HIV co-infection services in Saskatchewan, and; (2) to suggest strategies that will 
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promote collaboration of prevention, treatment and care of patients with TB and HIV co-
infection in Saskatchewan. 
 
What does the study involve? 
This part of the study involves an audio recorded in-person interview.  The interview will take 
about one hour. The interview questions ask you to share your knowledge and thoughts about TB 
and HIV programming in Saskatchewan.    
 
What are the benefits of participating in this study? 
If you choose to participate in this study there may be no direct benefits to you.  The benefits will 
be derived at the end of this study from the research findings on the collaborative opportunities 
for TB and HIV programming in Saskatchewan, with the potential for improved efficiency, 
accessibility, and adherence to treatment for those co-infected with TB and HIV in 
Saskatchewan.  
 
Are there possible risks and discomfort? 
We do not anticipate there will be any risks involved with participation. 
 
What happens if I decide to withdraw? 
Participation is entirely voluntary.  You can withdraw from the study at any point in time without 
any penalty. The information that is shared will be held in strict confidence and discussed only 
with my supervisors Dr Shelley Kirychuk and Dr Heather Ward. If you decide to enter the study 
and withdraw at later time information will be retained for analysis.  
 
Will I be informed of results? 
At the completion of the study the research team will create a summary of the research results, 
which will be provided to you upon completion, if you wish. 
Would you like to receive a copy of the research results? 
 
Yes _______       No _______ 
 
What will the study cost me? 
You will not be charged for any research-related activities. You will not be paid for participating 
in this study. You will not receive any compensation, or financial benefits for being in this study, 
or as a result of the data obtained from research conducted under this study. 
 
Will my taking part in this study be kept confidential? 
Your confidentiality will be respected.  Research records identifying you may be inspected in the 
presence of the Investigator or his or her designate, by representatives of the University of 
Saskatchewan’s College of Medicine, and the University of Saskatchewan’s Research Ethics 
Board for the purpose of monitoring the research. However, no records, which identify you by 
name or initials, will be allowed to leave the Investigators' offices. Confidential codes only 
known to the researcher will be used to identify responses. The transcribed interview with only 
codes and no names will be kept in a locked filing cabinet in the office of the Supervisor Dr. 
Shelley Kirychuk at the University of Saskatchewan.  All coding keys will be kept separate from 
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the data.  All data and coding keys will be locked in the offices of the researcher or Dr. Kirychuk 
at the University of Saskatchewan and will be kept for a minimum of 5 years. The results of this 
study may be presented in a scientific meeting or published, but your identity will not be 
disclosed. 
 
Questions or Concerns 
If you have any questions or want more information about this study before, during or after 
participation, you can contact Dr. Olaniyi or one of the supervisors at:  Dr. Abayomi Olaniyi. 
306-966-7885; Dr. Shelley Kirychuk. 306-966- 6649 or Dr. Heather Ward. 306-966-2180. 
If you have any concerns about your rights as a research participant and/or your experiences 
while participating in this study, contact the Chair of the University of Saskatchewan Research 
Ethics Board, at 306-966-2975.   This research project has been approved on ethical grounds by 
the University of Saskatchewan Research Ethics Board on __________________. 
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APPENDIX B 
Consent to Participate 
Needs Assessment for a Tuberculosis (TB) and Human Immunodeficiency Virus/Acquired 
Immunodeficiency syndrome (HIV/AIDS) co-infection program in Saskatchewan 
□   I have read (or someone has read to me) the information in this consent form. 
□ I understand the purpose and procedures and the possible risks and benefits of the study.  
□ I was given sufficient time to think about it. 
□ I had the opportunity to ask questions and have received satisfactory answers. 
□ I understand that I am free to withdraw from this study at any time for any reason and the 
decision to stop taking part will not affect my future relationships. 
□ I give permission to the use and disclosure of my de-identified information collected for the 
research purposes described in this form. 
□ I understand that by signing this document I do not waive any of my legal rights. 
□ I understand that I will be audio recorded as part of this interview 
□ I will be given a signed copy of this consent form. 
 
 
I agree to participate in this study: 
  
          
Name of Participant   Signature   Date 
  
      
Researcher’s Signature   Date 
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APPENDIX C 
 Interview Protocol and Guide 
CODE: 
Date: 
Place: 
Interviewer: 
Occupation of participant: 
 
Instructions 
1) Opening statement and greeting 
2) Describe Aims, Objectives and rationale of research 
(Read Introduction in consent form) 
Main interview questions  
1. Tell me about your role? 
Probe: the position /role; what the actually do; what are the define responsibilities: how long 
have they worked. 
 
2. What is your comment on the situation of TB and HIV in the community? 
Probe: explore awareness/attitudes/perception on co-infection 
 
3. What are your views about collaborative TB/HIV healthcare services? 
Probe: explore awareness/attitudes/perception and their ideas about collaborative services. 
 
4. -What type of collaborative TB/HIV activities do you offer? 
-Where do you receive your directive from? 
-What are your thoughts on the implementation or feasibility of these activities? 
-What support do you receive from higher levels of management? 
Probe: exactly what TB/HIV services do they provide if any; explore managerial hierarchy; 
inquire on site infrastructure/resources/coordinative capacity; explore support from 
management regarding financial/training/motivation; What they perceived as barriers or 
facilitators for TB and HIV service provision; what are their likes/dislikes on providing added 
services; access to services. 
 
5. How do you think collaborative TB/HIV services will be received/adopted by the 
patients you serve? 
Probe: specific ways of promoting TB/HIV care; inquire about service uptake; how they perceive 
patient’s decision; example of patient experience. 
 
6. What do you think about screening HIV-positive patients for TB or TB patients for 
HIV? 
Probe:  probe on stigmatizing views; patient or provider initiated, opt-in or opt-out. 
7. How do you coordinate treating patients who may be receiving medical care for 
another condition (i.e., TB or HIV) from another health facility? 
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Probe: explore programs’ coordinative capacity and referrals; what are on ground 
barriers/facilitators to non-collaborative program; what is their personal experience- is the level 
of collaboration making work easier or more difficult? 
 
8. Can you think of any ways to improve the delivery of health services in relation to 
TB and HIV infections? 
Probe: gather comments on how constraints/barrier may be resolved 
 
9. Who else will you recommend to be interviewed?
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APPENDIX D 
Framework matrix 
PHASE 1 and 2 of PRECEDE model 
a) Quality of life 
b) Epidemiological Assessment 
Participant Community/Physical environment. 
(Urban/Rural/Remote, 
Type of service in community, 
 Disease situation in community) 
 
Effectiveness of program/health system constraint. 
(Utilization of services, 
Stigmatization, 
Screening methods, 
Data management, 
Barrier, Adherence) 
 (06/1) TB, mostly found among First Nations. 
- Areas of low and high incidence 
Administratively, data collection, policy, and budget, TB and 
HIV programs work in silos. 
-Data for TB and HIV co-infection cannot be easily verified. 
TB does not have access to HIV data. 
 (04/1) People should open up about doing drugs or HIV 
status 
 
 (04/2) Big problem in community  
 (04/3) Lots of friends have HIV and Hep C. 
-Happy with service in PA and the location of 
clinic 
- Lots of stigmatization because people are not educated 
enough. 
-HIV clinic set up adequate in terms of location, and getting 
medication. 
 (04/4) HIV big problem  
(08/1) Mostly among IDU’s  
-Overcrowding. 
-Organization link HIV patients and those at risk 
to available services; these are Social services, 
housing, addiction services, and legal helps. 
-Adherence is poor. 
-Completion of treatment affected by lack of knowledge, 
stop medication when they get better. Start medication when 
they experience a flare up. 
-Combine daily witness of methadone therapy with TB or 
HIV drugs. Patients on Methadone are always compliant. 
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-Mobile services in hospital treatment centers and 
prisons. 
-Provide education materials in drop centers, safe 
sex materials and needle exchange programs. 
-Drive them to appointment centers 
-Rare that addict miss methadone. 
-The pharmacists are important to improve adherence. Most 
patients have a good relationship with them. 
-Language can be a barrier especially people from North 
Saskatchewan. 
-Patients are not coerced to do screening. 
-Access HIV service due to other social concerns, for 
example; housing, no food for some days, warrant for arrest. 
-All clients are triaged to know their needs and to establish 
confidence. Then keep track of appointments and give 
friendly reminder for medications. 
 (01/1) Convergence of 2 small epidemics. 
-HIV has overtaken TB in terms of epidemic in 
Saskatoon. 
-Consult in PA and La Ronge 
All HIV patients are tested for TB using TST. 
-Mode of transportation to PA by car, and La Ronge by 
plane. 
-From an operational point of view DOT is good for TB and 
HIV co-infection. Taking into cognizance not counting 
stigma and recognition of patients 
 (02/1) Raising rate of HIV a big concern 
 
-TB a reportable disease 
-HIV test for all TB patients above 13 years, 
whether on treatment or prophylaxis. 
-Program report to SHR then Provincial ministry 
of health, then PHAC. 
-TB advisory committee comprising health 
ministry, Lab, lung association, NITHA, FNIB, 
Northern medical health. 
-Difficult to get feedback from patients. 
-Do opt out screening. 
-Very mobile population 
 
 (02/2) -Huge problem in Northern community. Stigmatization not really bad in First nation communities it 
has normalized 
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-“One stop shop” comprising; Diagnosis, follow 
up, referral, Needle exchange program. 
-New diagnosis enters through TB. TB program 
does a physical exam. If positive follow with 
MEDs. And keep connected with a physician 
 
-Do Methadone and DOT 
 
 (02/3) -Work with Clinicians and community nurses. 
-Set up clinics, contact tracing and Medication 
audit. Report drug adverse effect. Work with 
people doing DOT. 
-Has stationery, mobile clinics. Also do tele 
health. 
Some communities are open to accepting people with TB. In 
others TB is a taboo. 
 
Workers do DOT. The policy is for treatment to be 
minimally invasive to a patient’s lifestyle. 
-Positive TST are booked and refer to a TB specialist 
physician. X ray then done. 
-Some stigmatization around TB less in HIV 
 
(09/1) Problem of poverty. 
-Mostly in Northern Saskatchewan. 
-Often have co-infected patient. 
-**Coordination between TB and HIV pharmacist 
to administer medication. 
-Delivery of drugs are” siloed” but not treatment 
of patients with TB and HIV 
Medication prone to side effects and easily lead to resistance. 
-Some communities think TB or HIV do not exist among 
them. 
-Fear of people knowing about their diseases because most 
of the health workers are known to them. 
 (02/4) Program implemented in accordance to SHR and 
provincial strategies of 2010-2014. 
-Link with TB is through share patient 
management. 
-Mandate to have all above 14 years TB tested for 
HIV. 
-Staff: Manager, Pharmacist, SW and supporting 
staff. 
-Determinants of adherence to drugs are; housing, addiction 
issues, chaotic lifestyle affecting medical appointment, 
medication fatigue. 
-Gay population is adherent to taking medication. 
-IDU’s are usually less adherent to taking medication. 
-Schedule appointment don’t work. Except drop in. 
-RUH location is difficult to access and therefore difficult to 
manage appointment. 
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-Work with Infectious disease specialists. 
-Street gang to get all IDU to test for HIV. 
-Tough to access rural and remote areas. 
-Some doctors o to Northern communities. 
-**Lots of staff turnover. 
-Goal to increase uptake of screening by 50% from 2009 
data. This has been achieved through by education and 
automatic screening. 
-Service focus on harm reduction, Blood work, getting 
immunization, education. 
 (07/1) -Determinants of adherence to drugs are; housing, 
addiction issues, chaotic lifestyle affecting 
medical appointment, medication fatigue. 
Gay population is adherent to taking medication. 
-IDU’s are usually less adherent to taking medication. 
-Schedule appointment don’t work. Except drop in. 
-RUH location is difficult to access and therefore difficult to 
manage appointment. 
-Goal to increase uptake of screening by 50% from 2009 
data. This has been achieved through by education and 
automatic screening. 
-Service focus on harm reduction, Blood work, getting 
immunization, education. 
Some do not want to be screened even when they know their 
partners are HIV positive. 
-Double stigmatization with TB/HIV co-infection, especially 
in northern community. Patient may shut down 
 (07/2) Mostly among drug users, those involved with 
sex trade, chronic alcohol users and sexual 
transmission. 
-Poverty, residential school survivors, and factors 
that create a low self-image or poor self-esteem. 
-AIDS Saskatoon created 601 outreach were people 
irrespective of drug addiction and previous criminal records 
have their basic needs met,e.g. Food requirement, laundry, 
computer use, resumes, and socialization. 
-Informal drop in model with no intake process, no 
paperwork, no requirement for self-identification. 
-We are available for everyone on their terms. 
-Focus more on risk reduction now, e.g. Condom 
distribution, developing and distribution of literature in plain 
language and sent to urban and rural areas. 
-People know about services by word of mouth. Do AIDS 
awareness week 
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 (03/1) -In Rural and remote areas, stigmatization is a 
challenge because of familiarity of patient with 
service provider. Confidentiality may not be 
assured 
It is important to have all partners on board for collaborative 
program. 
-Funding must be adequate and dedicated to ensuring 
sustainability. There is tendency to tag funding of a program 
to another with the same capacity and staff and expect to do 
more 
 (01/2) TB and HIV are emerging problem in 
Saskatchewan. 
-From archeology and anthropological studies TB 
existed pre-contact in North America. 
-The epidemic was due to starvation, poverty, and 
overcrowding. 
Effectiveness of program depends on psycho-social 
stabilization. 
-Co-occurrence with addiction has increased HIV mortality.  
-Through Methadone-assisted recovery program, the patient 
has access to see addiction counselor and physician. 
-Interaction with the pharmacist is also beneficial. 
-It is important we treat people and not the disease (HIV 
patient saying I don’t want to be treated for HIV because it 
will only prolong his life…..) 
-Lack of transportation for some services. If they are first 
nations and covered by treaty to attend medical 
appointments. 
-Combination of DOT and methadone will be effective 
-They come for their medication every day, and have good 
interaction with the pharmacist. 
-Health care delivery can be by distal model or raveling 
clinic. 
-Due to the mobility of the first nation’s people, some 
services can be accessed in the city. Access is better in rural 
where service is culturally sensitive. 
 (05/1)   Ideally 2-4 viral load testing should be done per year after 
diagnosis. HIV genotype testing to check for drug resistance 
should be done before medication or change of medication. 
-Large land mass, but sparse and widely distributed 
population. Difficult to have lab in all populations. 
-May be solved by Telehealth or medicine. 
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-Transportation in small communities is the biggest problem. 
-Solution to adherence can be by the use of smart phone. 
Minutes 
 
PHASE 3 of PRECEDE model 
Behavior and environmental assessment 
 
Participant Behavior linked with TB/HIV 
-Risk factors 
-Help seeking behavior 
06/1 They are risk takers. 
- High mobility of population from remote/rural to urban areas 
04/1 Scared to tell about HIV. 
-Drugs, Alcohol and difficulty getting out the habit. 
-Inadequate education and lack of jobs 
04/2 Inability to keep up with date to fill prescription. 
- Disclosure of sharing needles to partners 
04/3 - Denial. 
- Life choices, Sharing needles and unprotected sex 
04/4  
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08/1 Denial about HIV 
01/1  
02/1  
02/2  
02/3  
09/1  
02/4 - Increase of HIV among IDU’s.(Majority) 
- Gays and bisexual. 
- Disease process are not the same, but affect similar population with similar circumstances 
07/2 - HIV patients have lots of life stressors. Alleviating some of these stresses should be part of a prevention 
strategy.  
- If basic needs of individuals are met they will be inclined to engage in better prevention. 
- Living conditions contribute to illness e.g. overcrowding. 
- Unhealthy family of origin. 
- Embedded in reserve is not healthy to navigate their lived environment. 
03/1 - Increased incidence of HIV in the past decade. 
- Saskatchewan has the highest rate of new infection in Canada. 
- Rate of HIV peaked 2 years ago with 200 new cases. 
- 70% of cases among IDU. 
- In Northern perspective the rate of HIV is similar to the provincial. 
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- There are areas of hot beds for HIV. 
- Progress made in terms of TB program. 
- Rate of being infected with TB is low if you are born in Canada. Except among high risk groups, e.g. homeless 
or incarcerated in a correctional facility or immigrant from endemic countries. 
- The northern areas have a high rate of new and persistent TB. Some have periodic outbreaks. 
- The northern Saskatchewan with a population of 36,000 has 50% of TB cases in Saskatchewan. This is similar 
to HIV rates. 
- Now started to see high rates of TB/HIV co-infection, but not everywhere. This is a potential significant threat 
in our context. 
01/2 - Interface between host and environment. 
- TB is deprivation, poor housing, and poverty. 
- 70%-80% of HIV in Saskatchewan caused by IDU. 
- There is an interface between HIV and drug an addiction 
- Many addicts have a history of trauma, abuse, neglect, and sexual abuse, physical and emotional abuse. 
- Chaos in their daily lives. No housing, income support, and are involved with criminal activities to get money. 
Some in sex trade. 
- Need to stabilize the individual first before medication. 
05/1  
07/1 - Fear to disclose HIV so that they are not labelled as IDU. 
- Homelessness and poverty 
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PHASE 4 of PRECEDE model 
Predisposing factors 
Enabling factors 
Reinforcing factors 
 
Participants Predisposing factors. 
(Values, Perception, knowledge, 
attitudes) 
Enabling factors. 
(Manpower availability, 
availability of resources, 
accessibility) 
Reinforcing factors. 
(Attitudes of peers, health 
personnel and community 
members) 
06/1  Issue of confidentiality and 
stigmatization. 
- Saskatchewan run different TB 
and HIV program 
No support, stigmatization concern. 
04/1 Made bad choices in life. 
- We go through struggles in life 
 - Like coming to P.A health 
facility. It is like a close knit 
family. 
- Nothing here in PA. People live 
on drugs and alcohol and trying 
hard to get out of them. 
04/2  Moved to Little Red (45 min. 
drive to PA) from Sturgeon Lake 
Familiar with health workers. 
- I only tell those I associate with of 
HIV status. 
- They are comfortable with me, no 
bad feelings 
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04/3 Some HIV positive patient tells 
others, they do not have the 
disease. 
- Grateful baby does not have it.  
 - Rude and judgmental health 
workers. 
- Some wear gloves even when 
taking the pulse. 
- Some people behave badly to you. 
- Needle haring and unprotected 
sex. 
04/4   Some are helpful, some stay away 
from you. 
08/1 - Knowledge is improving. Some 
people still call it dirty disease 
- No formal appointment people 
just walk in. 
- Multiple sources of funding; 
Ministry of health, Saskatoon 
health region. 
- Always high demand for 
additional manpower. Especially 
in mental and addiction services. 
- Referrals from case managers, 
Positive living program (U of S), 
Avenue A community center, 
Nursing staff in hospitals. 
- Patient are referred to Westside 
clinic, 2nd Avenue clinic, 
Willowgrove, Idylwide 
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01/1 In some reserve HIV is 
criminalized and vilified. 
- Smooth delivery of treatment in 
reserves depends on leadership 
and health care staff who are non-
judgmental. 
- TB conduct clinic off site. 
- Had to look for funds to go to 
PA 
Worry about confidentiality and 
anonymity in reserves. 
- This varies from place to place. 
- It depends on nonjudgmental chief 
and popular health staff. 
- In some reserve HIV is 
criminalized and vilified. 
- DOT is good if identification of 
patients and stigma can be 
controlled. 
02/1 - A big concern in the general 
population 
- HIV education has come a long 
way. 
- Some patients in the North are 
transferred to Saskatoon. 
- Coordination between TB and 
HIV programs for patients with 
both infections. For medication, 
Blood work, and skin testing 
- Some TB drugs are not 
compatible with HIV drugs. 
- There are mobile clinics for TB. 
Scheduling time and frequency of 
operation may be a challenge. 
- No resources to see all the 
people that need to be seen. 
- Education to create awareness. 
- A patient preferred to tell people 
that she had HIV, but in actual fact 
had TB. Thought should be the 
other way round. 
02/2 You never know when you are 
going to see them. Always in and 
out. 
Most IDU are First Nations. 
Appointments are not easy to fix. 
Once you have a client you try not 
to let them stray from you. This is 
the mindset. 
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Do mainly phone referrals, this 
takes 75% of the time. 
- Some lost in the mix in the 
process of getting appointment, 
treatment and getting medication. 
- Funding through the Parkland 
Health Region. 
- Inadequate staff. Recent case 
audit shows 200 clients who are 
HIV positive 
- We take them to TB control 
ourselves when they have a positive 
skin test. 
- Explain procedures and referrals. 
- They live in close community, 
close homes and a lot of IV drug 
use. 
- First Nations community has high 
rates of IV drug use and limited 
access to needle exchange program 
so they end up sharing needles. 
- Men who had sex with men is on 
the rise in PA. 
- The population is very transient. If 
you place a skin test you will not 
know where they are in a couple of 
days. 
02/3  Have stationary and mobile 
clinics. Also have telehealth 
service 
 
09/1 - People in Saskatchewan do not 
know the statistics about HIV and 
TB co-infection rates. 
- Under education about what is 
happening in the society. 
Access to medication is central in 
Saskatoon. This is restrictive. 
Patients have to travel to get 
medication. 
- 2 pharmacists. Saskatoon takes 
care of Northern SK. Regina the 
South. 
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- We tell them about co - infection 
rates and it is increasing. 
- Approved prescription can be 
filled anywhere. 
- PA is different, no pharmacist 
attached. Consultation is through 
ID physician. 
- Pharmacy: patient ratio poor in 
Saskatoon 
02/4 - Multifactorial, partly due to 
patients, their disruptive life. Also 
the appointment system where 
they are told to come back later to 
read the skin result. 
RUH is hard to get to. It is hard to 
get patient to read result of test. 
- There is funding to recruit 
physicians. PLP has its own 
funding from provincial health. 
- HIV strategy funds have first 
time funds for 3 years. 
- Lots of Funding for HIV, but is 
mainly temporary. (SW for 3 
years)  
- Need for staff training and 
additional funds for TB/HIV co-
infection. 
- Struggling to recruit ID doctors. 
Long waiting list of newly 
diagnosed cases. Sometimes wait 
for 1 year. 
- TB funding is different from 
HIV funding for northern support. 
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- Transportation cost is huge. 
07/1 - Initially it was getting drugs for 
HIV, now it is convincing patients 
to take the drugs. 
- A lot of people do not think it is 
a problem. Because it affect 
mainly the IDU (the forgotten 
people). 
- Lot of misconception about how 
it is transmitted. 
- Some people feel it is a gay 
disease. 
- People have the opinion it is a 
death sentence 
  
07/2 - Most clients already have 
challenging life issues and having 
TB or HIV is part of scrappy 
things they encounter. 
- They know doing IDU is illegal, 
this push them underground. They 
are not ready to talk about this. 
- Prevention requires people to 
admit they are doing something 
illegal. 
- Overcoming this hurdle has 
helped in harm reduction. 
- Office open for limited hours of 
the day. People need 24hrs 
service. 
- Main challenge is not able to 
provide housing services. 
- 2/3 of funding from Public 
health agency of Canada (Federal 
government). Rest from 
provincial funding and donations 
and fundraising. 
- Rely mostly on volunteers and 
are used mainly for fundraising 
and administrative duties like 
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- Service providers should initiate 
talk about discrimination and 
stigmatization. 
writing newsletters Most are not 
comfortable with interacting 
some of the clients e.g. 
Alcoholics. Also rely on students 
doing practicum. 
03/1  In primary care perspective, there 
is no resident specialized HIV 
services. We rely on visiting 
infectious   disease specialist or 
Internal medicine specialist, who 
conduct clinics in LaLouche and 
LaRonge locations. 
- Access difficult for those living 
outside these communities, they 
may need to travel to the big 
centers in Saskatoon or Prince 
Albert  
- Some clients do not have 
coverage for travel expenses, 
which is another challenge. 
- TB has an established 
centralized program in TB 
Saskatoon Health region, with 
services delivered through 
partners; these are Northern 
health service, Public health 
department in health regions, 
Primary health care, First Nation 
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partners and the Ministry of 
health. 
- TB program is long established 
and have relationship with the 
communities through mobile and 
regular clinics. With HIV 
services, establishment of 
program depends on the 
community. 
- People do not want to access 
services close to home. May be 
familiar with service providers. 
- The community is key to 
planning and service delivery. 
01/2  - What we have is case 
management. Outreach staff goes 
to the homes of patients.  
- Not co-management 
- TB and HIV is a complex issue 
which is multifactorial. 
- Should be more efficient in 
resource allocation. 
- High intensity coordinated care 
is needed in the initial  
- Stage for stabilization. 
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- It is a mental health issue. 
Stabilization is hard to achieve 
and complicated. 
- Care should be integrated into 
the Primary Health Care Model. 
- They need to graduate out of 
Social determinants/factors. The 
most important is affordable 
housing. 
- A form of Environmental 
management. 
- Co-management requires cross 
training. Somebody doing 
infectious disease should be 
trained in addiction. 
- Interdisciplinary Teamwork 
required. 
- Tribal council work with people 
they already align or have rapport 
with. 
05/1  The resources that go into 
communicable diseases should be 
combine under one group. 
- HIV and Hep C is under 
Communicable disease control in 
Regina. Completely separated 
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from TB control which is based in 
Saskatoon. 
- It is good to pool resources 
together since TB and HIV affect 
the same population, in terms of 
staff. 
- Usually need staff because they 
provide a wide range of services. 
- There is need for Medical Lab 
tech. A lot of them will be retiring 
in 5 to 10 years.  
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PHASE 5 of PRECEDE model 
Administrative and Policy assessment 
                                                              Type of collaboration 
                                                               Met and Unmet needs 
         TB/HIV medication 
Participant Type of collaboration Met and Unmet needs TB/HIV medication 
06/1 Partial integration and 
collaboration is good. 
- One clinic for both will not 
be successful. 
- Full integration difficult to 
achieve. 
- Support partial integration of 
services with a focus on human 
behavioral issues and 
environmental interaction. 
  
04/1  - It is good to have a health 
worker check on us once a 
while. 
- There are days that symptoms 
get worse. We may encounter 
lack of attention or 
discrimination in walk-in 
clinic. 
Got use to going for 
medication every week 
because she was on 
methadone. 
- Now on bi-weekly because 
she is not on methadone. 
- Common law died with full 
blown AIDS. 
- The medication makes me 
nauseous. 
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- Go around the communities 
telling her story and 
encouraging patients to take 
medication. 
- It is a struggle going through 
the pills. 
- Cannot eat and get stiff in the 
stomach 
04/2  Transportation is a problem. - Initially getting medications 
every month. I don’t have to 
come to town every month 
- They will not give you for 
more than 7 days 
- Hard to get pills every week. 
- Go one or two days without 
taking pills 
04/3 -Having the services together 
is handy. 
- DOT is good, sometimes 
people are too sick to get up 
 Started taking medication 
when she became pregnant. 
Stop medication before 
pregnancy. 
- Taking HIV medication 
makes her nauseous. 
- Seeking for marijuana license 
because it helps. 
- The common law also takes 
medication 
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04/4  - Is get medication from 
methadone clinic 
It is always good to get the 
medication in Methadone 
clinic. 
- Medications made me sick 
and I quit taking them for 4 
years.  
01/1 - I do not make rules for TB 
program, they’re very much on 
their own. 
- No provincial structure for 
HIV that is comparable to TB. 
- The referral system has 
worked very well  
- Worthwhile if DOT can be 
incorporated into HIV 
- Not good at detecting latent 
TB infection. 
- No provincial TB/HIV co-
infection program. 
- Good that TB clinic is 
conducted off site 
- TB and HIV drugs cause 
reconstitution inflammatory 
syndrome 
02/2 Entry point (new diagnosis), 
positive HIV, if the skin test is 
positive for TB, the TB team 
will do a physical examination 
and decide care plan. 
- If already on HIV medication 
and positive for TB, the TB 
control worked round HIV 
medication. So we all keep 
connected. 
- Nine months TB medication 
by DOT should be given in 
- Always short of staff. Rotate 
available staff to work with ID 
physician, Lab, and skin 
testing. 
- Referral cannot be tracked to 
know if appointments were 
honored. 
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conjunction with HIV 
medications. 
- do referral, TB clinic about 7 
blocks way. 
02/3 - Prefer TB and HV patients to 
be seen in one clinic.  
- Less appointment are 
required. 
- Easier on patients 
- Transportation is an issue. 
Difficult to contact patients by 
phone. Numbers may have 
changed or no reception in the 
area 
 
09/1 - Pharmacist can give both TB 
and HIV together instead of in 
isolation. 
- It is easier to test for HIV on 
the TB side. 
- We cannot get patients to 
come for reading after Skin 
test. 
- Getting medication is a 
challenge it depends on where 
they live. TB drugs are 
dispensed to TB crew. 
- HIV drugs are access through 
regular pharmacy. 
- Stocking of drugs is a 
challenge, especially in rural 
areas.  
- Patients move back and forth 
through the province and the 
correctional centers (provincial 
or federal). No continuity on 
release from prison. 
- Loss opportunity to educate 
patients. 
- Medication prone to side 
effects and easily convert to 
resistance. 
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- First six months of the 
administration of medication is 
critical to establish a routine on  
- Health workers in some of 
the communities are well 
known to patients. 
02/4 - Like Co-infection infection 
program because of synergy 
and similar health 
determinants. 
- Program should include TB, 
HIV and Hep C. 
- There is some form of 
collaboration at the moment. 
TB & PL are under the same 
director. There is TB/HIV 
working group where 
information is shared and 
standard tests discussed. 
- Collaborative program will 
need rework, staff training, 
resources and manpower. 
- Lots of problems getting the 
patient to come back to read 
Mantoux test. 
- Appointments are difficult 
arranged with patients. This 
may be due to patient’s 
disruptive life. May be 
structural when patients are 
expected to come back after 3 
days for reading. 
- Staff need training in TB 
management. 
- HIV/TB co-infection 
program will need rework of 
staff training and funds. 
- Lots of funding, but 
temporary. 
- Lots of turnover in the 
position of HIV coordinator. 
- Delivery of HIV medication 
through DOT is worth trying. 
A dual DOT 
- The disadvantage is TB drugs 
are taken for a limited time. 
HIV medication taken for life. 
- Challenges on timing of 
taking medication. 
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- Vigorously promoting HIV 
testing. The goal is to increase 
testing by 50%. 
- Street gangs working hard to 
promote testing among IDU’s 
07/1 - There has been discussion 
about location in one primary 
care, but stigmatization is 
huge. 
- Single entry process, but 2 
sites, clinics for +HIV. These 
sites are RUH and West side 
community clinic. Patients are 
referred by Family doctors. 
- We ran across patients who 
have tried alternative medicine 
(Aboriginal medicine) and 
prayers. 
- A lot of success with DOT 
when it comes to methadone. 
But not everybody is on 
methadone. 
- Gap is social 
 
08/1 - Nice to have some sort of 
collaboration. 
- Referral better. That is what 
work for us and the nurses. We 
get referral by phone 
  
02/1 - We had a discussion about 
TB/HIV joint service. 
- Need for more research. 
- It is complex. TB short 
treatment plan, whereas HIV is 
lifetime. 
- Challenges with DOT 
providers at provincial level. 
Unique structure in the 
reserves versus RHA. 
- TB workers in reserves are 
hired by Health Canada. The 
nurse in the community 
delegates delivery of 
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- Same social determinant. 
- Joint staff training on TB 
/HIV is important. 
- Logistical difficulty to have 
the 2 program in one place. In 
terms of staffing, training, 
physicians. But it can be done. 
- We are diligent with TB 
medication, but HIV is self-
administered. 
- Key piece to have someone 
oversee the delivery of both 
medication,e.g. a community 
health worker. 
- In the process of developing 
a document on the role and 
responsibility of DOT 
providers. 
medication to patients. No 
supervisory or accountability 
role on TB workers. 
07/2 - The ideal is to have people 
work together. 
- Funding model does not 
support collaborative service. 
- Competition for funding 
created animosity amongst 
health providers 
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01/2 - I think the best model is that 
of the West Side community 
clinic. 
- Family physician treats 
patient for addiction. Has an 
infectious disease specialist. 
Health region provides 
addiction counselor.  
- Population approach, harm 
reduction and addiction 
medicine as outreach 
strategies. So that they can be 
brought into detox, 
rehabilitation and other 
services. 
- The 2 diseases are 
complicated and in a 
challenging clinical scenarios. 
- In order not to lose synergy 
these diseases cannot be 
treated in silos. 
- The program should bring 
key players together in order to 
provide comprehensive, 
coordinated, wraparound, 
Efficient, respectful, and cost 
effective services. 
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- Disease of entry into service 
does not matter. 
- Mental health and addiction 
should be integrated. 
- Opportunity to look at 
collaboration between 
addiction and other specialties 
like infectious diseases 
03/1 - TB/HIV collaborative service 
makes sense and should be 
patient centered. 
- TB/HIV collaborative 
services are on the radar for 
implementation. 
- Service delivery in Northern 
Saskatchewan is complex. 
- We have managed to avoid 
multi drug resistant TB. There 
are efforts to see that TB is 
brought under control 
- Expansion of services 
depends heavily on the 
specialists. Transportation to 
Northern Saskatchewan needs 
to be addressed. 
 
05/1 - Need for strong and clear 
policy on diagnosis,  treatment 
and prevention (looking at the 
social determinants, e.g. 
lifestyle, housing etc) 
  
 
194 
 
 
APPENDIX E 
Community based organizations in Saskatchewan. 
• Athabasca Health Authority, Mamaweetan Churchill River & Keewatin Yatthe 
➢ Scattered Sites/601 La Ronge (AIDS Saskatoon) 
• Prairie North Health Region 
➢ Battlefords Family Health Centre (Aboriginal Primary Health Centre) 
➢ Meadow Lake Alliance Church 
➢ Lloydminster Native Friendship Centre 
➢ Meadow Lake Outreach Ministries 
• Prince Albert Parkland Regional Health Authority 
o PA Metis Women’s Association 
o Family Futures 
o 601 Prince Albert (AIDS Saskatoon) 
• Regina Qu’Appelle 
➢ All Nation’s Hope AIDS Network 
➢ AIDS Programs South Saskatchewan - Circle of Courage 
➢ Carmicheal Outreach 
➢ Planned Parenthood Regina 
➢ Street Workers Advocacy Program (SWAP) 
• Saskatoon Health Region 
➢ AIDS Saskatoon 
➢ Out Saskatoon (formerly Avenue Community Centre for Gender & Sexual Diversity) 
➢ Person's Living With AIDS Network of Saskatchewan 
➢ Saskatoon Indian Metis Friendship Centre 
• Sunrise Health Region, 601 Yorkton (AIDS Saskatoon) 
  
195 
 
APPENDIX F 
 TB/HIV Indicators Measured in HIV Care Setting 
Indicator A1 Percentage of adults and children enrolled in HIV care who began 
TB treatment. 
Indicator A2 Percentage of adults and children enrolled in HIV care who 
underwent TB screening. 
Indicator A3 Percentage of HIV-positive TB patients who are on CPT during 
anti-TB treatment. 
Indicator A4 Percentage of HIV-positive patients who start or continue taking 
ART during anti-TB treatment. 
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APPENDIX G 
World Health Organization Permission 
• permissions@who.int 
To:abayomi.olaniyi@yahoo.ca 
Cc:permissions@who.int 
13-Sep-2017 at 8:20 PM 
Dear Dr Olaniyi 
 
Thank you for your request for permission to reproduce, reprint or translate certain WHO 
copyrighted material. 
 
On behalf of the World Health Organization, we are pleased to authorize your request to 
reproduce the WHO materials as detailed in the form below, subject to the terms and conditions 
of the non-exclusive licence below. 
 
If you have questions regarding this authorization, please contact permissions@who.int. 
 
We thank you for your interest in WHO published materials. 
 
Kind regards, 
WHO Permissions team 
 
 
WORLD HEALTH ORGANIZATION (WHO) 
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Non-exclusive licence to use selected WHO published materials 
 
You submitted a request, through WHO’s online platform, for permission to reprint and reproduce 
certain WHO copyrighted material (the "Licensed Materials"). This is a legal agreement (the 
"Agreement") between you and WHO, granting you a licence to use the Licensed Materials 
subject to the terms and conditions herein.  
Read this Agreement in its entirety before using the Licensed Materials. 
 
 
By using the Licensed Materials, you enter into, and agree to be bound by, this 
Agreement. 
 
This licence is granted only for original materials belonging to WHO. If any part of the 
WHO published materials you wish to reproduce are credited by WHO to a source other 
than WHO, those materials are not covered by this Agreement and are not part of the 
Licensed Materials. You are responsible for determining if this is the case, and if so, you 
are responsible for obtaining any necessary permission from the source of those third-
party materials prior to their use. 
 
If you enter into this Agreement on behalf of an organization, by using the Licensed Materials you 
confirm (represent and warrant) that you are authorized by your organization to enter into this 
Agreement on the organization’s behalf. In such a case, the terms "you" and "your" in this 
Agreement refer to, and this Agreement applies to, the organization. 
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WHO grants this licence to you based on the representations and warranties you made in 
the licence request you submitted through WHO’s online platform. If any of those 
representations and/or warranties are or become false or inaccurate, this licence 
agreement shall automatically terminate with immediate effect, without prejudice to any 
other remedies which WHO may have. 
 
If you have questions regarding this Agreement, please contact permissions@who.int. 
 
1. Licence. Subject to the terms and Conditions of this Agreement, WHO grants to you a 
worldwide, royalty free, non-transferable, non-sublicensable, non-exclusive licence to use, 
reproduce, publish, and display the Licensed Materials in the manner and using the media 
indicated in the Permissions Request Form you submitted to WHO (the "Licensed Use"). This 
licence is limited to the current edition of your publication. Future editions or a different use of the 
Licensed Materials will require additional permission from WHO. If your request includes 
translation into different languages, then non-exclusive permission is hereby granted to translate 
the Licensed Materials into the languages indicated. 
 
2. Retained Rights. Copyright in the Licensed Materials remains vested in WHO, and WHO 
retains all rights not specifically granted under this Agreement.  
 
3. Mandatory Acknowledgement. In every instance of the Licensed Use, you must make suitable 
acknowledgement of WHO, either as a footnote or in a reference list at the end of your 
publication, as follows: 
"Reprinted from Publication title, Vol /edition number, Author(s), Title of article / title of 
chapter, Pages No., Copyright (Year)." 
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In addition, If the Licensed Materials originate from the WHO web site, you must also include the 
URL reference and the date accessed. 
 
Translations of the Licensed Materials should be attributed as follows:  
"Translated with permission of the publisher from Publication title, Vol /edition number, 
Author(s), Title of article / title of chapter, Pages No., Year." 
 
 
4. Altering or Modifying the Licensed Materials. As part of the Licensed Use, you may minimally 
alter or adapt figures and tables in the Licensed Materials to match the style of your publication. 
Any other alteration or modification of the Licensed Materials (including abbreviations, additions, 
or deletions) may be made only with the prior written authorization of WHO.  
 
5. Appropriate and Prohibited Uses. You must use the Licensed Materials in a factual and 
appropriate context. You may not use the Licensed Materials in association with any product 
marketing, promotional, or commercial activities, including, without limitation, in advertisements, 
product brochures, company-sponsored web sites, annual reports, or other non-educational 
publications or distributions. 
 
6. No WHO endorsement. You shall not state or imply that WHO endorses or is affiliated with 
your publication or the Licensed Use, or that WHO endorses any entity, organization, company, 
or product.  
 
7. No use of the WHO logo. In no case shall you use the WHO name or emblem, or any 
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abbreviation thereof. Notwithstanding the foregoing, if the WHO name and/or emblem appear as 
an integral part of the Licensed Materials (e.g. on a map) you may use the name and/or emblem 
in your use of the License Materials, provided the name and/or logo is not used separately from 
the Licensed Materials.  
 
8. No Warranties by WHO. All reasonable precautions have been taken by WHO to verify the 
information contained in the Licensed Materials. However, WHO provides the Licensed Materials 
to you without warranty of any kind, either expressed or implied, and you are entirely responsible 
for your use of the Licensed Materials. In no event shall WHO be liable for damages arising from 
your use of the Licensed Materials.  
 
9. Your Indemnification of WHO. You agree to indemnify WHO for, and hold WHO harmless 
against, any claim for damages, losses, and/or any costs, including attorneys' fees, arising in any 
manner whatsoever from your use of the Licensed Materials or for your breach of any of the 
terms of this Agreement. 
 
10. Termination. The licence and the rights granted under this Agreement shall terminate 
automatically upon any breach by you of the terms of this Agreement. Further, WHO may 
terminate this licence at any time with immediate effect for any reason by written notice to you.  
 
11. Entire Agreement, Amendment. This Agreement is the entire agreement between you and 
WHO with respect to its subject matter. WHO is not bound by any additional terms that may 
appear in any communication from you. This Agreement may only be amended by mutual written 
agreement of you and WHO.  
 
12. Headings. Paragraph headings in this Agreement are for reference only.  
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13. Dispute resolution. Any dispute relating to the interpretation or application of this Agreement 
shall, unless amicably settled, be subject to conciliation. In the event of failure of the latter, the 
dispute shall be settled by arbitration. The arbitration shall be conducted in accordance with the 
modalities to be agreed upon by the parties or, in the absence of agreement, with the rules of 
arbitration of the International Chamber of Commerce. The parties shall accept the arbitral award 
as final. 
 
14. Privileges and immunities. Nothing in or relating to this Agreement shall be deemed a waiver 
of any of the privileges and immunities enjoyed by WHO under national or international law 
and/or as submitting WHO to any national court jurisdiction. 
*** 
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APPENDIX H 
McGraw Hill permission
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